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INTRODUCTION 
Mouse Major Histocompatibility Complex 
The Major Histocompatibility Complex (MHC) of the mouse, 
the H-2 complex, was first discovered by Peter Qorer in 1936. 
Gorer, using rabbit ant1-mouse serum, demonstrated that an 
antigen present on strain A erythrocytes was absent from the 
erythrocytes of strain C57BL (Gorer, 1936a,b). Subsequent 
studies by Gorer showed that this antigen, designated 
antigen-II by Gorer, was under the control of an autosomal 
dominantly expressed locus and that incompatibilities for 
antigen-II resulted in tissue graft rejection in mice (Gorer, 
1937; 1938). Gorer along with George Snell later showed that 
the locus controlling antigen-II resided on linkage group IX, 
later identified as chromosome 17 (Gorer et al., 1948). 
Since this locus controlled a transplantation antigen, it was 
referred to as the histocompatabi11ty-2 or H-2 locus. It is 
now known that the H-2 locus is really a set of closely 
linked genes which encode proteins that are found on the 
surface of cells and are involved in the immune response. 
The H-2 locus is now referred to as the H-2 complex. 
The H-2 complex, shown in Figure 1, is located at the 
centrometric end of chromosome 17 and spans about 2 
cent1morgans (cM), corresponding to approximately 4000 
kilobase pairs (kb) of DNA (Steinmetz and Hood, 1984). There 
The Mouse Major Histocompatibility Complex 
Chromosome 17 
Region Qa Tia 
No. of 
Genes 
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Figure 1. The genetic map of the mouse Major Histocompatibility Complex, or 
H-2 complex. The known protein products of each region are shown. 
The number of genes present in each region, which varies accord­
ing to the strain of mouse, is also shown. This figure is based 
on Klein (1986), Klein and Figueroa (1986), Stephen et al. 
(1986), and Muller et al. (1987) 
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are three classes of protein encoded by the H-2 complex 
designated class I, class II, and class III (Hood et al., 
1983; Steinmetz and Hood, 1984; Klein, 1986; Flavell et al., 
1986). Class I proteins include the classical 
transplantation antigens, encoded by the K and D regions, and 
the hematopoietic differentiation antigens, encoded by the Qa 
and Tla regions. Class II proteins, encoded by the I region, 
are known as the la or immune response-associated antigens. 
Class I and II proteins are involved in cell mediated and 
humoral immune responses. Class III proteins, encoded by the 
S region, include a subset of serum proteins (C4, Bf, C2, 
Sip) involved in the complement system, 21-hydroxylase (21-
OH), and tumor necrosis factor (TNF). 
The collection of all MHC genes on a single chromosome, 
or the collection of alleles on one chromosome in a mouse 
strain, is referred to as the haplotype. Therefore, a mouse 
strain that has the H-2'» haplotype is a strain that carries 
the b allele at all MHC loci. 
Organization of class I genes 
Class I genes are found in the K, D, Qa, and Tla regions 
of the H-2 complex. The organization of class I genes in the 
BALB/c (H-2d ) and C57BL/10 (H-2'> ) or BIO, mouse strains is 
known in detail and is shown in Figure 2. The current view 
of the class II and III gene organization is also shown. The 
Region r 
Qa TIa 
H Z-'-HW T TO Tj IMRr , "l,W'' mm, 
K2 K" *f3 Apipta 3I.OHA Bl TNF0 03Û4 oàoÏQb 6tP ft 16 IB TUmmTU TIa Ho-U 
K) Kb A03 AgEgEor 21-OHA Bl TN^  0*» Q2 Q506 09 n K6 T10 112 
Figure 2. Organization of class I genes in the H-Z" (BALB/c) haplotype and 
H-2i> (C57BL/10 or BIO) haplotype. The positions of the genes 
shown is relative and does not represent actual kilobase pair 
distances. The figure is adapted from Weiss et al. (1984), 
FI aven et al. (1985), Klein (1986), Klein and Figueroa (1986), 
Stephan et al. 0986), and MQIIer et al. (1987). Abbreviations 
used in this figure are defined in the text 
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number of class I genes of the H-2<' haplotype has yet to be 
agreed upon. Stelnmetz et al. (1982) originally reported 36 
class I genes. This was later revised to 36 (Winoto et a1., 
1983) and then to 31 (Steinmetz and Hood, 1984). Other 
investigators have reported 31-33 class I genes in the H-2C 
haplotype (Klein, 1986; Klein and Figueroa, 1986). Twenty-
six class I genes have been reported for the H-2^ haplotype 
(Weiss et al., 1984). The class I genes of the H-2<' (BALB/c) 
and the H-2b (BIO) haplotypes can be aligned by comparison of 
the restriction maps of the various clusters (Weiss et al., 
1984; Klein, 1986; Klein and Figueroa, 1986; Stephan et al., 
1986; MOI1er et al., 1987), as shown in Figure 2. This 
comparison has revealed that there are BALB/c genes 
equivalent to nearly all of the 26 BIO genes. However, there 
are 12 BALB/c genes that do not have counterparts in the B10 
genome (Mellor, 1986), most of which are located in the Tla 
region. Overall, most of the class I genes in both the 
BALB/c and C57BL/10 map to the Qa and Tla regions (Winoto et 
al., 1983; Weiss et al., 1984). 
In the K region, the two K genes (K1 and K" or K** ) are 
in about the same position in the H-a" and H-2d haplotypes, 
occupying about 40 kb. In the D region, the position of the 
D" gene is occupied by the L** gene in the H-2<* haplotype and 
there are at least four other genes in the H-2«' haplotype 
that are absent in the H-2** haplotype (01, 02, 03 and 04). 
6 
The D<* gene Is active while genes 01-04 are inactive. 
The Qa genes (designated as Q by Weiss et al., 1984) 
align well in the two haplotypes. There are only two 
differences between them: (1) the Q3 gene Is missing in the 
H-2*' haplotype; and (2) the Q8 and Q9 genes of the 14-2** 
haplotype are fused into a single gene, 08/9, in the H-2C 
haplotype. The Q7 gene in the BIO mouse is the allele of the 
27.1 gene in the BALB/c mouse (Steinmetz et a1., 1981), which 
is now referred to as 07^. 
In the BIO Qa region, individual genes can be arranged 
into groups (Q5-Q7-Q9 and Q6-Q8-Q10) in which members of the 
group are very similar (>99% ONA sequence homology) (Weiss et 
al., 1984; Devi in et al., 1985). Even numbered genes are 
also very similar to odd numbered genes, for example Q7 is 
96% homologous with Q8 at the ONA level (Klein, 1986). The 
similarity of even and odd numbered genes (Q4/Q5, Q6/Q7, 
Q8/Q9) suggests that that genes Q4-Q9 arose from a series of 
gene duplications of an ancestral pair of class I genes in 
the Qa region (Weiss et al., 1984). 
The similarity of the K region genes to the Qa region 
genes (K gene to Q6/Q8 and K1 to Q7/Q9) suggests that the K 
region was generated by duplication or translocation of a 
similar pair of ancestral genes from the Qa region to the 
present location of the K region (Weiss et al., 1984). This 
is supported by large number of serological cross-
7 
reactivities between Qa and K region molecules and few cross-
reactivities between Qa and D (Cook et al., 1983; Figueroa et 
al., 1983; Sharrow et al., 1984). 
The Qa/Tla region genes in rodents appear to be the 
least conserved in evolution when compared to other class I 
genes (Rogers, 1985). This is apparent when one compares the 
Tia region of the BIO and BALB/c mice, where the greatest 
number of differences exist. By restriction mapping, T1-T10 
genes in both haplotypes are closely related except that the 
H-2^ hap Tot y pe is missing the T4 gene found in the H-2«» 
haplotype. No counterparts of the T11-T18 genes in the H-Z** 
haplotype are found in the H-Z" haplotype. The location of 
the T11-T18 cluster of genes is not known but is thought to 
be located at the telomeric end of the H-2 complex (Klein, 
1986). The T11-T18 genes of the H-Z" haplotype are 
homologous (by restriction map analysis) to the T1-T6 genes 
of both the H-2C and H-2^ haplotypes, suggesting that part of 
the Tia region in the BALB/c mouse has been duplicated 
(Fisher et al., 1985; Devlin et al., 1985). 
The gene organization of other haplotypes has not been 
as extensively studied as the H-2<' and H-20 haplotypes, 
although a little is known about the H-2'< (AKR strain) 
haplotype. Stephen et al. (1986) found that the AKR strain 
possesses only one D region gene and that the Q1 gene 
corresponds to the Q1 gene in the BIO and BALB/c strains. In 
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this way the AKR Is quite similar to the BIO strain in that 
both have only one D region gene, while the BALB/c has five D 
region genes. Stephan et al. (1986) suggested that the BIO 
and AKR reflect the older 0 region gene organization (only 
one gene) and that the five D region genes of the BALB/c 
arose from unequal crossing over. The AKR has also been 
found to possess the Q4, Q5, and Q10 genes, which correspond 
the Q4, Q5, and Q10 genes of both the BALB/c and C57BL/10 
strains (Weiss, 1987). 
Structure and function of class I transplantation antigens 
The class I transplantation antigens, K, D, and L, are 
integral cell surface glycoproteins composed of two 
polypeptide chains and are found on virtually all nucleated 
cells. The heavy chain of the class I molecule has a 
molecular weight of 45,000 daltons and is encoded by genes of 
the H-2 complex. The 12,000 dalton light chain, 02-
microglobulIn, is encoded by a gene located on chromosome 2 
of the mouse. The heavy chain has been divided into five 
protein domains (Coligan et al., 1981) and is about 350 amino 
acids long (Klein, 1986). The a1, a2, and a3 domains are 
each about 90 amino acids long (Malissen et al., 1982) and 
constitute the extracellular part of the class I molecule. 
The portion of the class I molecule that spans the cell 
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membrane, the transmembrane (TM) piece, is about 40 amino 
acids long. The intracellular portion (CYT) of the class I 
molecule is about 30 amino acids long. The 02-microglobulin 
(Bam) protein is non-covalently associated with the a3 domain 
of the heavy chain (Yokoyama and Nathenson, 1983). 
The three dimensional structure of a human class I 
molecule has recently been solved by Bjorkman et al. (1987a) 
and is shown in Figure 3A. The a1 and a2 domains, known to 
be the most polymorphic in the class I molecule (Klein, 
1986), sit atop the Oz-microglobulin protein and the a3 
domain of the heavy chain. The a1 and a2 domains each 
consist of an antiparallei 3-pleated sheet, composed of four 
antiparallel 3-strands, spanned by long a-helical regions. 
The two a-helical regions combine with the 3-pleated sheet to 
form a deep grove approximately 25 A long and 10 A wide. The 
3-pleated sheet forms the bottom of the groove and the a-
helixes form the sides. The groove is located on the top 
surface of the molecule. 
The dimensions of the groove are consistent with the 
size of a processed antigen or small peptide 10-20 amino 
acids long. The most polymorphic amino acid regions in the 
a1 and a2 domains have been found to lie along the inside of 
the groove (Bjorkman et al., 1987b). Therefore, based on the 
location and the presence of polymorphic amino acid regions, 
this groove is most likely a binding site for the foreign 
Figure 3. Protein and gene structure of a class I 
protein. (A) Schematic representation of a 
human class I protein. The heavy chain con­
sists of the a1, a2, and a3 domains (the 
transmembrane and cytoplasmic domains were 
excised In the crystals). The light chain, 
32~m1croglobulIn Is associated non-covalently 
with the class I heavy chain. This figure Is 
from Bjorkman et al. (1987a). (B) The 
exon/intron organization of a typical class 
I gene and the Bz-microglobulin gene. The 
following abbreviations are used: L, leader 
sequence; TM, transmembrane; and 3'UT, 3' 
untranslated region 
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antigen that Is recognized by cytotoxic T lymphocytes. Many 
amino acids critical for cytotoxic T lymphocyte recognition 
of the class I molecule are located in the groove. Studies 
by Bjorkman et al. (1987b) support this hypothesis. 
The exon/intron organization of a typical class I gene 
and the Sa-microglobulin gene is shown in Figure 3B. All 
mouse class I transplantation genes that have been completely 
sequenced are comprised of eight exons, which correlate with 
the protein domains of the the class I molecule, and seven 
introns (for a listing of sequenced class I antigens see 
Smith et al., 1986; Klein, 1986; Maloy, 1987). The first 
exon encodes the leader sequence, while the second, third, 
and fourth encode the three external domains of the protein. 
The fifth exon encodes the transmembrane domain and the 
sixth, seventh, and eighth exons encode the cytoplasmic tail 
and the 3' untranslated region. 
The 02-microglobulin gene is encoded on chromosome 2 of 
the mouse (Coligan et al., 1981). Exon 1 encodes the leader 
sequence and exons 2 and 3 encode the 02-microglobulin 
molecule and a portion of the 3' untranslated region (Parnes 
and Seidman, 1982; Daniel et al., 1983). 
The class I transplantation antigens exhibit a high 
degree of polymorphism in mouse populations (Hood et al., 
1983). Fifty or more alleles exist for K and D class I genes 
in both wild and inbred populations of mice (Klein, 1979). 
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The overall homology of the class I polypeptides to each 
other Is between 76 and 94% (Hood et al., 1983). 
The K, D, and L class I antigens function as recognition 
elements In the cell-mediated Immune response. Cytotoxic T 
lymphocytes recognize these antigens In association with 
viral antigen on the infected cell's surface (Zinkernagel and 
Doherty, 1980). It is these antigens which are also 
responsible for tissue graft rejection. 
Structure and function of class I differentiation antigens 
and genes 
The class I differentiation antigens are encoded by 
genes of the Qa/TIa region. These antigens differ from the 
transplantation antigens in several ways. Unlike the K, D, 
and L class I antigens, the differentiation antigens are much 
more restricted in their tissue distribution. Qa antigens 
are limited in expression to hematopoietic stem cells and 
subsets of B and T lymphocytes (Kincade et al., 1980; Harris 
et al., 1984). Tla antigens are mainly limited to T 
lymphocytes and to certain T cell leukemias (Michaelson et 
al., 1986). The Qa/Tla antigens also differ from the 
transplantation antigens in that they have no known function, 
however, their limited tissue distribution suggests they play 
a role in differentiation. The K, D, and L class I antigens 
are recognized by cytotoxic T lymphocytes in an H-2-
14 
restricted manner, but Qa region differentiation antigens are 
recognized by H-2-unrestricted cytotoxic T lymphocytes 
(Forman et a1., 1982). Lastly, the Qa/TIa class I antigens 
are far less polymorphic than the K, D, and L class I 
antigens (Flaherty, 1981; Michaelson et al., 1982; Chen et 
al., 1987). 
The protein structure of Qa region proteins is similar 
to K and D region proteins, especially in the amino acid 
sequence of the extracellular domains. The only amino acid 
that is found in all Qa region proteins and in no K or D 
region proteins is the lysine at position 176. This one 
change results in a different glycosylation pattern for all 
Qa region proteins when compared to K and D region proteins. 
The exon-intron structure of the Qa region genes is 
similar to the gene structure of the class I transplantation 
antigens (eight exons/seven introns), and this is especially 
true of exons 2-4 (Maloy, 1987). Only the Q10 gene differs 
from this exon-intron arrangement, having only seven exons 
(Lew et al., 1986a; Chen et al., 1987). Qa region molecules 
can be distinguished from K, 0, and Tla region molecules 
because they terminate in the transmembrane region encoded by 
exon 5. This is caused by either a deletion that results in 
a frame shift or a premature stop codon in exon 5. The 
result of this chain termination is a protein that has a 
shortened transmembrane portion and no cytoplasmic portion. 
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The protein structure of Tla region proteins is also 
very similar to K and D region molecules. Although they 
retain the basic structure of most class I proteins, Tla 
proteins are different from K, D, and Qa region proteins in 
several ways. The amino acid homology in exons 2 and 3 
between Tla region proteins and K, D, and Qa region proteins 
is only 50-60%, while similarity within the Tla group is 
greater than 90% (Maloy, 1987). Regions of diversity in Tla 
region proteins occurs between residues 34 and 48, a region 
of high conservation in K, D, and Qa region proteins. 
Finally, Tla region proteins differ in their glycosylation 
patterns when compared to other class I proteins. 
The gene structure of the Tla region molecules consists 
of 6 exons (Chen et al., 1987). The entire cytoplasmic 
domain, encoded by exons 6, 7, and 8 in class I 
transplantation antigens, is encoded entirely by exon 6. 
Qa region proteins There are three Qa region class I 
differentiation antigens, Qa-2, Q10, and Qb-1. It was the 
discovery of the Qa-2 antigen (Flaherty, 1976) that first 
defined the Qa region of the H-2 complex. The Qa-2 antigen 
has been the most extensively studied of the Qa region 
proteins. 
The Qa-2 antigen has a molecular weight of 40,000 
daltons and is associated non-covalently with 32-
microglobulin (Michaelson et al., 1981). The heavy chain is 
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about 6000 dattons less than the heavy chain of the K, D, and 
L antigens. The lower molecular weight of the Qa-2 antigen 
Is due to the chain termination sequence In exon 6, resulting 
in a shorter polypeptide. Soloski et al. (1982) was able to 
place the Qa-2 antigen In the class I protein family by 
showing a strong homology between Qa-2 and other class I 
molecules by partial amino acid sequence analysis. The 
homology between Qa region genes and K and D region genes Is 
89% (Lew et al., 1986a). There are 2 alleles of the Qa-2 
antigen, Qa-2*, which denotes the presence of Qa-2 on adult 
cells and Qa-2'>, a null allele, which denotes the absence of 
Qa-2 on adult cells. 
Qa-2 antigen expression is thought to be controlled by 
the H-2D gene (Hogarth et al., 1982; Rucker et al., 1983). 
Expression of the Qa-2 antigen was found to be 8-10 times 
higher in H-2D'> strains than in H-2D<' or H-2DQ strains 
(Hogarth et al., 1982). An H-2«' mutant strain, B10.D2-H-
2d"i, showed higher amounts of Qa-2 expression than did the 
parental B10.D2 (H-2d) strain (Hogarth et al., 1983), again 
suggesting that control of Qa-2 expression lies in the D 
region genes. 
No structural genetic polymorphism has been detected on 
isoelectric-focusing gels for the Qa-2 antigen (Michaelson et 
al., 1982). These experiments, along with the gene 
organization (both BALB/c and C57BL/10 are similar in the Qa 
region), suggest that the Qa-2 antigen has a more conserved 
structure than K, D, or L antigens (Robinson, 1987a). There 
has been a report of heterogeneity of the Qa-2 expressed on 
cloned cytotoxic T lymphocytes (Sherman et al., 1984). It 
was found that in cloned cytotoxic T lymphocyte cell lines 
that the molecular weight and isoelectric focusing pattern 
varied for the Qa-2 antigen. Sherman et al. (1984) suggested 
that this heterogeneity of Qa-2 is a result of differential 
splicing of RNA transcripts in the different cytotoxic T 
lymphocyte clones. 
The Qa-2 antigen exists not only in the cell surface 
form, but also in a secreted form. Soloski et al. (1986) 
showed that in activated T lymphocytes approximately 70% of 
newly synthesized Qa-2 proteins are secreted as soluble 
molecules, with a molecular weight the same as cell surface 
Qa-2 (40,000 daltons). In addition, resting T lymphocytes 
expressed only membrane-bound cell surface Qa-2. Robinson 
(1987b), using pulse-chase experiments with activated T 
lymphocytes, suggested that Qa-2 is first expressed on the 
cell membrane and is then released as a soluble protein. 
The identity of the gene(s) in the Qa region that encode 
the Qa-2 antigen has been the subject of intense research. 
Flaherty et al. (1985) first demonstrated in BALB/cJ (Qa-2*) 
and BALB/cBy (Qa-2b) substrains that the BALB/cBy is missing 
a portion of DNA in the Qa region (a 3.7 kb Xba I DNA 
18 
fragment). A11 Qa-2* strains tested possess this 3.7 kb 
fragment, whereas all Qa-2'> strains tested are missing this 
fragment. Mellor et al. (1985) extended these studies and 
found that the segment of DNA that Is lost in the BALB/cBy 
strain Is probably the equivalent of the Q6 and Q7 genes in 
the C57BL/10 mouse. In addition, Mellor et al. (1985) found 
that antlsera against Qa-2 Immunopreclpltated polypeptides 
from cell lysates of Q6-Q9 (from BIO mouse) transfected L-
cells, but not from Q1-Q5 or 010 transfected L-ce11s. The 
ability of ant1-Qa-2 antlsera to immunopreclpltate proteins 
encoded by the 06*, 07*, 08*, and 09* genes was consistent 
with the similarity of the 06-09 genes, as determined by 
restriction map analysis (Weiss et al., 1984) and DNA 
sequence data (Devlin et al., 1985). These studies suggest 
that the 06-09 genes are Involved In Oa-2 expression. 
Studies of the H-2^ and H-2k haplotypes showed extensive 
deletions in their Oa regions, which gives rise to the Oa-2* 
genotype (O'Neill et al., 1986). The deletion In the H-2'< 
haplotype encompasses genes 06-09, while in the H-2^ 
haplotype the 01-09 genes are deleted. The deletion of 06-09 
was common in both haplotypes suggesting that these genes 
encode the Oa-2 antigen. O'Neill et al. (1986), based on 
Southern blot analyses of the H-2*, H-2', and H-2k 
haplotypes, suggested that 06 and/or 08 determine the Qa-2 
antigen. 
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Studies by Stroynowski et al. (1985) and Straus et a1. 
(1985) showed that a hybrid Q7*/Ld molecule (a1 and a2 
domains from 07*, and a3, TM, and CYT domains from ) was 
expressed on the cell surface of transfected mouse L cells. 
These studies suggest that 07" might encode the Qa-2 antigen 
in the BALB/c mouse. 
Waneck et al. (1987) showed that a chromosomal Q7*> gene 
and a Q7^ gene construct driven by the Moloney murine 
leukemia virus long terminal repeat can express Qa-2 in a 
tissue-specific manner on the surface of transfected R1.1 
thymoma cells. A Q7^ cDNA from a cytotoxic T cell clone 
expressed Qa-2 protein on the cell surface of mouse L cells, 
suggesting that the lack of expression on L cells of Qa 
region genes was due to an element in the 3' end of the gene 
that was affecting RNA processing (Waneck et al., 1987). 
More recently, Sherman et al. (1988) has shown that Qa-2 
antigen encoded by two Q?" genomic clones and by a Q?" cDNA 
construct in transfected R1.1 cells have the same molecular 
weight. Biochemical comparison of Qa-2 encoded by the Q7'> 
cDNA construct with Qa-2 expressed constitutively on C57BL/10 
spleen cells reveals that they have the same molecular 
weight, and identical chemical and enzymatic cleavage 
patterns (Sherman et al., 1988). These data provide strong 
evidence that the Qa-2 antigen expressed in the C57BL/10 
mouse is encoded by the Q7*> and/or the Q90 genes. Although 
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Q6 and/or Q8 are thought to encode the Qa-2 antigen based on 
Southern blot analyses by O'Neill et a1. (1986), the role of 
QgD and Q8^ in the expression of Qa-2 cannot be clarified 
until Q6/Q8 transfectants are available for analysis. 
The expression of Qa-2 on the cell surface and in a 
secreted form and the termination of the polypeptide in exon 
5 suggests that the Qa-2 is not an integral protein like the 
K, D, and L antigens, but is anchored to the cell membrane 
via a phospholipid anchor. Stroynowski et al. (1987) found 
that Q7* and Q7^ genes transfected into hepatoma cells 
expressed Qa-2 in a cell surface form and a secreted form. 
They further demonstrated that the Q7 product, Qa-2 antigen, 
is selectively released from hepatoma cells by 
phosphatidylinositol-specific phospholipase C (Ptd-Ins-PLC), 
an enzyme that specifically cleaves the phosphatidylinosital 
found in phospholipids. Waneck et al. (1988) showed that 
C57BL/10 spleen cells released Qa-2 antigen when treated with 
Ptd-Ins-PLC and that K and D antigens were not affected. 
This confirmed that the Qa-2 antigen is anchored to the cell 
membrane via a phospholipid tail, unlike K and 0 antigens, 
which are integral membrane proteins. Similar analysis of 
Q7b and Q9t> transfected R1.1 thymoma cells yielded the same 
results (Waneck et al., 1988). The significance of the 
phospholipid anchoring of the Qa-2 antigen may lie in 
explaining how the Qa-2 antigen is first expressed on the 
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cell surface and Is then enzymatlcal1y cleaved to become the 
secreted form. 
The Q10 protein is a secreted molecule that was first 
found expressed in C57BL/10 mouse liver (Cosman et al., 
1982). Termination sequences in exon 5 cause a loss of the 
transmembrane and cytoplasmic portions so that the Q10 
protein is secreted rather than expressed on the cell 
surface. Q10 is a 40,000 dalton protein that is associated 
with 02-microg1obu1In (Maloy et al., 1984), and is encoded by 
the Q10 gene. This protein is found secreted in the liver 
and serum and the amount present is strain dependent (Lew et 
al., 1986b). In serum, Q10 is part of a high molecular 
weight complex with a molecular weight of 200,000 to 300,000 
daltons (Robinson, 1987a). There is little or no 
polymorphism associated with the Q10 molecule (Maloy et al., 
1984). 
The Qb-1 molecule is the most recently identified Qa 
region protein product (Robinson, 1985). Qb-1 is a 41,000 
dalton molecular weight glycoprotein that is associated with 
02-microglobulin. It is secreted in the spleen, lymph node, 
and bone marrow but not in the thymus (Robinson, 1985). It 
occurs in at least 2 allelic forms, Qb-1* and Qb-I", both 
forms similar in size but different in their isoelectric 
points. Most mouse strains are Qb-1* or Qb-I*, however, some 
strains showed no expression of Qb-1 and therefore are 
designated as Qb-io. Immunopreclpitatlon and pulse-chase 
experiments confirmed that the Qb-1 is secreted normally, 
unlike the Qa-2 which is first expressed as a cell surface 
protein and then released as a secreted protein (Robinson, 
1987b). Recent DNA sequence information on the Q4 gene shows 
that the deduced protein sequence is identical to the Qb-1 
protein sequence (Robinson et al., 1988). Gene transfer 
experiments with the Q4 gene show that a 41,000 dalton 
glycoprotein is secreted that is associated with 32-
microglobulin, and is biochemically indistinguishable from 
Qb-1 (Robinson et al., 1988). 
Tia region proteins The Tia region of the H-2 complex 
has two serologically defined antigens, TL and Qa-1. Old et 
al. (1963) first discovered a series of antigens, now called 
TL, expressed on radiation induced leukemia cells. Linkage 
studies showed that the TL antigen was encoded by the Tia 
(thymus leukemia antigen) locus. The TL antigen is a cell 
surface glycoprotein of 45,000-48,000 molecular weight that 
is associated with Bz-microglobulin (Flaherty, 1981). The TL 
antigen is limited in expression to thymocytes, some thymic 
leukemias and activated T lymphocytes (Old et al., 1963; 
Flaherty, 1981; Cook and Landolfi, 1983). Six serologically 
defined alleles of TLA exist (Tla*-Tla*), the most common 
alleles being Tia*, Tia", and Tia® (Shen et al., 1982). Mice 
with these three alleles differ in the quantity of TL antigen 
expressed on their thymocytes (Michaelson et al., 1983). 
Qa-1, a cell surface antigen, is a 46,000 dalton protein 
also encoded by the Tia region (Stanton and Boyse, 1976). It 
is associated with 02-microglobulin and has four 
serologically defined alleles, Qa-1*, Qa-1^, Qa-I®, and Qa-I* 
(Rich and Cook, 1984). Initial studies showed that Qa-1 was 
expressed on lymph node cells, thymus cells and a 
subpopulation of T lymphocytes (Stanton and Boyse, 1976). In 
later studies, Qa-1 was found to be expressed on splenic B 
lymphocytes as well (Harris et al., 1984). 
Preimplantation Embryo Development 
Morphological aspects 
Embryonic and fetal development in the mouse takes 
approximately 20 days, of which 4.5 days are spent as a free-
floating, independent embryo, first in the oviducts and then 
in the uterus. The embryo begins as a 1 cell embryo and 
undergoes a series of cleavage divisions to produce a 
blastocyst embryo, ready for implantation. It is this period 
of time before implantation, while the embryo is free-
floating in the oviducts and uterus, that defines the 
preimplantation period of development. 
Preimplantation embryonic development begins with the 
fertilization of an ovum, approximately 80 pm in diameter. 
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Shortly after ovulation, aeveral eggs, protected by the zona 
pellucida, an acellular glycoprotein covering, travel to the 
ampulla of the oviduct. It ie here in the oviduct that 
fertilization takee place. The entering eperm triggers the 
second meiotic division of the egg. The haploid set of 
maternal and paternal chromosomes décondense and form two 
distinct haploid pronuclei at about 4-9 hours post-
fertilization (Pedersen, 1986; BQrki, 1986). Approximately 
15-18 hours following fertilization, the nuclear membranes 
break down, a common mitotic spindle forms, and the first 
cleavage division of the zygote takes place. Subsequent 
cleavage divisions take place at approximately 12 hour 
intervals (Wilkins, 1986). 
The embryo undergoes six cleavage divisions defining six 
approximate stages of development: oocyte, 2 cell, 4 cell, 8 
cell, morula and blastocyst. During these cleavage divisions 
the embryo passes from the oviducts and towards the uterus. 
It is at the second cleavage stage (oocyte to 2 cell embryo) 
that the cleavage divisions become asynchronous (Davenport, 
1979; Pedersen, 1986). 
After the third cleavage division, the embryo now 
consisting of approximately 8 cells, or blastomeres, 
undergoes compaction (Lewis and Wright, 1935). During 
compactation the cells flatten against one another so that 
cell-cell contact is maximized and all intercellular spaces 
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are obliterated. Two types of cell surfaces are created: 
free (facings outwards towards the zona pellucida); and 
apposed (flattened against an adjacent cell) (Wiley, 1984). 
This creates a polarity In the embryo, which is a 
prerequisite for the segregation of two different cell 
lineages in the blastocyst embryo (BUrki, 1986). 
From the 8 eel 1 stage the compacted embryo undergoes a 
fourth cleavage division to produce a 16-32 cell morula 
embryo. At this stage the blastomeres begin secreting a 
fluid into a developing central cavity called the blastocoel. 
The morula embryo undergoes a fifth cleavage division and 
reexpansion to form the blastocyst, a hollow, nearly 
spherical fluid-filled ball of cells, which is both the 
implanting structure and the carrier of the precursor cells 
of the true embryo. It is at the morula stage that the first 
evidences of differentiated cells are seen. 
The final phase of preimplantation development involves 
the formation of the two different types of cell lineages, 
the trophectoderm, and the inner cell mass (ICM). The 
trophectoderm is a layer of outer cells (approximately 45) 
surrounding the blastocoel and the ICM is an asymmetrically 
localized group of 15-20 cells (Wilkins, 1986). The 
trophectoderm invades the uterine wall and forms the 
placenta, while the ICM forms the embryo proper and some 
extraembryonic membranes. The blastocyst embryo hatches from 
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the zona pellucida and implants in the uterine wall about 4.5 
days after fertilization. 
Biochemical aspects 
The mouse embryo inherits a large supply of maternal RNA 
(0.35 ng/embryo total RNA and 0.7 pg/embryo po1y(A)+RNA) that 
is stored in the unfertilized egg (Piko and CIegg, 1982). 
There is a sharp drop in total and po1y(A)+RNA levels at the 
2 cell stage (0.24 ng/embryo total RNA and 0.26 pg/embryo 
po1y(A)+RNA), which is interpretated as the specific 
degradation of maternal oocyte-type mRNA (Piko and Clegg, 
1982). The reaccumulation of mRNA in the embryo (by 
embryonic transcription) at the 2 cell stage has been well 
documented using Northern and dot blot experiments on histone 
and actin mRNAs (for a complete review, see Schutz, 1986). 
From the 2 cell stage on, embryonic genome expression 
accelerates. By the morula stage, total RNA synthesis is 
almost 16-fold more rapid than at the 2 cell stage (Clegg and 
Pi ko, 1982). 
Protein synthesis is active throughout early development 
and in the unfertilized egg (Wilkins, 1986). The average 1 
cell embryo contains approximately 28 ng total protein, both 
of maternal and embryonic origin (Brinster, 1967). Although 
much of the early protein synthesis is carried out on 
maternal templates, Pratt et al. (1983), using two-
27 
dimensional gel electrophoresis, showed that embryonic 
encoded proteins are detectable by the early 2 cell stage. 
The transition from maternal to paternal glucose phosphate 
isomerase (Duboule and BUrki, 1985) in individual embryos can 
be seen as early as the S cell stage. 
Enzyme activity is also evident in the early stages of 
embryo development. Lactate dehydrogenase has been shown to 
be active as early as the oocyte stage (Brinster, 1965). 
Warner and Hearn (1977) have shown that RNA polymerase 
activity can be detected at the 2 cell stage. Hypoxanthine 
phosphoribosyl-transferase activity has been noted in 8 cell 
embryos by Epstein et al. (1978). 
Embryo Survival 
Prenatal mortality has been observed in all mammalian 
species studied, although there are differences among the 
species to the extent and timing of embryo death. In the 
human population it has been estimated that 78% of 
fertilizations fail to result in live births (Roberts and 
Lowe, 1975). In a study by Edmonds et al. (1982), 81.9% of 
the conceptuses were lost prior to 12 weeks and most of these 
losses (91.7%) occurred subclinically without the knowledge 
of the mother. In the pig 30% of the embryos die within the 
first 40 days of gestation (Pope and First, 1985). In the 
mouse prenatal mortality has been shown to be as low as 20-
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25% (Bradford, 1969) and as high as 30-40% (Falconer, 1960). 
It Is of fundamental Interest to understand why fetal loss 
occurs despite natural selection for efficient reproduction. 
Wilmut et al. (1986) suggests that there are 3 routes 
leading to fetal loss: (1) the embryo may be abnormal; (2) 
the maternal environment may be unable to support normal 
development; or (3) there may be an inappropriate 
relationship between the embryo and the mother. These 
factors may act separately or in combinations to influence 
embryo survival. Each of these factors will be discussed 
below. 
First, the embryos may be abnormal due to inherited 
defects, such as chromosomal abnormalities or genetic 
mutations. In 50-61.5% of spontaneously aborted human 
fetuses (in the 1st and 2nd trimester), gross chromosomal 
abnormalities are present (Boue et al., 1975; Hassold et al., 
1980). In mice and rabbits approximately 5% of the 
preimplantation embryos are abnormal (Qosden, 1973; 
Fechheimer and Beatty, 1974). Genetic mutations found in the 
T complex of the mouse can also cause fetal loss. The t"32 
lethal factor of the T complex causes developmental arrest of 
the morula embryo and the t*" and t*i* factors cause fetal 
death during in the postImplantation period (Bennett, 1975; 
Rogers et al., 1985). 
Secondly, fetal loss may be due to an abnormal maternal 
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environment because of an abnormal reproductive tract or 
Inapproplate hormonal relationships. The high fetal loss 
seen in aged females is largely due to reduced uterine 
capability (Adams, 1970; Gosden, 1979). The Importance of 
the maternal environmental in determining embryo survival is 
best seen in mice selected for reproductive performance. 
Female mice selected for large litter size show a decrease in 
prenatal mortality (Joakimsen and Baker, 1977; Bakker et al., 
1978), whereas mice selected for small litter size show 
greater prenatal mortality (Moler et al., 1981). Bradford 
(1979) showed, by cross-breeding mice, that maternal genetic 
effects on fetal loss were due to recessive alleles and that 
the genes for high survival show a strong degree of 
dominance. 
Changes in uterine secretions, induced by ovarian 
hormones in the maternal environment, can also affect embryo 
survival. This has been best studied in sheep (Wilmut and 
Sales, 1981; Wilmut et al., 1985a,b). A sequence of four 
phases was found to be essential for successful pregnancy: 
1) a period of high progesterone before mating; 2) estradiol 
equivalent to that which Induced estrus; 3) a low peri-
ovulatory value of progesterone; and 4) a higher value of 
progesterone typical of the luteal period in the estrus 
cycle. In rabbits, the levels of estradiol and progesterone 
are important in the development of the endometrium and its 
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receptivity to the embryo (Beler and Mootz, 1979). Recently, 
Forman et al. (1988) found that elevated estradiol 
concentrations at the time of ovulation had an adverse effect 
on Implantation and fetal development of human embryos. 
Lastly, embryos may die because of an inapproplate 
relationship with the maternal environment. The timing of 
the prelmplantatlon period of development Is crucial for 
survival of the mammalian embryo. A close degree of 
synchronization Is necessary between the development of the 
uterus and the development of the embryo If Implantation and 
subsequent fetal development Is to be successful. McLaren 
and Michle (1956) demonstrated that mouse embryos transferred 
to a uterus at an earlier stage of development wait for the 
uterus to catch up developmental 1y before Implanting, whereas 
embryos transferred to a uterus at a later stage of 
development die. Doyle et al. (1963) found that embryos one 
to two days older than the uterus survived to term in embryo 
transfer experiments, but embryos younger than the uterus had 
retarded cleavage rates and died. It is known that In 
rodents, blastocysts have the capacity to remain in a state 
of arrested development until the uterus is ready for 
implantation (Mayer, 1963). 
Asynchronous and synchronous embryo transfer experiments 
have established the importance of synchrony between the 
maternal environment and embryo development in mammals other 
31 
than the mouse as well. This has been shown In the rat 
(Dickmann and Noyes, 1960; Beyer and Zellmaker, 1973), the 
pig (Webe1 et al., 1970; Pope et al., 1982; Pope et al., 
1986), the rabbit (Chang, 1950; Adams, 1971), the cow 
(Sreenan and Diskin, 1987), and in sheep (WHmut and Sales, 
1981). 
The Importance of developmental synchronization between 
mother and embryo suggests that the tempo of development 
during the preimplantation period may also be crucial in 
determining embryo survival. Gates (1965) found that when 
slow cleaving and fast cleaving embryos were transferred to 
opposite horns of recipient mice synchronously, the slow 
cleaving embryos survived to term only one-third as 
frequently as did the more rapidly dividing embryos. The 
most retarded embryos were found to be up to two cleavage 
divisions behind the more rapidly dividing embryos after 
embryo transfer. This delay in development caused the 
embryos to be out of synchrony with the uterus, although they 
were transferred synchronously, and this led to embryonic 
mortality. This suggested that the retarded rate of cleavage 
could contribute to fetal loss after implantation (Gates, 
1965). This observation was supported by Larsen and Generoso 
(1984) who found that maternal genotype influences the 
incidence of post-implantation death and that the high 
incidence of fetal loss was associated with slow development 
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of embryos. 
There Is also a limit to the uterine capacity to foster 
embryonic development, suggesting that crowding of the 
embryos in the uterus may contribute to fetal loss. Doney et 
al. (1973) showed that embryo survival in sheep is at a 
maximum if a11 of the embryos are not crowded into one 
uterine horn. This has also been found true in pigs 
(reviewed in Pope and First, 1985). 
There are many factors affecting embryo survival in the 
mammalian species. A11 of the factors discussed above 
suggest that an overall principle governs the success of 
embryonic and fetal development, that is, the successful 
interaction of the embryo with the uterine environment. 
The Ped Gene 
The tempo of mouse preimplantation embryo development is 
important for embryo survival, as discussed above. In mice, 
the embryo must develop at a rate that coincides with the 
development of the uterus for fetal development to be 
successful. Thus, the control of cleavage divisions in the 
preimplantation period may play a role in embryo survival. 
As mentioned earlier, at the 2 cell stage cleavage 
becomes asynchronous so that at a certain time after 
fertilization some embryos contain more cells than others. 
This was first noticed by Gates et al. (1961) who found that 
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hybrid (BALB/c x 129) mouse blastocysts contain more cells 
than the maternal (BALB/c) blastocysts. Whitten and Dagg 
(1962) found differences in the rate of cleavage division in 
embryos between the 129 and BALB/c inbred strains of mice. 
Differences in ce11 number per embryo at the blastocyst stage 
of preimplantation development between inbred mouse strains 
were also noted by McLaren and Bowman (1973), who found that 
C3H embryos had fewer cells per embryo than did C57BL 
embryos. Similar studies in different Inbred mouse strains 
by Titenko (1977), Niwa et a1. (1980) and Shire and Whitten 
(1980) all suggested that differences in cleavage divisions 
are genetically determined. 
The observation that the C3H strain and the CBA strain 
produced embryos that are slow developing (McLaren and 
Bowman, 1973; Titenko, 1977) and that both of these strains 
are of the H-2k haplotype led to the hypothesis that the H-2 
complex influences the timing of preimplantation mouse embryo 
development (Verbanac and Warner, 1981). Further analysis of 
the association of slow development with the H-2k haplotype 
by use of inbred and congenic mouse strains clearly 
demonstrated that an H-2 complex gene(s) was affecting the 
rate of cleavage division in the preimplantation period 
(Qoldbard et al., 1982a). Analysis of reciprocal congenic 
pairs of mice further demonstrated that slow development is 
associated with the H-2k haplotpe and fast development with 
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the H-2b haplotype (Qoldbard et al., 1982b). These 
observations led to the proposal of the existence of an H-2 
linked gene, Ped (prelmplantation embryo development), which 
Influences the rate of cleavage divisions In early mouse 
embryos (Qoldbard et al., 1982b). Qoldbard and Warner (1982) 
analyzed congenic strains on the C57BL/10Sn background and 
found that fast development Is associated with the b, d, q, 
s, and u haplotypes, whereas slow development is associated 
with the k and r haplotypes. C57BL/10Sn congenic mice have 
the same background genes and differ only in genes of the H-2 
complex. Thus, the only difference between slow and fast 
developing strains was the genes of the H-2 complex. 
Furthermore, Qoldbard and Warner (1982) showed that the Ped 
gene mapped to the D end of the H-2 complex. The properties 
of the Ped gene are discussed below and are summarized in 
Table 1. 
There are two functional alleles of the Ped gene, slow 
and fast, defined by the rate of development of 
prelmplantation embryos. The Ped gene phenotype of a strain, 
whether the strain produces embryos that are slow or fast 
developing, is determined by assessing the number of cells 
per embryo at various points during the prelmplantation 
period. Analysis of the Ped gene phenotype of Fi crosses 
between congenic strains (C57BL/10Sn, Ped fast, and 810.BR, 
Ped slow) demonstrated that the fast allele of the Ped gene 
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Table 1. Ped gene properties^ 
1. There is a gene Ped (preimplantation mouse embryo 
development), linked to the H-2 complex, that influences 
the rate of cleavage division in mouse preimplantation 
embryonic development. 
2. There are 2 functional alleles of the Ped gene, slow and 
fast, as defined by the rate of development of pre-
plantation mouse embryos. 
3. The fast allele of the Ped gene is dominant, with no 
obvious effect of the maternal egg cytoplasm. 
4. The Ped gene does not influence the time of ovulation. 
5. Ped gene expression is apparent at the time of the first 
cleavage division. 
6. It is not known whether the Ped gene influences the time 
of implantation or length of gestation. 
7. There is complete concordance of Ped gene phenotype and 
Qa-2 antigen expression. Mouse strains that express the 
fast Ped allele are Qa-2*, while mouse strains that 
express the slow Ped allele are Qa-2«». 
1 Based on Verbanac and Warner (1981), Goldbard et al., 
(1982a,b), Goldbard and Warner (1982), and Warner et al. 
(1987b, 1988). 
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is dominant (Goldbard et al., 1982b). Since reciprocal Fi 
crosses gave similar results there is no evidence for any 
effect of the maternal egg cytoplasm on Ped gene expression. 
Studies by Goldbard et al. (1982a) have shown that the 
Ped gene does not influence the time of ovulation. Both fast 
(CS7BL/10Sn) and slow developing (BIO.BR, C57BR/cdj) strains 
ovulated within two hours of each. This also suggests that 
differences in ovulation rate does not account for 
differences in cleavage rate of preimplantation mouse 
embryos. When the time of the first cleavge division was 
examined it was found that differences existed between slow 
and fast developing strains, with the fast developing strains 
(C57BL/10Sn) cleaving about three to six hours ahead of the 
slow developing strains (BIO.BR, C57BR/cdj) (Goldbard et al., 
1982a). The action of the Ped gene is apparent at the time 
of the first cleavage division and also influences the 
subsequent rate of cleavage (Goldbard et al., 1982a). It is 
not known whether the Ped gene influences the time of 
Implantation or length of gestation. 
The association of the Ped gene with the H-2 complex has 
been deduced from the Ped gene phenotype of congenic mouse 
strains on the C57BL/10Sn and C57BL/6 backgrounds, (reviewed 
by Warner et al., 1987b; Warner et al., 1988). Recently, the 
association of the Ped gene with the H-2 complex has been 
shown to be a true linkage by Warner et al. (1987b), by 
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showing the segregation of Fed gene phenotype with genes of 
the H-2 complex In backcross generations. 
There Is complete concordance of Red gene phenotype with 
Qa-2 antigen expression, but with no other Qa region product 
(see Table 2). Mouse strains that are Ped fast express Qa-2 
antigen on their adult cell surfaces (Qa-2*), whereas mouse 
strains that are Ped slow lack Qa-2 antigen on their cell 
surfaces (Qa-2'>) (see Table 2). These data suggest that the 
Ped gene is located in the Qa region of the H-2 complex 
(Warner, 1986; Warner et al., 1987a,b). 
The protein product of the Ped gene is unknown as well 
as how the Ped gene influences the rate of development. 
Expression of Class I Molecules on Preimplantation 
Mouse Embryos 
Proteins expressed on the surfaces of cells are known to 
participate in several developmental processes, such as cell-
cell recognition, adhesion, communication and motility. 
Interactions with proteins on the cell surface can Induce 
intracellular changes in metabolism, the cell cycle and gene 
expression. The cell surface of mammalian embryos may also 
be of developmental significance as early as the 
preimplantation period in regulating development and gene 
expression from the 1 cell stage to the blastocyst stage 
(Johnson and Calarco, 1980). Cell surface proteins on mouse 
preimplantation embryos may play a role in cell-cell 
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Table 2. Concordance of Ped gene phenotype and Qa-2 antigen 
expression* 
H-2 Qa Region Mean Cell Fed Gene 
Strain Haplo- Proteins»» No./Embryo Phenotype 
type Qa-2 Qb-1 (SEM)e 
Inbred 
A/J a a a 32.9 (1.5) Fast 
C57BL/10SnJ b a b 33.1 (2.1) Fast 
C57BL/6J b a b 29.6 (1.7) Fast 
DBA/2J d a ND<* 30.5 (1.4) Fast 
C3H/HeJ k b a 24.3 (0.4) Slow 
C57BR/cdjJ k b ND 18.7 (1.0) Slow 
CBA/J k b ND 18.9 (1.0) Slow 
DBA/1 J q a ND 30.2 (1.5) Fast 
SJL/J s a ND 31.9 (2.0) Fast 
BIO Conaenic 
BIO.A/SgSnJ a a ND 32.0 (1.1) Fast 
B10.D2/nSnJ d a a 39.1 (1.5) Fast 
B10.BR/SgSnJ k b a 22.8 (1.3) Slow 
BIO.Q/Ds q a ND 30.2 (1.3) Fast 
BIO.RIII/SgDv r b c 25.4 (0.9) Slow 
BIO.S/Ds s a c 33.9 (2.4) Fast 
BIO.PL/J u a ND 30.4 (1.7) Fast 
BIO.AM/SgDv h3 a ND 29.6 (1.7) Fast 
B10.A(4R)/SgDv h4 a ND 30.7 (1.9) Fast 
B10.A(5R)/SgDv 15 a ND 31.1 (1.5) Fast 
B6 Conaenic Recombinant 
B6.K1 b b a 20.4 (1.1) Slow 
B6.K2 b a a 31 .0 (1.4) Fast 
•Table adapted from Warner et al. (1988). 
bQio (Qa region protein not listed), is non-polymorphic 
and is secreted in all of the strains listed below. 
«Determined by the Tarkowski air-drying technique (1966) 
at 89 hours post-hCG. 
dND = not determined. 
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recognition (ICM-trophectoderm, trophectoderm-uterine cells), 
adhesion, communication (differentiation into ICM and 
trophectoterm cells), motility (formation of the blastocoel, 
trophectoderm invasion of the uterine wall), and cell surface 
proteins may act as receptors for the induction of 
intracellular changes (Johnson and Calarco, 1980). 
The expression of H-2 class I transplantation antigens 
on the surface of preimplantation mouse embryos has been an 
extensively studied area because of the important role the 
antigens may play in cell-cell interaction during 
morphogenesis. The study of the presence of H-2 antigens on 
embryonic surfaces may also help explain maternal tolerance 
of the fetus despite paternal protein expression in the 
fetus. 
H-2 antigens have been detected on preimpIantation mouse 
embryos using a variety of antisera and techniques. Searle 
et a1. (1976) first demonstrated the presence of H-2 antigens 
on blastocyst stage embryos using congenic alloantisera with 
an immunoperoxidase labeling technique coupled with electron 
microscopy. Krco and Goldberg (1977) using congenic antisera 
and a cytotoxicity assay demonstrated the presence of H-2 
antigens on 8 cell embryos. Using congenic alloantisera, 
Webb et al. (1977) precipitated H-2 antigens that had been 
internally and externally labeled from blastocyst stage 
embryos. Indirect Immunofluorescence demonstrated the 
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presence of H-2 antigens on oocytes (Heyner and Hunziker, 
1979). 
A more sensitive embryo cytoxoclty assay based on the 
incorporation of ®H-thym1dine by live cells, was developed by 
Cozad and Warner (1981, 1962) to examine H-2 expression on 
embryos of various H-2 haplotypes. The assay, using congenic 
a 1 l e a n t i s e r a ,  d e t e c t e d  t h e  p r e s e n c e  o f  H - 2 * h a p l o t y p e  
antigens on blastocysts and H-2*'k'd haplotype antigens on 8 
cell embryos. Warner and Spannaus (1984), using both 
congenic alloantisera and monoclonal antibodies and 
immunoperoxidase labeling coupled with electron microscopy, 
also detected H-2 antigens on 8 cell and blastocyst stage 
embryos. 
A highly sensitive enzyme linked immunosorbent assay 
(ELISA) was developed by Qoldbard et al. (1984), and using 
monoclonal antibodies detected the presence of H-2 antigens 
at the blastocyst stage. Qoldbard et al. (1985) found 
expression of H-2 antigens at all stages of preimplantation 
development (unfertilized eggs to blastocyst embryos), and 
that the expression was not due to adsorption cytophilically, 
but due to synthesis by the embryos themselves. Using the 
ELISA technique Warner et al. (1987a) has shown the presence 
of Qa-2 antigen (a class I differentiation antigen) on 
preimplantation mouse embryos. Qa-2 antigen was detected on 
oocytes, 2 cell, 4 cell and blastocyst stage embryos with the 
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greatest expression found on blastocyst stage embryos. 
The presence of H-2 antigens on embryos can be Inferred 
from several other observations as well. Sawicki et al. \ 
(1981) found 02-m1crog1obu1in expression on early mouse 
embryos. Since 02-microglobulin expression is associated 
with H-2 antigen expression (Arce-Qomez et al., 1977), it can 
be inferred that H-2 antigens are present on mouse embryos. 
Tanaka et a1. (1983) found H-2 antigen and 32-microglobu1in 
expression on mouse trophoblast cell clones, suggesting that 
the trophoblast cells of the blastocyst embryo express H-2 
antigen. Stage-specific insulin binding (morula and 
blastocyst stage) was found in preimplantation mouse embryos 
by Rosenblum et al. (1986). Due et al. (1986) found that the 
insulin receptor is associated with class I proteins in place 
of 02-microglobulin. Therefore, if insulin is binding to 
insulin receptors on mouse embryos, which are associated with 
H-2 antigens, it can again be inferred that H-2 antigens are 
present on preimplantation mouse embryos. 
Specific Goals 
The major purpose of this work was to study to role of 
the Major Histocompatibility Complex in non-immune functions 
such as development and reproduction. Experiments are 
presented to answer several questions. It is known that the 
uterine environment can Influence embryo development (Moler 
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et al., 1981). Is the Ped gene phenotype of an embryo an 
Inherent trait, or is fast and slow preimplantation 
development a result of the uterine environment? The 
concordance of Ped gene phenotype and Qa-2 antigen 
expression, shows the Ped gene is associated with the Qa 
region. Based on these observations, is the Ped gene linked 
to the Qa region? Embryo survival studies suggest that the 
tempo of development during the preimplantation period may be 
crucial for subsequent fetal survival. Does the Ped gene, by 
controlling the tempo of development, play a role in embryo 
survival? Observations in our laboratory and by L. Flaherty 
(unpublished) suggest that Qa-2* mice breed more poorly than 
Qa-2" mice. What then, is the role of the Qa-2 antigen in 
reproduction? 
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MATERIALS AND METHODS 
Mice 
The following mouse strains were obtained from the 
Jackson Laboratory, Bar Harbor, ME: A/J, B10.BR/SgSnJ, 
B10.D2/nSnJ, C57BL/6J, CS7BL/10SnJ, BALB/cJ, and BALB/cByJ. 
The A/J, B10.BR/SgSnJ, B10.D2/nSnJ, C57BL/6J, C57BL/10Sn, and 
BALB/cByJ strains are abbreviated as A, BIO.BR, B10.D2, 
C57BL/6, CS7BL/10, and BALB/cBy throughout this dissertation. 
CF1 mice were obtained from the Charles River Breeding 
Laboratories, Wilmington, MD. BIO.M breeding pairs were 
obtained from Chella David (Mayo Clinic, Rochester, MN) and 
bred and maintained in our laboratory. The B6.K1, B6.K2, 
B6.K3, and B6.K4 breeding pairs were obtained from Lorraine 
Flaherty (New York State Department of Health, Albany, NY) 
and bred and maintained in our laboratory. The (B6.K2 x 
B6.K1)Fi and (B6.K1 x B6.K2)Fi x B6.K1 backcross mice were 
produced and maintained in our laboratory. The mice were 
housed in a day-night controlled room (lights on 4 a.m. to 6 
p.m. central standard time) with food and water ad libitum. 
Monoclonal Antibodies 
The 27-11-13 hybridoma cell line was obtained from David 
Sachs (Immunology Branch, National Cancer Institute, 
Bethesda, MD). The N-S.8.1 hybridoma cell line was obtained 
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from the American Type Culture Collection (ATCC) (Rockville, 
MD). The 141.16.6 monoclonal antibody, in ascites fluid, was 
obtained from Ian McKenzie (Department of Pathology, 
University of Melbourne, Victoria, Australia). The following 
hybridoma supernatants were also obtained from David Sachs: 
695H1-1-2, 695H2-7-6, 695H1-12-1, 695H1-9-9, 695H1-7-3, 
696H1-7-5, 695H1-5-9, and 695H1-1-8. A summary of the 
properties of the monoclonal antibodies described above are 
given in Table 3. 
The hybridoma cell lines, 27-11-13 and N-S.8.1, were 
maintained in Dulbecco's Modified Eagles Medium, with 4500 
mg/m1 glucose (DMEM) (QIBCO, Grand Island, NY), 10% fetal 
bovine serum (FBS) (HyClone Laboratories, Logan, UT), 0.1% 
antibiotics-antimycotics (QIBCO), and 5% gentamicin (QIBCO). 
The cells were grown at 37'C in 7% CO2 in air. 
27-11-13 and N-S.8.1 were purified from ascites fluid by 
a modification of the sodium sulfate precipitation method 
described in Williams and Chase (1967). Ascites fluid was 
diluted with an equal volume of 0.2M phosphate buffer, pH 
7.0. A sufficient amount of a 25% saturated NazSO* solution 
was added, while stirring at room temperature, to give a 
final concentration of 18%. The precipitate was recovered by 
centrifugation at 5000 g for 10 minutes. The precipitate was 
redissolved in 0.1M phosphate buffered saline with 0.1% NaNz, 
pH 7.0 (PBS) to 40% of the original ascites volume. A second 
45 
Table 3. Summary of the monoclonal antibodies used in this 
dissertation 
Monoclonal Isotype Specificity Reference 
Antibody 
CO 1 1 C
M 
mouse IgQz# anti -Db/dL*# Ozata and Sachs 1981 
N-S.8.1 mouse IgQzb anti -SRBC1 Raschke, 1980 
141.16.6 mouse IgQz* anti -Qa-2 Hogarth et al. 1982 
695H1-1-2 mouse igQzm anti -Qa-2 Sachs, unpublished 
695H2-7-6 mouse IgQzm anti -Qa-2 Sachs, unpublished 
695H1-12-1 mouse IgQz a anti -Qa-2 Sachs, unpublished 
696H1-9-9 mouse IgQz# anti -Qa-2 Sachs, unpublished 
695H1-7-3 mouse IgQz# anti -Qa-2 Sachs, unpublished 
695H1-7-5 mouse M
 
CO
 
»
 
anti -Qa-2 Sachs, unpublished 
695H1-5-9 mouse IgQz# anti -Qa-2 Sachs, unpublished 
695H1-1-8 mouse IgQz# anti -Qa-2 Sachs, unpublished 
1SRBG = Sheep Red Blood Cell. 
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precipitation was effected by addition of a sufficient volume 
of 25% saturated NazSO# to give a final concentration of 12%. 
The precipitate was recovered by centrlfugatlon as before and 
PBS added to just dissolve the precipitate. The antibody was 
then desalted by dialysis against PBS. Antibody 
concentration was calculated by measuring the absorbance at 
280 nm, assuming an extinction coefficient of 1.4 (Ey et al., 
1978). 
141.16.6 was received as ascites fluid, clarified by 
centrlfugatlon at 5000 g for 10 minutes, and then frozen in 
50 Ml aliquots at -70'C until use. The ant1-Qa-2 hybridoma 
supernatants were received as lyophillized powder and were 
brought up in either 0.5 ml or 1.0 ml sterile HzO, as 
directed by the Information sent by D. Sachs. The 
supernatants were stored at -70*C in 50 pi aliquots until 
use. 
Cell Line 
The EL-4 tumor cell line was obtained from the ATCC and 
has been previously described (Gorer, 1950). EL-4 is a T 
cell lymphoma cell line that expresses H-2* and Qa-2*. The 
EL-4 cell line was maintained in DMEM with 10% horse serum 
(QIBCO), 0.1% antlbiotics-antimycotics, and 0.5% gentamicln. 
Cells were grown at 37*C, in 7% CO2 in air. 
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Superovulation and Collection of Embryos 
Mature female mice (2 to 6 months of age) were 
superovulated with 5 I.U. pregnant mare serum (PMS) (Sigma, 
St. Louis, MO), injected at the 9th hour of the light cycle, 
followed 48 hours later by 10 I.U. human chorionic 
gonadotropin (hCG) (ICN BioMedicals, Inc., Costa Mesa, OA). 
Each female was placed in an individual cage with one male 
immediately following the hCQ Injection, and vaginal plugs 
were checked the next morning. The plug positive females 
were sacrificed by cervical dislocation and embryos collected 
into either Whitten and Biggers (1968) medium or saline (0.15 
M NaCl, 0.1% NaN2, pH 7.0), at various times post-hCG 
injection, depending on the desired developmental stage of 
the embryos (see Table 4). Whitten and Biggers medium is a 
chemically defined growth medium for preimpIantatIon mouse 
embryos. All manipulations of the embryos were done with a 
Bausch and Lomb dissection microscope, finely drawn pipettes, 
and 0.5 ml watchglasses. 
Flow Cytometric Analysis of Qa-2 Antigen Expression 
Detection on spleen Ivmphocvtes 
Spleens were excised from mature mice 8-12 weeks of age. 
The spleens were injected with enough RHF (RPMI-1640 medium 
[GIBCO], 25mM Hepes, 10% heat-Inactivated IgG-free fetal 
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Table 4. Developmental stages of preImplantation 
mouse embryos and the corresponding hours 
post-hCQ injection 
Hours post-hCQ Stage of Development 
44-47 Late 2 cell 
53-56 4 eel 1 
66-68 8 cell 
77-87 Morula 
89-96 Blastocyst 
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bovine serum [GIBCO], 0.1% NaNz to puff the spleen up. The 
spleen was then forced through a 40 gauge screen with a 1 ml 
syringe plunger Into a 10 ml beaker. To form a single cell 
suspension the cells were gently pipetted up and down to 
break up clumps. 
Spleen lymphocytes were Isolated from the cell 
suspension by centrlfugatlon over a Ficoll-Hypaque density 
gradient (density = 1.084, 9% Ficoll [Pharmacia Fine 
Chemicals, Piscataway, NJ] and 34% Hypaque [Winthrop 
Laboratory, New York, NY] adjusted to the proper density with 
a hygrometer). The cell suspension was layered over 1.0 m1 
of Ficoll-Hypaque (previously filtered through a 0.22 pm 
MIllex-QV sterilizing filter [Minipore Corporation, Bedford, 
MA]) In a 1.5 ml centrifuge tube and centrlfuged for 3 
minutes at 12,000 g. The lymphocyte layer was collected Into 
a fresh 1.5 ml centrifuge tube and washed two times with RHF. 
After the last wash the cells were counted and adjusted to 1 
X 107 cells/ml in RHF. 
The assay was performed In 96 well Serocluster "V" vinyl 
plates (Costar, Cambridge, MA). 50 Ml of cells and 50 pi of 
anti-Qa-2 antibody, diluted In RHF, were added per well and 
Incubated for 1 hour at 4'C. The cells were washed 4 times 
In RHF at 4'C and 50 pi of approplately diluted fluorescein-
conjugated affinity purified goat anti-mouse IgG Fc fragment 
(y-chain specific) (Cappel, Cooper Biomedical, Malvern, PA) 
were added. The cells were Incubated for 1 hour In the dark 
at 4'C, then washed as before. The cells were resuspended In 
100 pi of RHF and put on Ice until analyzed. 
The samples were run on the EPICS 752 Flow Cytometer 
(EPICS Division of Coulter Corporation, Hialeah, PL), using 
an argon laser at 488 nm, and gated on forward angle light 
scatter and 90* light scatter to exclude debris and monocytes 
from the analysis. Fluorescence data were collected using 
logarithmic amplification (logic) on 2 x 10* cells as 
determined by forward angle light scatter intensity. The 
data are displayed as immunofluorescence profiles in which 
logarithmically increasing fluorescence intensity (relative 
log fluorescence) is plotted in 256 channels on the x-axis 
and the relative cell number is shown on the y-axis. The 
data are also displayed as two parameter histograms in which 
logarithmically increasing fluorescence intensity (LIGFL) is 
plotted on the y-axis and cell size (SCAT1) on the x-axis. 
Detection on peripheral blood lymphocytes 
Heparinized microhematocrit capillary tubes (Allied 
Corporation, Fisher Scientific, Pittsburgh, PA) were used to 
collect 0.4 ml peripheral mouse blood from the orbital venous 
sinus. The blood was placed into 1.5 ml centrifuge tubes 
containing 375 pi PBS, 25 pi of 1000 units heparin/ml (Sigma) 
and 0.05% ethyleneglyco-bis-(0-amino-ethylether) N,N'-tetra 
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acetic acid (EQTA). The mixture was layered over 950 pi 
filtered F1co11-Hypaque (density = 1.094). After 
centrifugatlon at 2500 g for 8 minutes, the lymphocyte layer 
was collected into a fresh 1.5 ml centrifuge tube and washed 
2 times with RHF. After the final wash the lymphocyte pellet 
was resuspended in 150 |i1 RHF and added 50 Ml per well to a 
Serocluster "V" plate. The assay then followed the procedure 
outlined above for detection of Qa-2 on spleen lymphocytes. 
Cell Enzyme Linked Immunosorbent Assay (ELISA) 
Plating of cells 
EL-4 tumor cells were collected from tissue culture 
suspension by centrifugatlon at 2000 g for 10 minutes. The 
cells were washed 3 times with PBS and then resuspended in 
PBS at a concentration of 5 x 10" cells/ml. The wells of a 
96 well Immulon II "U" microtitration plate (Dynatech 
Laboratories, Inc., Alexandria, VA) were treated with 200 m1 
of 0.1 g/1 poly-L-lysine (Sigma) in PBS, for 1 hour at room 
temperature. Immulon II plates were used because of their 
enhanced protein binding capabilities. After washing the 
wells 3 times with PBS, 50 pi of EL-4 cells were added per 
well and allowed to settle for 1 hour at room temperature. 
The cells were then fixed to the wells by the addition of 
freshly prepared 0.05% glutaraldehyde (grade II, Sigma) in 
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PBS. Following a 30 minute Incubation at room temperature, 
the wells were washed 3 times with PBS, and 200 u1 of 200 
Iig/m1 gelatin (Difco Laboratories, Detroit, MI) containing 
0.1%,NaNz In PBS was added. The plates were stored at 4'C 
until use. 
GlISA @@9@Y 
The cell ELISA procedure was modified from Qoldbard et 
al. (1984). The plates of fixed EL-4 cells were washed 3 
times with PBS and 100 Ml of antibody, diluted In PBS with 
10% heat-Inactivated FBS, was added per well. The plates 
were Incubated for 2 hours at 37'C. Following the 
Incubations, the wells were washed 3 times with PBS, once 
with 0.2% Tween-20 In PBS (PT), and again with PBS. 50 pi of 
G-galactosidase conjugated F(ab*)2 fragments sheep anti-mouse 
IgQ (Hybridoma Screening Kit, Bethesda Research Laboratories, 
Qaithersburg, MD), diluted 1:100 in PBS with 10% heat-
inactivated FBS, was added per well. The G-galactosidase 
conjugated to F(ab')2 fragments of sheep anti-mouse IgG is 
referred to as the 0-galactosidase conjugate throughout this 
dissertation. Plates were then Incubated for 1 hour at 37'C. 
The washing procedure was repeated and 100 |il of substrate 
solution was added per well. The substrate solution, made 
fresh each time, is 4 mg/ml p-nltrophenyl-G-D-
galactopyranoside (pNPG) (Sigma) and 0.7 pl/ml 0-
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mercaptoethanol (BioRad, Richmond, CA) in assay buffer (lOmM 
Tris-HCT, lOmM NaCI, ImM MgClz, 0.1% NaNz, 10% heat-
inactivated FBS). The plates were incubated for 1 hour at 
37*0. The reaction was stopped by addition of 100 m1 of 0.1M 
NaaCOs and the color intensities were measured 
spectrophotometrically at 410 nm using an ELISA plate reader 
(Dynatech Laboratories, Inc.) 
Time Course Study of Substrate-Enzyme Reaction 
in the ELISA Assay 
The p-nitropheny1-0-D-ga1actopyranoside was made as 
previously described in the cell ELISA procedure. 50 m1 of a 
1:10" dilution of G-galactosidase conjugate to F(ab')2 
fragments of sheep anti-mouse IgQ were added per well in a 96 
well Immulon 1 "U" microtitration plates (Dynatech 
Laboratories, Inc., Alexandria, VA). 50 u1 of substrate were 
added and the plates incubated at 37'C. At 1 hour intervals, 
from 1 to 7 hours, 6 wells were stopped by addition of 0.1M 
NazCOa and the absorbance at 410nm read. 
Embryo ELISA 
Embryos were assayed for the presence of Qa-2 antigen on 
their cell surfaces using a modification of the enzyme linked 
immunosorbent assay (ELISA) previously described by Goldbard 
et a1. (1984). Embryos were collected into saline, as 
described previously, and washed 3 times in PBS. Embryos 
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were Incubated with either ant1-Qa-2 ascites or culture 
supernatant, diluted to the appropriate concentration In PBS 
with 10% heat-inactivated FBS, for 2 hours at 37*C. 
Following the incubation period, the embryos were washed 3 
times with PBS, a single time with PT, and again in PBS. The 
embryos were then Incubated with the 0-ga1actosidase 
conjugate, diluted 1:25 in PBS with 10% heat-Inactivated FBS, 
for 1 hour at 37'C. The 37'C incubations with 141.16.6 and 
the B-galactosidase conjugate were carried out In 2 well 
depression slides (0.5 ml volume) placed In humidified petri 
dishes. Embryos were washed as before and then placed 15 per 
well in a 96 well Immulon 1 "U" microtitration plate 
containing 100 pi of pNPQ substrate solution. Immulon 1 
plates were used for the embryo ELISA because they are 
designed to allow for less nonspecific binding and therefore 
relatively low background readings. The embryos were 
Incubated with the substrate at 37'C for 3-4 hours. The 
reaction was stopped by addition of 100 pi of 0.1M NazCOz and 
the color intensities measured spectrophotometrically at 410 
nm. 
In vitro Culture of Embryos 
Embryos were collected into Whitten and Biggers medium, 
as described previously, and immediately placed in an 
atmosphere of 5% CO2 in air to maintain optimal. pH. The jji 
55 
vitro culture method is a modification of that of Brinster 
(1963). Embryos were placed in 50 pi drops of Whitten and 
Biggers medium under preequi1ibrated paraffin oil in 60 x 15 
mm tissue culture dishes (Becton Dickson, Oxnard, CA). The 
culture dishes were incubated in a humid atmosphere of 7% COz 
in air at 37'C for various lengths of time (see Results 
section for details). To minimize any possible differences 
between culture dishes, each dish contained embryos from both 
of the mouse strains cultured in vitro. 
Determination of Cell Number per Embryo 
Cell number per embryo for 1 cell to 5 cell embryos was 
determined by microscopic inspection on a Bausch and Lomb 
dissection microscope. For later stages of development the 
embryos were subjected to a modification of the Tarkowski 
(1966) air-drying technique. Embryos were washed three times 
in Ringer's solution (3mM CaClz, 5mM KCl, 0.15M NaCl) 
followed by three washes in 0.6% sodium citrate. Embryos 
remained in the sodium citrate solution for 5-15 minutes, 
depending on the developmental stage, to allow maximum 
swelling of the cells. Next, the embryos were placed on a 
clean sTide and 0.20 ml of freshly prepared fixative (three 
parts absolute ethano1:one part glacial acetic acid) added. 
The slides were stained with Qeisma stain (GIBCO) for 24 
hours, after which the number of nuclei were counted using a 
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Zeiss phase-contrast microscope at 400X magnification. 
Statistical Analyses 
Significant differences of mean cell number per embryo 
among strains were assessed by Student's t tests. A two 
sample test was used to determine If values obtained for a 
certain mouse strain were significantly different from values 
obtained from prototype slow and fast developing strains. 
Data were analyzed using the Statistical Analysis System 
(SAS) PROC TTEST procedure (see Appendix B for program). To 
account for experimental variation, the degrees of freedom 
were based on the number of experiments. 
For the in vivo and in vitro kinetic studies, 
statistical differences in the slopes of the rate of 
development were found using multiple linear regression 
analysis. Data were analyzed using SAS and a General Linear 
Models procedure (PROC QLM) (see Appendix B for program). 
The dependent variable was Logz Cell Number per embryo (LCN), 
while the independent variables were mouse strain and time 
(hours post-hCQ or hours ±n vitro). Logs Cell Number per 
embryo is used for statistical analyses because the embryos 
are undergoing doubling cleavage divisions during development 
(McLaren and Bowman, 1973). Some of the time points had 
replications (number of experiments) and in each experiment a 
certain number of embryos were scored. All of these sources 
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of variation are accounted for In the PROC QLM analysis of 
variance. Through the PROC QLM procedure the linear 
equations for the rate of development lines were obtained. 
The coefficients were then compared using a Student's t test. 
Determination of Time of Ovulation 
Female mice (2-6 months of age) were injected with PMS 
and hCQ, as previously described, but were not mated. Grogps 
of three mice were killed every two hours from 8 hours post-
hCQ to 16 hours post-hCQ injection and the clutch of ovulated 
eggs removed by teasing the oviduct apart. The clutch was 
treated with 300 units/ml of hyaluronidase (Sigma) to 
disperse the cumulus cells and allow counting of the number 
of ova ovulated. 
Segregation Analysis of the Ped Gene 
A diagram of the scheme for the segregation analysis is 
shown in Figure 4. Backcross embryos were generated by the 
mating of (B6.K29 x B6.K1^)Fi females to B6.K1 males. After 
collection of the embryos at 93 hours post-hCQ, the embryos 
were divided into blastocysts and morulas and Qa-2 typed 
using the embryo ELISA procedure previously described. The 
embryos were Qa-2 typed using 141.16.6 diluted 1:8 in PBS 
with 10% heat-inactivated FBS. 
58 
Generation of Fi 
B6.K1 0  X B6.K29 
(Qa-2*, Eftfli alow) (Qa-2*, Ead fast) 
(B6.K1 X B6.K2)Fi 
(Qa-2*/b, Ped fast) 
Generation of 
Backcross: 
Predicted Rate 
of Development; 
(B6.K1 X B6.K2)Fi 9 X B6.K1d 
50% fast 
(blastocysts) 
50% slow 
(morulas) 
Predicted 
Qa-2 Expression: a/b b/b 
Figure 4. Experimental plan for segregation analysis of the 
Ped gene 
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Embryo Survival Study 
BreedlnA 9*999 and Qa-2 typing 9f backcroee mice 
For the embryo survival study breeding cages containing 
either 2 (B6.K19 x B6.K2d)Fi9 and 1 B6.K1d, or 2 (B8.K29 x 
B8.K1d)Fi9 and 1 B6.K1^ were set up. Both the male and 
female breeders were 8-10 weeks of age. Cages were checked 
each morning and evening for newborn pups and the date of 
birth and number born (dead and alive) recorded. At 3 1/2 to 
4 weeks of age the mice were weaned and Qa-2 typed using the 
indirect immunofluorescence assay on the flow cytometer for 
Qa-2 expression on spleen lymphocytes as previously 
described. The experimental plan for the embryo survival 
study is shown in Figure 5. 
Statistical analvses 
The ratio of Qa-2*/b or Qa-2"»/* mice to Qa-2*/* mice at 
weaning (3 1/2 to 4 weeks of age) was compared to the 
expected Qa-2 ratio using chi-square analysis. Only litters 
that had 100% survival to weaning were Qa-2 typed and used in 
the chi-square analysis. This would eliminate any ratio 
distortion due to death before weaning and Qa-2 typing. 
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Generation Qf Fij. 
BG.KId  X  B6.K29 
(Qa-2b, £ad slow) (Qa-2*, gad fast) 
(B6.K1 X B6.K2)Fi 
(Qa-2*/b, Ped fast) 
Generation of 
Backcross 
Puds;  (B6.K1 X B6.K2)Fi 9 B6.K1d 
Predicted Qa-2 
Expression of 
backcross mice: a/b b/b 
Figure 5. Experimental plan for embryo survival study 
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B6.K1, B6.K2 and Fi Litter Records 
Breeding cages for study 
B6.K1 and B6.K2 breeding cages were set up containing 2 
females and 1 male per cage. Fi breeding cages were set up 
containing either 2 B6.K1 females and 1 B6.K1 male, or 2 
B6.K2 females and 1 B6.K2 male. A11 of the breeders used In 
this study were 8-10 weeks of age at thé time of the initial 
set up (see Table 69, in Appendix C, for ages and cage 
identification). The cages were checked each morning and 
evening for newborn pups and the date born, number of pups 
born (alive and dead), and birth weights (live pups only) 
recorded. The mice were weaned at 3 1/2 to 4 weeks of age. 
At this time the mice were sexed and the weaning weight 
recorded. 
Statistical analyses 
Average birth weight, litter size (number of pups/litter 
at birth), and weaning weights were compared using Student's 
t tests. Analyses were performed using paired comparisons 
with the PROC TTEST procedure (see Appendix B for program). 
The degrees of freedom for the comparison of average birth 
weight is based on the number of litters born. The degrees 
of freedom for litter size and weaning weights is based on 
the number of litters born and number of mice weaned. 
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Male to female ratios at weaning were compared to 
expected ratios using chi-square analysis. Only litters that 
had 100% survival to weaning were used in the chi-square 
analyses of ma1e:fema1e ratios. 
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RESULTS 
Development of a Flow Cytometric Assay for 
Detection of Qa-2 Antigen on Lymphocytes 
An Indirect immunofluorescence assay was developed to 
detect Qa-2 antigen on spleen and peripheral blood 
lymphocytes using the EPICS flow cytometer. The assay, 
diagrammed in Figure 6, involved using an anti-Qa-2 
monoclonal antibody (141.16.6) as the primary antibody and a 
fluorescein conjugated goat anti-mouse IgQ (Fc fragment, 7-
chain specific) antibody, which binds to the primary 
antibody, as the fluorescence marker. A mouse strain that 
lacks expression of Qa-2 antigen on its cell surface (Qa-2*) 
was used as the negative control in all of the experiments. 
The samples were analyzed on the EPICS 752 Flow Cytometer and 
gated on forward angle light scatter and 90* light scatter to 
remove debris and monocytes from the analysis. 
For typical flow cytometric analyses 5 x 10* cells to 5 
X 10= cells per well are commonly used. In initial 
experiments 5 x 10^ cells per well were used and 5 x 10^ 
cells analyzed. To Increase the accuracy of the sampling 
statistics, the number of cells per well was increased to 5 x 
10= so that a greater number of cells could be analyzed (2 x 
10*) by the flow cytometer. For the experiments on the flow 
cytometer, 50 pi of 1 x 10^ cells/ml were used to give a 
final concentration of 5 x 10= cells per well. This 
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Figure 6. Schematic diagram of the indirect immuno­
fluorescence assay on the EPICS flow cytometer 
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concentration of celle le coneletent with the number ueed by 
Sharrow et al. (1984) for analyele of Qa-2 expreeeion on 
lymphocytee. To increaee the eeneitivity of the aeeay, the 
data wae analyzed on the logarithmic ecale and the 
photomultiplier tube (PMT) voltage turned up to increaee the 
eeneitivity to low level fluoreecence. 
To determine the optimal conditione for the aeeay, 
141.16.6 and the fluoreecein conjugated goat anti-mouee IgQ 
Fc fragment (referred to henceforth ae the fluoreecein 
conjugate) were titrated on mouee spleen lymphocytee. The 
titration of 141.16.6 on B6.K2 (Qa-2*) and B6.K1 (Qa-2*) 
epleen lymphocytee is shown in Figure 7. The fluoreecein 
conjugate wae used at a dilution of 1:200 as determined by 
preliminary experiments (data not shown). A dilution of 
1:10* of 141.16.6 was chosen for the assay because 141.16.6 
bound strongly to the Qa-2 antigen on Qa-2* cells and only 
minimally to Qa-2* cells. 
Figure 8 shows the titration of the fluorescein 
conjugate on B6.K2 and B6.K1 epleen lymphocytes. 141.16.6 
was used at a dilution of 1:10*, as determined from Figure 7. 
From the titration curve, a dilution of 1:200 (of a 1 mg/ml 
stock solution) was chosen for the assay. At this 
concentration the Qa-2* cells can be readily distinguished 
from Qa-2'» cells. 
For the indirect immunofluorescence assay on the flow 
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Figure 7. Titration of 141.16.6 (anti-Qa-2) on B6.K2 (Qa-2*) 
(•) and B6.K1 (Qa-2b) (!) spleen lymphocytes using 
the indirect immunofluorescence assay. The 
fluorescein conjugated goat anti-mouse IgG Fc 
fragment was used at a dilution of 1:200. A total 
of 2 X 10* cells was analyzed for each point and 
the mean log fluorescence calculated using the 
INTGRA program on the Coulter EASY 88 data 
analysis system 
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Figure 8. Titration of the fluorescein conjugated goat anti-
mouse ZgG Fc fragment on B6.K2 (Qa-2") (•) and 
B6.K1 (Qa-2*) (!) spleen lymphocytes using the 
indirect immunofluorescence assay. 141.16.6 
(anti-Qa-2) was used at a dilution of 1:10*. A 
total of 2 X 10< cells was analyzed for each 
point and the mean log fluorescence calculated 
using the INTGRA program on the Coulter EASY 88 
data analysis system 
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cytometer then, 141.16.6 was used at a 1:10* dilution and the 
fluorescein conjugate used at a 1:200 dilution of a 1 mg/ml 
stock solution. The parameters for this assay were chosen 
using the spleen lymphocytes at a concentration of 5 x 10* 
cells per well and analyzing 2 x 10* cells. 
Parameters for the Cell ELISA 
The cell ELISA used is a modification of the assay 
developed by Qoldbard et al. (1984). The cell ELISA allows 
detection of H-2 antigens on fixed tumor cells. It is 
diagrammed in Figure 9. The assay involves the binding of an 
anti-H-2 monoclonal antibody (27-11-13, anti-D*/dLd or 
141.16.6, anti-Qa-2) or a negative control antibody (N-S.8.1, 
anti-sheep red blood cells [anti-SRBC]) to EL-4 cells (H-2*, 
Qa-2*). A second layer is added, B-galactosidase conjugated 
to F(ab')2 fragments of sheep anti-mouse IgQ (referred to 
henceforth as the G-galactosidase conjugate), that binds to 
the primary antibody. The substrate, p-nitrophenyl-3-D-
galactopyranoside (referred to henceforth as pNPG), is 
cleaved by the 0-galactosidase enzyme and a bright yellow 
product is produced that has an absorbance at 410nm. 
The parameters for the cell ELISA, the concentration of 
primary antibody and the B-galactosidase conjugate, were 
selected by simultaneous titration of 27-11-13 and the 3-
galactosidase conjugate on EL-4 cells. An unrelated 
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Cell ELISA 
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EL-4 cells 
Figure 9. Schematic diagram of the cell ELISA 
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monogTonal antibody, N-S.8.1 (anti-SRBC), was chosen as the 
negative control. The concentration of the substrate, pNPG, 
Is at a saturating concentration of 4 mg/ml. Figures 10-13 
show the results of titrating 27-11-13 and N-S.8.1 at 
different 3-ga1actos1dase conjugate concentrations. The best 
titration of 27-11-13 was achieved at a 1:100 dilution of the 
G-galactosldase conjugate. At this dilution there Is a 
maximum difference between 27-11-13 and the negative control, 
N-S.8.1, at a concentration of 0.1 mg/ml. 
The Importance of the cell ELISA lies In Its role as a 
cellular model for the embryo ELISA. Antibodies to be used 
to detect antigens on embryos (using the embryo ELISA 
procedure) are first tested on cells in the cell ELISA. The 
antibody to be used in the embryo.ELISA to detect the 
presence of Qa-2 antigen, 141.16.6 (ant1-Qa-2), was therefore 
tested in the cell ELISA before trying it on embryos. The 
141.16.6 antibody was titrated on EL-4 cells using the G-
galactosidase conjugate at 1:100. The titration of 141.16.6 
is shown in Figure 14. N-S.8.1 was used as the negative 
control. From this titration curve, the optimal dilution of 
the 141.16.6 antibody on cells is 1:50. At this dilution 
there is maximum binding of 141.16.6 to the Qa-2 antigen on 
EL-4 cells and minimal binding of N-S.8.1 to EL-4 cells. The 
results of the cell ELISA in Figure 14 show that the 141.16.6 
monoclonal antibody effectively detects Qa-2 antigen in the 
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Figure 10. Titration of 27-11-13 (anti-Db/dL*) (•) on EL-4 
cells (H-2b) using the cell ELISA. N-S.8.1 
(anti-SRBC) (!) was used as the negative control 
The G-galactosidase conjugate was used at a 
dilution of 1:100. Results are reported as the 
A410nm per well (each dilution was tested in 
triplicate). The error bars represent the 
standard error of the mean 
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Figure 11. Titration of 27-11-13 (anti-Db/dL*) (•) on EL-4 
cells (H-2b) using the cell ELISA. N-S.8.1 
(anti-SRBC) (!) was used as the negative control. 
The B-galactosidase conjugate was used at a 
dilution of 1:200. Results are reported as the 
A410nm per well (each dilution was tested in 
triplicate). The error bars represent the 
standard error of the mean 
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Figure 12. Titration of 27-11-13 (anti-Qb/dL*) (•) on EL-4 
cells (H-2*) using the cell ELISA. N-S.8.1 
(anti-SRBC) (!) was used as the negative control. 
The 3-galactosidase conjugate was used at a 
dilution of 1:400. Results are reported as the 
A410nm per well (each dilution was tested in 
triplicate). The error bars represent the 
standard error of the mean 
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Figure 13. Titration of 27-11-13 (anti-Qb/dL*) (•) on EL-4 
cells (H-2b) using the cell ELISA. N-S.8.1 
(anti-SRBC) (!) was used as the negative control. 
The G-galactosidase conjugate was used at a 
dilution of 1:800. Results are reported as the 
A410nm per well (each dilution was tested in 
triplicate). The error bars represent the 
standard error of the mean 
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Figure 14. Titration of 141.16.6 (anti-Qa-2) (•) on EL-4 
cells (Qa-2*) using the cell ELISA. N-S.8.1 
(anti-SRBC) (!) was used as the negative control. 
The G-galactosidase conjugate was used at a 
dilution of 1:100. Results are reported as the 
A410nm per well (each dilution was tested in 
triplicate). The error bars represent the 
standard error of the mean 
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ELISA sandwich method and that it can be used to detect Qa-2 
on embryonic cell surfaces in the embryo ELISA. 
Parameters for the Embryo ELISA 
The embryo ELISA, a method for detection of H-2 antigens 
on preimplantation mouse embryos, has been modified from 
Qoldbard et al. (1984). It is similar to the cell ELISA 
procedure except that embryos are assayed rather than fixed 
tumor cells. A diagram of the embryo ELISA is shown in 
Figure 15. The following parameters of the embryo ELISA were 
determined: (1) the length of incubation of the embryos with 
the substrate; (2) the number of embryos needed per well to 
detect Qa-2 antigen; (3) the optimal concentration of 
141.16.6 to be used in the assay; and (4) the optimal 
concentration of G-galactosidase conjugate to be used in the 
assay. Experiments were undertaken to determine these 
parameters. 
To maximize the substrate-0-galactosidase conjugate 
reaction in the embryo ELISA assay, the linearity of the 
reaction was studied. The time course of the pNPG reaction 
with the G-galactosidase conjugate is shown in Figure 16. 
The reaction is linear up to 4-5 hours at 37'C, when it then 
reaches a plateau. Based on this result, embryos were 
incubated with the pNPG at 37'C for 3-4 hours in the embryo 
ELISA procedure. 
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Figure 15. Schematic of the embryo ELISA 
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Figure 16. Time course of B-galactosidase conjugate reaction 
with p-nitrophenyl-3-D-galactopyranoside (pNPQ) 
substrate. The results are reported as the 
A410nm per well (each point represents the 
average of 6 wells). The error bars represent 
the standard error of the mean 
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Immature C57BL/6 females (3 1/2 to 4 weeks of age) were 
used as the source of embryos for all of the embryo ELISA 
experiments because they produce 2-3 times the number of 
embryos produced by mature females (greater than 6 weeks of 
age). For the experiments to optimize the conditions for the 
embryo ELISA, embryos were collected at 93 hours post-hCQ 
(blastocyst stage of development). 
To determine the optimal number of embryos to be used 
per well in the assay, the absorbance at 410nm was measured 
as a function of the number of C57BL/6 (Qa-2*) embryos per 
well. The 141.16.6 monoclonal antibody (anti-Qa-2) was used 
at a dilution of 1:10 and the G-gaTactosidase conjugate used 
at a dilution of 1:25. These initial dilutions were chosen 
based on preliminary embryo ELISA results (data not shown). 
The results are shown in Figure 17. From this experiment 15 
embryos per well was chosen for subsequent embryo ELISAs. 
This gives a low background and is also a reasonable number 
of embryos to collect from inbred mouse strains in order to 
have at least duplicates for each point. 
The titration of 141.16.6 and the B-galactosidase 
conjugate on C57BL/6 embryos is shown in Figures 18 and 19. 
The 3-ga1acto8idase conjugate was used at a dilution of 1:25 
for the titration of 141.16.6. A dilution of 1:8 of 141.16.6 
was determined to be the best from Figure 18. A dilution of 
1:25 was chosen for the 0-galactosidase conjugate based on 
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Figure 17. Titration of the number of embryos per well. The 
embryo ELISA was performed on C57BL/6 (Qa-2*) 
blastocyst embryos (collected at 93 hours post-
hCG) using 141.16.6 (anti-Qa-2) (•) at a dilution 
of 1:10 and N-S.8.1 (anti-SRBC) (!) as the 
negative control, at a dilution of 1:10. The 
S-galactosidase conjugate was used at a dilution 
of 1:25. The results are reported as the A410nm 
per well (one well per point) 
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Figure 18. Titration of 141.16.6 (anti-Qa-2) (•) on C57BL/6 
(Qa-2*) blastocysts (collected at 93 hours post-
hCG) using the embryo ELISA. N-S.8.1 (anti-SRBC) 
(!) was used as the negative control. The G-
galactosidase conjugate was used at a dilution of 
1:25. Each dilution was tested in duplicate. 
The results are reported as the A410nm per well 
(15 embryos/well) and the error bars represent 
the standard deviations 
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Figure 19. Titration of the 3-ga1acto8ldase conjugate on 
C57BL/6 (Qa-2*) blastocysts (collected at 93 
hours post-hCG) using the embryo ELISA. 141.16.6 
(ant1-Qa-2) (•) was used at a dilution of 1:8 and 
N-S.8.1 (anti-SRBC) (!) was used as the negative 
control at a dilution of 1:8. Each dilution of 
the G-galactos1dase conjugate was tested in 
duplicate. The results are reported at the 
A410nm per well (15 embryos/well) and the 
error bars represent the standard deviations 
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Figure 19. 
In summary, the conditions for the embryo ELISA are as 
follows: (1) an incubation of 3-4 hours of the embryos with 
the substrate at 37'C; (2) 16 embryos per well; (3) 141.16.6 
at a dilution of 1:8; and (4) the G-galactosidase conjugate 
at a dilution of 1:25. 
Ped Gene Expression by Embryos Cultured in vitro 
CF1 in vivo/in vitro rate of development 
To demonstrate that Ped gene expression is not solely 
dependent on the uterine environment, but rather is an innate 
property of the embryos themselves, the rate of cleavage 
division of preimplantation mouse embryos was examined in 
vitrp. 
Using a modification of Brinster (1963), an in vitro 
culture method for embryos was developed using outbred CF1 
embryos. CF1 embryos were collected at 44, 56, 68 and 80 
hours post-hCQ, corresponding to the 2 cell, 4 cell, 8 cell, 
and morula stages of development. The embryos were cultured 
in vitro for 24 hours and the mean cell number per embryo 
determined by the Tarkowski air drying technique. The mean 
cell number per embryo was also assessed at the time of 
collection to determine the rate of development in vivo. 
The in vitro and in vivo rate of development for CF1 
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embryos are shown In Figure 20. The data are plotted as the 
logz cell number versus hours post-hCQ (time after the hCQ 
injection), and statistically analyzed as previously 
described in the Materials and Methods section. The lines 
are drawn from a multiple linear regression analysis because 
each point represents several experiments. The data used for 
Figure 20 are shown in Table 5. The slopes of the lines are 
not statistically different from one another, meaning that 
development in vitro simulates development in the uterine 
environment (in vivo). The culture method developed allows 
the embryos to successfully develop outside of the uterus. 
Figure 20 also shows that 1q vitro embryo development 
lags behind embryo development in vivo. Though the Iq vitro 
development of embryos imitates the development seen in the 
uterine environment, in vitro development is lagging behind. 
This can be attributed to the shock that the embryos undergo 
when flushed from the uterine horns into room temperature 
Whitten and Biggers medium. Bowman and McLaren (1970) also 
found that embryos cultured in vitro lagged behind embryos 
allowed to develop in the uterus. They attributed this to 
lower metabolic rates in embryos cultured in vitro (Menke and 
McLaren, 1970). Given a long enough incubation period, 
embryos developing in vitro do display the same number of 
cells per embryo as do embryos developing in vivo, but at a 
later time point (see Figures 21-24 below). 
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Figure 20. In vivo (•) and in vitro (•) development of CF1 
embryos. The equations of the lines are as 
follows: in vivo, y = -3.07 + 0.0903x and in 
vitro, y = -2.85 + 0.0615X. The correlation 
coefficient for the in vivo curve is 0.994, and 
for the in vitro curve, 0.980. The slopes of the 
lines are not statistically different 
(0.2<P<0.4). The raw data used for the 
statistical analyses are shown in Table 36 (see 
Appendix A) 
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Table 5. Mean cell number per embryo and logz cell number 
In CF1 mice after different timee of collection 
(in vivo) and development in vitro. Raw data are 
shown in Tables 29-35 (see Appendix A) 
Hours post- No. No. Mean Cell No./ Logz Cell 
hCG Expts. Embryos Embryo (SEM) Number 
Scored 
In vivo 
44 2 46 
56 2 51 
68 2 44 
80 2 44 
In vitro 
68 2 44 
80 2 47 
92 2 50 
104 2 46 
2.0 (0.0) 1.00 
3.7 (0.1) 1.89 
7.9 (0.1) 2.98 
19.0 (0.5) 4.24 
7.2 (0.2) 2.84 
10.7 (0.4) 3.42 
27.1 (0.6) 4.76 
49.9 (1.7) 5.64 
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Although the In vitro development lags behind the in 
vivo development, the culture method developed does allow the 
embryos to be taken out of the uterus and to develop 1q vitro 
without the influence of the uterine environment. 
B10.BR and C57BL/6 in vivo/in vitro development 
To see whether embryos cultured 1q vitro maintain their 
Red gene phenotype, the culture method used in the CF1 
experiments was applied to slow and fast developing strains 
in our mouse colony. The BIO.BR (H-2k), a slow developing 
strain, expresses the slow Red allele (Goldbard et al., 
1982a), and the C57BL/6 (H-2»), a fast developing strain, 
expresses the fast Red allele (Gollnick, 1986). Embryos were 
collected from both strains at 44 hours post-hCQ (late 2 cell 
stage) and 65 hours post-hCQ (8 cell stage), and incubated in 
vitro for 24 and 30 hours, respectively. These incubation 
times were chosen experimentally to maximize the difference 
in the rate of development between the B10.BR and C57BL/6 
embryos in vivo and in vitro. Goldbard and Warner (1982) 
previously demonstrated that development proceeds as a step 
function so that any difference in the rate of development 
between two strains depends on the time points chosen for 
analysis. 
Figure 21 shows the mean cell number per embryo for both 
the B10.BR and C57BL/6 strains in the in vitro analysis at 68 
88 
hours post-hCQ (2 cell embryos cultured 24 hours). When 
comparing the data of Figure 21 to the Iq vivo data at a 
similar cleavage stage (65 hours post-hCQ) In Figure 22, the 
difference 1n the rate of cleavage division seen in vivo Is 
maintained in vitro. Figure 23 shows the results of the in 
vitro analysis at 95 hours post-hCQ (8 cell embryos cultured 
30 hours). When comparing this data to the in vivo data at a 
similar cleavage stage (89 hours post-hCQ) In Figure 24, 
again, the difference In the rate of cleavage division seen 
in vivo is maintained in vitro. The data in Figure 24 are 
similar to data previously reported by Goldbard et al. 
(1982a) for the BIO.BR strain at 89 hours post-hCG and by 
Gollnick (1986) for the C57BL/6 strain at 89 hours post-hCG. 
The Pad gene phenotype of the embryos Is maintained after 
removing them from the uterine environment and allowing them 
to develop in vitro. A summary of the data for Figures 21-24 
is found in Table 6. 
B10.BR and B10.D2 in vitro rate of development 
The B10.BR and C57BL/6 are not congenic strains and 
therefore differ not only at the H-2 region but also in their 
background genes. To minimize the effect of these non-H-2 
genes on in vitro development, two congenic strains, BIO.BR 
(H-2K, Ped slow) and BIO.02 (H-2<', Ped fast). were studied in 
vitro. The BIO.BR and B10.D2 strains derive their background 
B10.BR C67BL/6 
Figure 21. Analysis of 2 cell BIO.BR and C57BL/6 embryos 
after in vitro culture. Embryos were collected 
at 44 hours post-hCG and cultured for 24 hours 
(total time post-hCG, 68 hours). The error bars 
represent the standard error of the mean. BIO.BR 
is significantly lower than C57BL/6 (P<0.05) 
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Figure 22. In vivo analysis of BIO.BR and C57BL/6 embryos at 
65 hours post-hCG. The error bars represent the 
standard error of the mean. B10.BR is signifi­
cantly lower than C57BL/6 (P<0.01) 
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Figure 23. Analysis of 8 cell BIO.BR and C57BL/6 embryos 
after i_n vitro culture. Embryos were collected 
at 65 hours post-hCG and cultured in vitro for 30 
hours (total time post-hCG, 95 hours). The error 
bars represent the standard error of the mean. 
B10.BR is significantly lower than C57BL/6 
(P<0.01) 
40-1 
92 
I 
s 
ô 
5 
o 
2 
30-
20-
10-
B10.BR C57BL/6 
Figure 24. In vivo analysis of BIO.BR and C57BL/6 embryos at 
89 hours post-hCG. The error bars represent the 
standard error of the mean. BIO.BR is 
significantly lower than C57BL/6 (P<0.01) 
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Tabla 6. Summary of the In vitro and In vivo analysis of 
B10.BR and C57BL/6 embryos. Raw data are shown 
in Tables 37-44 (see Appendix A) 
Hours No. of No. of Mean Cell 
Strain post-hCQ Expts. Embryos No./Embryo 
Scored (SEN) 
In vitro 
BIO.BR 68 3 77 7 .0 (0 . 2 ) *  
C57BL/6 68 3 77 8 .2 (0 .2) 
BIO.BR 95 4 57 32 .2 (1 .3)^^ 
C57BL/6 95 4 61 40 .9 (1 .3) 
In vivo 
BIO.BR 65 4 64 7. .5 (0. 
C57BL/6 65 4 62 8. ,4 (0. 2) 
BIO.BR 89 1 32 21. 4 (0. 
C57BL/6 89 1 34 31. 6 ( 1 .  3) 
* Significant!y lower than CS7BL/6 at P<0.05. 
••Significantly lower than C57BL/6 at P<0.01. 
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genes from the C57BL/10Sn strain and differ only at the H-2 
region, thus eliminating background gene effects. 
To extend the analysis of ±q vitro development of 
embryos, the BIO.BR and B10.D2 embryos were allowed to 
develop in vitro over a longer period of time corresponding 
to the preimplantation period. Embryos from both strains 
were collected at 44 hours post-hCQ (late 2 cell stage) and 
cultured in vitro for 24, 46, and 64 hours. The mean cell 
number per embryo at 24, 46, and 54 hours in vitro was 
determined and then plotted as the logz cell number versus 
hours in vitro, as shown in Figure 25. A summary of the data 
for Figure 25 is shown in Table 7. 
The lines are drawn from a multiple linear regression 
analysis because each point represents several experiments. 
The statistical analysis of the slopes of the lines shows 
that there is a significant difference between the rate of in 
vitro development between the BIO.BR and B10.D2 embryos 
(P<0.001). BIO.02 embryos develop at a faster rate than do 
B10.BR in vitro, demonstrating that the difference in the 
rate of cleavage division seen in vivo is maintained in vitro 
throughout the preimplantation development period. 
The data presented in Figures 21-25 clearly show that 
embryos removed from the uterine environment still express 
their respective Fed alleles. Fed gene expression is not 
solely a function of the uterine environment, but is an 
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Figure 25. In vitro development of B10.D2 (•) and 81 O.BR (!) 
embryos. The equations of the lines are as 
follows: B10.D2, y = 1.248 + 0.0763X and BIO.BR, 
y = 1.452 + 0.0614X. The correlation coefficient 
for the B10.D2 curve is 0.998, and for the BIO.BR 
curve, 0.995. The slopes of the lines are 
statistically significant (P<0.001). The raw 
data used for the statistical analyses are shown 
in Table 51 (see Appendix A) 
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Table 7. Summary of the In vitro analysis of BIO.BR and 
BIO.02 embryos. Raw data are shown in Tables 
45-50 (see Appendix A) 
Hours 
Strain in vitro 
No. of 
Expts. 
No. of 
Embryos 
Scored 
Mean Gel 1 
No./Embryo 
(SEM) 
Logs Cell 
No. 
B10.BR 24 5 54 7.6 (0.2) 2.93»^ 
B10.BR 46 5 51 21.0 (0.7) 4.40^^^ 
B10.BR 54 5 50 26.3 (0.7) 4.72^^* 
B10.D2 24 5 57 8.4 (0.2) 3.07 
BIO.02 46 5 58 28.4 (0.8) 4.83 
B10.D2 54 5 50 40.2 (1.3) 5.33 
••Significantly 
at P<0.01. 
lower than B10.D2 at 24 hours in vitro 
•••Significantly 
vitro at P<0.001. 
lower than BIO.02 at 46 and 54 hours in 
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Innate property of the embryos themselves. 
Response of Inbred and Congenic Mouse Strains 
to Human Chorionic Gonadotropin (hCQ) 
Differences In each strain's response to human chorionic 
gonadotropin (hCG), the hormone used for superovulation, 
could result In different ovulation times. The possibility 
arises that fast developing strains maintain their Fed fast 
phenotype 1q vitro because their response to hCG causes an 
earlier ovulation time than the slow developing strains. 
Therefore, at the time the embryos were collected the fast 
developing embryos would have a greater development potential 
than the slow developing strains because of the earlier 
ovulation time. 
To demonstrate that the difference In cleavage rates Iq 
vitro between slow developing mice (BIO.BR) and fast 
developing mice (C67BL/6 and B10.D2), as seen in Figures 21-
25, is not due to differences In response to hCQ, the time of 
ovulation of BIO.BR, BIO.02 and C57BL/6 mice was examined. 
The results of these experiments are shown in Figure 26. All 
three strains ovulated at the same time, indicating that both 
slow and fast developing strains had similar responses to 
hCQ. 
These findings are consistent with those found by 
Goldbard et al. (1982a) for two other mouse strains, 
C57BL/10Sn (Ped fast) and C57BR/cdj (Ped slow). Therefore, 
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Figure 26. Time of ovulation of C57BL/6 (•), 810.BR (#), and 
B10.D2 (•) mice. Three mice of each genotype 
were sacrificed at each time point. The error 
bars represent the standard error of the mean 
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It appears that Red gene phenotype Is, in general, not due to 
differences in ovulation times. The results in Figure 26 
rule out the possibility that differences in response to hCG 
are responsible for differences in cleavage rates in vitro. 
Ped gene expression In vitro is not due solely to the 
influence of the uterine environment, nor to differences In 
response to hCQ (ovulation times), but is due to the 
expression of the embryonic genome. 
Association of the Ped Gene with the Qa Region 
B6.K1 and B6.K2 congenic recombinant strains 
Analysis of the jn vivo rate of development The 
66.K1 and B6.K2 are congenic recombinant strains on the 
C57BL/6 (B6) background, isolated from a (B6-Tla* x B6-H-
2k)Fi x B6-H-2k backcross. They have been described in 
detail by Flaherty (1976). They have the following 
genotypes: B6.K1 = K" D*» Qa-2^ Tla"; B6.K2 = K*» Qa-2* 
Tlab. By serological typings, therefore, these two strains 
differ only by genes in the Qa region of the H-2 complex 
(Flaherty, 1976). Previous work by Gollnick et al. (1985) 
showed that the B6.K1 (Qa-2*) strain was Ped slow, and that 
the B6.K2 (Qa-2") strain was Ped fast. This finding 
suggested that the Ped gene mapped to the Qa region. These 
Initial analyses were done only at 89 hours post-hCG 
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(blastocyst stage of development). The Importance of the 
B6.K1 and B6.K2 strains to other analyses of Fed gene 
function, deemed it necessary to study Ped gene expression in 
these strains in detail. To determine whether the Ped gene 
phenotype of each was due to differences in the rate of 
development or to differences in the timing of the first 
cleavage division, the rate of development over the entire 
preimplantation period of development was examined. 
To look at Ped gene expression during the 
preimplantation period of development, B6.K1 and B6.K2 
embryos were collected at 47, 53, 65, 77 hours post-hCQ, 
corresponding to the late 2 cell, 4 cell, 8 cell, and morula 
stages of development. These data were combined with the 
data at 89 hours post-hCQ previously collected by Gollnick et 
al. (1985) and plotted in Figure 27 and summarized in Table 
8. The data are plotted as Toga cell number versus hours 
post-hCQ and statistically analyzed as previously described 
in the Materials and Methods section. The lines are drawn 
from a multiple linear regression analysis because each point 
represents several experiments. The slopes of these two 
lines are statistically different from one another (P<0.05), 
meaning that the rate of development la vivo of the B6.K2 
embryos is faster than that of the B6.K1 embryos. Ped gene 
expression is apparent at the Ist cleavage division (at 47 
hours post-hCG there are differences in cell number per 
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Figure 27. Rate of development (in vivo) of B6.K2 (•) and 
B6.K1 (!) embryos. The equations of the lines 
are as follows: B6.K2, y = -2.801 + 0.0883x and 
B6.K1, y = -2.697 + 0.0782X. The correlation 
coefficient for the B6.K2 curve is 0.978, and for 
the B6.K1 curve, 0.994. The slopes of the lines 
are statistically significant (P<0.05). Raw data 
used for the statistical analyses are shown in 
Table 60 (see Appendix A) 
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Table 8. Summary of the In vivo development of B6.K1 and 
B6.K2 embryos. Raw data are shown in Tables 52-
59 (see Appendix A) 
Strain 
Hours 
post-hCG 
No. of 
Expts. 
No. of 
Embryos 
Scored 
Mean Ce11 
No./Embryo 
(SEM) 
Log: Cell 
No. 
86.Kl 47 1 62 1.9 (0.1 ) 0.93 
86. Kl 53 2 54 2.7 (0.1) 1 .43 
86.Kl 65 2 54 6.1 (0.2) 2.60 
86.Kl 77 2 58 8.9 (0.2) 3.15 
86. Kl 89 1 33 20.1 (1.1)* 4.33 
86. K2 47 1 42 2.1 (0.1) 1 .07 
86. K2 53 1 56 3.9 (0.1) 1.96 
86. K2 65 2 51 8.6 (0.2) 3.10 
86. K2 77 2 49 18.4 (0.3) 4.20 
86. K2 89 2 78 31 .0 (1.4)* 4.95 
•Data from GoUnick et al. (1985). 
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embryo, as determined by the least squares line, between the 
two strains) and the Ped gene also Influences the subsequent 
rate of development (as seen by the slopes of the lines being 
significantly different). 
This result is consistent with the initial findings of 
Go11nick et al. (1986) that*the B6.K1 is a slow developing 
strain, expressing the slow Ped allele, and that the B6.K2 is 
a fast developing strain, expressing the fast Ped allele. 
Since the B6.K1 and 86.K2 strains differ only in genes of the 
Qa region, these data support the hypothesis that the Ped 
gene is associated with the Qa region. 
Response to hCQ To demonstrate that the difference 
in cleavage rates 1q vivo between the B6.K1 and B6.K2 mice is 
not due to differences in response to hCG, the time of 
ovulation was determined for each strain. The results of 
these experiments, in Figure 28, show that the B6.K1 and 
B6.K2 strains ovulated at the same time. Differences in 
response to hCG, which leads to differences in the ovulation 
time between the two strains does not account for differences 
in cleavage rates seen in the two strains. 
The B6.K1 and B6.K2 strains will be used in subsequent 
analyses of the role of the Ped gene in embryo survival and 
the effect of Qa-2 antigen on reproduction. From the 
analyses in Figures 27 and 28, it is well established that 
the B6.K1 is a slow developing strain (Ped slow) and that the 
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Figure 28. Time of ovulation of B6.K2 (•) and 86.K1 (!) 
mice. Three mice were sacrificed at each 
time point. The error bars represent the 
standard error of the mean 
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B6.K2 18 a fast developing strain fPed fast). 
B6.K3 and B6.K4 congenlc recombinant strains 
The B6.K3 and B6.K4 mouse strains are congenlc 
recombinant strains on the B6 background that have been 
derived from the same backcross as the B6.K1 and B6.K2 
(Flaherty et al., 1985). From serological typing, the B6.K3 
and B6.K4 strains were found to differ only at genes in the 
Qa region (Flaherty et al., 1985). These mice are similar to 
the B6.K1 and B6.K2 in that they differ only in genes of the 
Qa region and were derived from the same backcross. However, 
the B6.K3 and B6.K4 are Independently derived recombinants 
and have a different H-2 haplotype (H-2k). 
To support the association of the Ped gene with the Qa 
region, the Ped gene phenotype of the B6.K3 and B6.K4 strains 
was determined by assessing the number of cells per embryo at 
89 hours post-hCG (blastocyst stage of development). The 
genetic makeup and the mean cell number per embryo for the 
B6.K3 and B6.K4 strains are shown in Table 9. The mean cell 
number per embryo of the B6.K3 and B6.K4 strains was then 
compared to the mean cell number per embryo of other Inbred 
and congenlc mouse strains, as shown in Table 10, to assess 
significant differences. The B6.K4 strain was found to be 
significantly lower than the B6.K3 (P<0.001), C57BL/6 (Qa-2*) 
(P<0.01), and B6.K2 (Qa-2*) (P<0.001) strains, indicating 
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Table 9. The mean cell number per embryo of B6 congenic 
recombinant strains at 89 hours post-hCQ. Raw 
data are shown in Tables 61-62 (see Appendix A) 
Class I Molecules No. of No. of Mean Cell 
Strain K 0 Qa-2 Tla Expts. Embryos No./Embryo 
Scored (SEM) 
B6.K3 k k a a 2 45 34.3 (1.6) 
B6.K4 k k b a 4 68 22.1 (0.8) 
Table 10. Comparison of B6.K3 and B6.K4 mean cell number 
per embryo at 89 hours post-hCG to other inbred 
and congenic mouse strains 
Comparison P* 
B6.K3 vs. B6.K4 <0.001 
B6.K3 VS.  C57BL/6» N.S .c  
B6.K3 vs. B10.BR0 <0.001 
B6.K3 VS.  B6.K1b <0.001 
B6.K3 VS.  B6.K2» N.S. 
B6.K4 VS.  C57BL/6 <0.01 
B6.K4 VS.  B10.BR N.S. 
B6.K4 VS.  B6.K1 N.S. 
B6.K4 VS.  B6.K2 <0.001 
*P values based on paired comparisons using Student's 
t tests. 
bData from Qollnick (1986). 
®N.S. = not significantly different. 
«Data from Goldbard et al. (1982a). 
ï ' 
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that the B6.K4 is a slow developing strain, expressing the 
alow Ped allele. The B6.K4 data were not significantly 
different from other slow developing strains (BIO.BR [Qa-2*] 
and B6.K1 [Qa-2*]) (see Table 10). The B6.K3 strain was 
found to be significantly higher than slow developing strains 
(Bio.BR [P<0.001] and B6.K1 [P<0.001]) but not significantly 
different from other fast developing strains (C57BL/6, 
B6.K2). Based on these data, the B6.K3 is expressing the 
fast Ped allele. 
The Ped gene phenotype of the B6.K3 and B6.K4 strains 
further supports the hypothesis that the Ped gene maps to the 
Qa region. In these congenic recombinants, there is 
concordance of Qa-2 expression with Ped gene phenotype, as 
seen with all other inbred and congenic strains examined 
(Warner et al., 1988). 
BALB/cJ and BALB/cBv substrains 
The BALB/c (H-2d) substrains, BALB/cJ (Qa-2*), and 
BALB/cBy (Qa-2*), differ in their Qa region genes and it was, 
therefore, of Interest to determine the Ped gene phenotype of 
these strains. Although they differ in their Qa region 
genes, other background gene differences exist since these 
are substrains and not congenic or recombinant strains. The 
mean cell number per embryo at 89 hours post-hCG (blastocyst 
stage of development) was determined to ascertain the Ped 
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gene phenotype of each. The mean cell number per embryo for 
the BALB/cJ and BALB/cBy strains is shown in Table 11. 
Comparison of the mean cell number per embryo of the BALB/c 
substrains to that of other inbred strains is shown in Table 
12. 
When comparing the mean cell number per embryo of the 
BALB/cJ to that of the BALB/cBy, the BALB/cBy is 
significantly lower (P<0.05), suggesting that the BALB/cBy is 
a slow developing strain, expressing the slow Red allele. 
This is further supported by the BALB/cBy being significantly 
lower than the fast developing C57BL/10 strain (P<0.05). The 
BALB/cJ strain was not significantly different from other 
fast developing strains (C57BL/6 and C57BL/10), and was 
significantly higher than the slow developing BIO.BR strain 
(P<0.001). The data suggests that the BALB/cJ is a fast 
developing strain, expressing the fast Red allele. 
The BALB/cBy data is somewhat interesting when it is 
compared to the BIO.BR and C57BL/6 data. The BALB/cBy is not 
statistically different from the CS7BL/6 (Red fast) or the 
B10.BR (Red slow) strains. The BALB/cBy falls in-between the 
slow (BIO.BR) and fast (C57BL/6) developing strains. This 
result suggests that besides the Red gene, background genes 
in the BALB/cBy are also influencing the rate of cleavage 
divisions. Previous studies of congenic strains on the 
BALB/c background have also suggested that genes other than 
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Table 11. The mean cell number per embryo of BALB/c 
substrains at 89 hours post-hCQ. Raw data are 
shown in Tables 63-64 (see Appendix A) 
H-2 Qa-2 No. of 
Strain Haplotype Molecule Expts. 
No. of 
Embryos 
Scored 
Mean Cell 
No./Embryo 
(SEM) 
BALB/cJ 
BALB/cBy 
d 
d 
a 
b 
2 
2 
81 
84 
35.3 (1.5) 
26.5 (1.4) 
Table 12. Comparison of BALB/cJ 
number per embryo at 
mouse strains 
and BALB/cBy mean cell 
89 hours to other Inbred 
Comparison P" 
BALB/cJ vs. BALB/cBy <0.05 
BALB/cJ VS.  C57BL/6b N.S.c 
BALB/cJ vs. C57BL/10d N.S. 
BALB/cJ vs. BIO.BRd <0.001 
BALB/cBy vs. C57BL/6 N.S. 
BALB/cBy vs. C57BL/10 <0.05 
BALB/cBy vs. BIO.BR N.S. 
•P values based on paired comparisons using Student's t 
tests. 
*Data from Go11n1ck (1986). 
®N.S. = not significantly different. 
"Data from Goldbard et al. (1982a). 
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the Fed gene (background genee) are Influencing early embryo 
development In the BALB/c (Goldbard and Warner, 1982). 
BIO.M congenic strain 
Ped gene phenotype The BIO.M (H-2f) mouse strain is 
missing a major portion of ONA in the Qa region corresponding 
to the Q1 through Q9 genes (O'Neill et al., 1986). The only 
gene present in the Qa region of the BIO.M strain is the 010 
gene which encodes the secreted 010 protein. The BIO.M 
strain was derived by Or. Chella David by crossing the 
C57BL/10 strain to the A.OA (a strain missing 01-Q9 genes) 
and selecting for the H-2' haplotype. If the Ped gene is 
located in the Qa region, the BIO.M strain (because it is 
missing a11 but one Qa region gene) should be a slow 
developing strain, expressing the slow Ped allele. 
Table 13 shows the mean cell number per embryo at 65 and 
89 hours post-hCQ for the BIO.M strain. Comparisons of the 
mean cell number per embryo of the BIO.M strain to that of 
other inbred and congenic strains is shown in Table 14. 
Contrary to what was expected, the BIO.M strain is a fast 
developing strain. At both 65 and 89 hours post-hCG the 
BIO.M is significantly higher than the BIO.BR (Ped slow) 
(P<0.001) strain and is even higher than the C57BL/6 (Ped 
fast) (P<0.001) and C57BL/10 (Ped fast) (P<0.001, 65 hours 
post-hCG; P<0.05, 89 hours post-hCG) strains. Since a11 of 
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Table 13. Analysis of cell number per embryo In the BIO.M 
strain at 65 and 89 hours post-hCQ. Raw data are 
shown in Tables 85-66 (see Appendix A) 
Hours post- No. of No. of Mean Cell No./ 
hCG Expts. Embryos Scored Embryo (SEM) 
65 4 79 10.8 (0.3) 
89 4 66 39.9 (1.2) 
Table 14. Comparison of BIO.M mean cell number per embryo at 
65 and 89 hours post-hCQ to.other inbred and con-
genic mouse strains at 65 and 89 hours post-hCQ 
Comparison Hours post-hCG P* 
BIO.M VS.  C57BL/6» 65 <0.001 
BIO.M vs .  C57BL/10C 65 <0.001 
BIO.M VS.  B10.BRC 65 <0.001 
BIO.M VS.  C57BL/6«> 89 <0.001 
BIO.M vs .  C57BL/10C 89 <0.05 
BIO.M VS.  B10.BRC 89 <0.001 
•P values based on paired comparisons using Student's t 
tests. 
bData from Gollnick (1986). 
cData from Goldbard et al. (1982a). 
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the evidence so far has shown an association of the Ped gene 
with the Qa region (see Tables 8-12), It appears that other 
genes are involved In control of cleavage division in the 
BIO.M mouse. 
Flow cvtometric anal vais of Qa-2 expression Since 
the BIO.M mice were bred in our laboratory, the question of 
their genetic purity was raised. The Qa-2 expression of male 
and female BIO.M breeding pairs was analyzed using the flow 
cytometric indirect immunofluorescence assay described 
earlier. All of the mice tested showed an absence of Qa-2 
molecules on their peripheral blood lymphocytes. A typical 
immunofluorescence profile showing the bound 141.16.6 (anti-
Qa-2) monoclonal antibody to BIO.M peripheral blood 
lymphocytes Is shown in Figure 29. B6.K1 peripheral blood 
lymphocytes were run as a negative control and the 
immunofluorescence profile superimposed on that of the BIO.M 
profile. The conclusion is that the BIO.M mice used for the 
Ped gene analysis were Indeed Qa-2b, so that the paradox of 
the Ped gene phenotype of the BIO.M remain. 
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Figure 29. Immunofluorescence profile of bound 141.16.6 
(anti-Qa-2) to BIO.M (Qa-2'> ) peripheral blood 
lymphocytes ( ). B6.K1 (Qa-2»> ) peripheral 
blood lymphocytes ( ) were used as the 
negative control. 141.16.6 was used at a 
dilution of 1:10* and the fluorescein conjugate 
at a dilution of 1:200 
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Qa-2 Expression on Adult and Embryonic Cells 
Detection of Qa-2 antigen on B6.K1 and B6.K2 aoleen and 
peripheral blood Ivmphocvtes 
The expression of Qa-2 antigen on B6.K1 and 86.K2 
lymphocytes was analyzed using an indirect immunofluorescence 
assay on the EPICS flow cytometer. The immunofluorescence 
profile of bound 141.16.6 (ant1-Qa-2) to B6.K2 (Qa-2*) spleen 
lymphocytes has been superimposed on the bound 141.16.6 to 
B6.K1 (Qa-2b) control lymphocytes and is shown in Figure 30A. 
The 141.16.6 monoclonal antibody detects the Qa-2 antigen 
present on B6.K2 spleen lymphocytes and does not bind to the 
B6.K1 control spleen lymphocytes nonspecifical1y. 
The immunofluorescence profile for the bound 141.16.6 on 
B6.K2 spleen lymphocytes (Figure 30A) is bimodal, indicating 
the presence of two populations of cells as detected by 
141.16.6. Figure 31 shows the two parameter histogram of the 
bound 141.16.6 to B6.K2 spleen lymphocytes. Log fluorescence 
(LIGFL) is plotted versus cell size (SCAT1). This plot 
reveals that the two populations are cells of the same size 
but of different fluorescence intensity. 
Qa-2 antigen expression on B6.K2 and B6.K1 peripheral 
blood lymphocytes was investigated next. Figure 30B shows 
the immunofluorescence profile of bound 141.16.6 to B6.K2 
peripheral blood lymphocytes, which has been superimposed on 
Figure 30. Immunofluorescence profiles of bound 141.16.6 
(anti-Qa-2) to B6.K2 (Qa-2*) ( —) and B6.K1 
(Qa-2*) ( ) lymphocytes. 141.16.6 was used 
at a dilution of 1:10* and the fluorescein con­
jugate at a dilution of 1:200. (A) Qa-2 
expression on spleen lymphocytes. (B) Qa-2 
expression on peripheral blood lymphocytes 
Relative Log Fluorescence 
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Figure 31. Two parameter histogram of bound 141.16.6 (anti-
Qa-2) to B6.K2 (Qa-2*) spleen lymphocytes. LIGFL 
represents log fluorescence and SCAT1 represents 
cell size. The arrows show the position of the 
two peaks seen in the immunofluorescence profile 
(see Figure 30A). 141.16.6 was used at a 
dilution of 1:10* and the fluorescein conjugate 
at a dilution of 1:200 
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the Immunofluorescence profile of bound 141.16.6 to B6.K1 
control peripheral blood lymphocytes. The profiles are very 
similar to that of the spleen lymphocytes in Figure 30A. Qa-
2 antigens are easily detected on B6.K2 peripheral blood 
lymphocytes by 141.16.6 and no cross-reactivity between 
141.16.6 and the B6.K1 control lymphocytes is seen. 
The immunofluorescence profile of the bound 141.16.6 to 
B6.K2 peripheral blood lymphocytes is bimodal, indicating 
that in the peripheral blood two lymphocyte cell populations 
are detected by 141.16.6. This same pattern was also present 
in the B6.K2 spleen lymphocytes (see Figure 30A). Figure 32 
shows the two parameter histogram (LIGFL versus SCAT1) of the 
bound 141.16.6 to B6.K2 peripheral blood lymphocytes. Again, 
two parameter analysis shows that the two cell populations 
detected by 141.16.6 are the same size, but the fluorescence 
intensity is different. The identity of the two peaks is not 
known at this time. 
Detection of Qa-2 antigen on B6.K1 and B6.K2 morula and 
blastocyst embryos 
The expression of Qa-2 antigen on B6.K1 (Qa-2*) and 
86.K2 (Qa-2*) embryos was examined using 141.16.6 (anti-Qa-
2). Morula stage embryos were collected at 87 hours post-hCQ 
and blastocyst stage embryos at 96 hours post-hCG and the 
expression of Qa-2 antigen on their embryonic cell surfaces 
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Figure 32. Two parameter histogram of bound 141.16.6 (anti-
Qa-2) to B6.K2 (Qa-2*) peripheral blood lympho­
cytes. LIGFL represents log fluorescence and 
SCAT1 represents cell size. The arrows show the 
position of the two peaks seen in the immuno­
fluorescence profile (see Figure 30B). 141.16.6 
was used at a dilution of 1:10* and the 
fluorescein conjugate at a dilution of 1:200 
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analyzed by the embryo ELISA procedure. The dilutions of the 
141.16.6 monoclonal antibody, 1:8, and the G-gaTactosidase 
conjugate, 1:25, were based on the titration experiments 
described earlier (see Figures 18 and 19). The expression of 
Qa-2 antigen on morula and blastocyst embryos is shown in 
Figure 33 and the data in Table 16. 
Qa-2 antigen can be detected at the blastocyst stage of 
development in the B6.K2 mouse but not on embryos in the 
B6.K1 mouse, as expected. This confirms previous reports of 
Qa-2 antigen expression on preimplantation mouse embryos by 
Warner et al. (1987a) using an IgM monoclonal antibody. 
Figure 33 also shows that Qa-2 antigen can be detected at the 
morula stage of development in the B6.K2 mouse but not in the 
B6.K1 mouse. This also confirms data which inferred that Qa-
2 antigen is present on morula stage embryos (see Figure 3 in 
Warner et al., 1987a). 
Detection of Qa-2 antigen on C57BL/6 soleen Ivmohocvtes with 
a panel of anti-Qa-2 monoclonal antibodies 
A panel of anti-Qa-2 hybridoma supernatants was tested 
for its reactivity to Qa-2 antigen on C57BL/6 (Qa-2*) spleen 
cells by using the indirect immunofluorescence assay and the 
EPICS flow cytometer. B6.K1 (Qa-2b) spleen lymphocytes were 
used as the negative cell control for each supernatant. The 
protein concentration of these anti-Qa-2 supernatants is 
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Figure 33. Qa-2 expression by B6.K2 (Qa-2*) and B6.K1 
(Qa-2b) embryos. Morula and blastocyst embryos 
were collected at 87 and 96 hours, respectively, 
and assayed for the presence of Qa-2 antigen by 
the embryo ELISA. 141.16.6 (anti-Qa-2) was used 
at a dilution of 1:8 and the 3-galactosidase 
conjugate at a dilution of 1:25. Results are 
reported as the A410nm per well (15 embryos/ 
well). A total of 45 embryos were used for each 
point. The error bars represent the standard 
error of the mean 
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Table 15. Detection of Qa-2 antigen on B6.K2 (Qa-2*) and 
B6.K1 (Qa-2*) embryos with 141.16.6 (anti-Qa-2) 
Mouse 
Strain 
Stage of 
Development 
A410nm/ 
Well* 
Mean A410nm/ 
Well (SEM) 
B6.K2 blastocyst 
0.64 
0.60 
0.66 
0.63 (0.02) 
B6.K1 blastocyst 
0.12 
0.09 
0.12 
0.11 (0.01) 
B6.K2 morula 
0.40 
0.43 
0.41 
0.41 (0.01) 
B6.K1 morula 
0.08 
0.06 
0.12 
0.09 (0.02) 
*Each well contained 15 embryos. 
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unknown so they were not diluted but rather used at the 
concentrations at which they were received. All of the 
supernatants tested were from hybridomas that secrete 
monoclonal antibodies of the IgGb# class. The reactivity of 
141.16.6 (anti-Qa-2) with C57BL/6 and B6.K1 lymphocytes 
served as a control for the assay. The mean log fluorescence 
for the reaction of each supernatant with C57BL/6 or B8.K1 
lymphocytes was calculated by the INTGRA analysis program on 
the EASY 88 system and plotted in Figure 34. All of the 
supernatants reacted strongly with the Qa-2 expressed on 
C57BL/6 lymphocytes and did not crossreact with the B6.K1 
lymphocytes. In addition, bimodal immunofluorescence 
profiles were obtained from the reaction of the supernatants 
with the C57BL/6 spleen lymphocytes (data not shown). 
Detection of Qa-2 antigen on C57BL/6 embrvos with a panel of 
anti-Oa-2 monoclonal antibodies 
The hybridoma supernatants described above were then 
tested for their reactivity to the Qa-2 antigen expressed on 
C57BL/6 blastocyst stage embryos. C57BL/6 (Qa-2*) blastocyst 
embryos were collected at 93 hours post-hCG and then analyzed 
for Qa-2 expression using the embryo ELISA procedure. 
141.16.6 (anti-Qa-2) was used as the positive control and N-
S.8.1 (anti-SRBC) as the negative control. The results are 
shown in Figure 35. Only 15 embryos were used at each point 
Figure 34. Reactivity of a panel of anti-Qa-2 hybridoma supernatants with 
C57BL/6 (Qa-2* ) and B6.K1 (Qa-2'> ) spleen lymphocytes. The 
diagonally striped bars represent the mean log fluorescence of 
bound anti-Qa-2 antibodies to C57BL/6 spleen lymphocytes and the 
open bars represent the mean log fluorescence of the bound anti-
Qa-2 antibodies to 86.K1 control spleen lymphocytes. The hybri­
doma supernatants are described in the Materials and Methods 
section and the "695H" prefix to their designation has been 
dropped for convenience. 141.16.6 (anti-Qa-2) was run as a con­
trol and used at a dilution of 1:10*. The fluorescein conjugate 
was used at a dilution of 1:200. these dilutions are based on 
titration curves on C57BL/6 spleen lymphocytes which were 
identical to the curves in Figures 7 and 8 (C57BL/6 titration 
curves not shown) 
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Figure 35. Reactivity of a panel of anti-Qa-2 hybridoma eupernatants with 
C57BL/6 (Qa-2*) blastocyst embryos (collected at 93 hours post-
hCG) using the embryo ELISA. 141.16.6 (anti-Qa-2) (thick 
diagonally striped bars) and N-S.8.1 (anti-SRBC) (triplet 
diagonally striped bars) were run as controls at dilutions of 
1:8. The 6-galactosidase conjugate was used at a dilution of 
1:25. Results are reported as the A410nm per well (15 embryos/ 
well). A total of 15 embryos were tested with each supernatant 
or antibody control 
Absorbance at 410nm 
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due to the limited amount of supernatant available and the 
low numbers of embryos collected. Therefore, these results 
represent a preliminary study only. The hybridoma 
supernatants failed to detect the Qa-2 antigen on C57BL/6 
embryos at a level comparable to that of the 141.16.6 
monoclonal antibody. Two of the supernatants, 1-1-2 and 1-
12-1, appear to be detecting Qa-2 antigen above the 
background. The apparent lack of reactivity may be due to 
the unconcentrated nature of the supernatants we received 
from Dr. Sachs. 
Qa-2 antigen expression in various mouse strains 
Qa-2 expression on B6.K2 spleen and peripheral blood 
lymphocytes, when analyzed with 141.16.6, revealed bimodal 
immunofluorescence profiles (see Figures 30A,B). Figures 31 
and 32 showed that in both the spleen and peripheral 
populations, the cells in the two immunofluorescence peaks 
were of the same size but of different fluorescence 
intensity. 
To investigate whether the bimodal profile is due to the 
mouse strain or to the reaction of 141.16.6 with Qa-2, 
strains available in our mouse colony were tested for Qa-2 
expression on their peripheral blood lymphocytes. A summary 
of the strains tested and the number of peaks in their 
immunofluorescence profiles is shown in Table 16. The 
1 
Table 16. Summary of Qa-2 antigen expression on 
peripheral blood lymphocytes in various 
mouse strains 
Strain Qa-2 
Molecule 
H-2 
Haplotype 
No. of Peaks 
In IF Profile 
B6.K1 b b -a 
B6.K2 a b 2 
86. K3 a k 2 
B6.K4 b k -
C57BL/6 a b 2 
C57BL/10 a b 2 
BALB/CJ a d 1 
BALB/cBy b d -
BIO.BR b k -
Bio.M b f -
B i o .02 a d 1 
A a a 1 
•No positive fluorescence peaks in immuno­
fluorescence profile. 
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Immunofluorescence profiles for each strain Is shown in 
Figure 36. Included in Figure 36 are the B6.K1, B6.K2, and 
810.M strains, which had been tested earlier (see Figures 29 
and 30A,B). 
Table 16 and Figure 36 reveal that Qa-2* strains show 
both bimodal and unimodal immunofluorescence profiles. 
Strains that are Qa-2* show no positive fluorescence peak(s) 
as expected. Analysis of the two parameter histograms (LIGFL 
versus SCAT1) reveals that in the strains showing bimodal 
immunofluorescence profiles, the two peaks are cells of the 
same size but of different fluorescence Intensity (see Figure 
37). This was the same result seen in the B6.K2 mouse both 
in the peripheral blood and spleen lymphocytes. 
The results in Figure 34 reveal that a panel of anti-
Qa-2 monoclonal antibodies also detected two peaks on the 
C57BL/6 as did the 141.16.6 monoclonal antibody (see Figure 
36E). This suggests that the presence of two populations of 
cells is not due to the reaction of the 141.16.6 monoclonal 
antibody with the Qa-2 antigen, but to some physical 
difference between Qa-2 from different mouse strains. A 
possible explanation for this phenomenon can be found in the 
Discussion section. 
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Figure 36. Immunofluorescence profiles of bound 141.16.6 (ant1-Qa-2) to 
peripheral blood lymphocytes of various mouse strains. 141.16.6 
was used at a dilution of 1:10* and the fluorescence conjugate 
at a dilution of 1:200. The identity of the profiles is as 
follows: (A) B6.K1 (Qa-2»); (B) B6.K2 (Qa-2*); (C) B6.K3 
(Qa-2«); (D) B6.K4 (Qa-2'>); (E) C57BL/6 (Qa-2*); (F) C57BL/10 
(Qa-2*); (G) BIO.02 (Qa-2*); (H) A (Qa-2«); (I) BIO.BR (Qa-2«>); 
(J) BALB/cJ (Qa-2*); (K) BALB/cBy (Qa-2»); and (L) BIO.M 
(Qa-2«> ) 
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Figure 37. Two parameter histograms of bound 141.16.6 
(anti-Qa-2) to (A) C57BL/6 (Qa-2«) (B) C57BL/10 
(Qa-2«) and (C) B6.K3 (Qa-2") peripheral blood 
lymphocytes. LIGFL represents the log 
fluorescence and SCAT1 represents cell size. 
141.16.6 was used at a dilution of 1:10* and the 
fluorescein conjugate at a dilution of 1:200. 
The arrows show the positions of the two peaks 
seen in the immunofluorescence profiles (see 
Figure 36) 
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Genetic Linkage of the Ped Gene to the Qa Region 
Experimental plan 
The concordance of Ped gene expression with Qa-2 antigen 
expression, as shown by Warner et a1. (1988), along with the 
data presented earlier (Tables 8-12) suggests an association 
of the Ped gene with the Qa region of the mouse H-2 complex. 
To prove that the Ped gene is linked to the Qa region, one 
must show simultaneous segregation of Ped gene phenotype with 
a marker in the Qa region (Qa-2 antigen) in backcross or Fz 
generations. Experiments were undertaken to evaluate the 
linkage of the Ped gene with the Qa region. The experimental 
plan for the linkage study is shown in Figure 4 (see 
Materials and Methods). 
Ped gene linkage was examined in backcross embryos, 
produced by mating (B6.K29 x B6.K1<^)Fi females to B6.K1 
males. At 93 hours post-hCG about half of the backcross 
embryos should be fast (blastocyst stage) and half should be 
slow (morula stage). The scheme in Figure 4 shows that 
linkage of the Ped gene to the Qa region would require that 
the fast Ped allele (blastocyst embryos) segregate with 
expression of Qa-2 antigen, and the slow Ped allele (morula 
embryos) with the absence of Qa-2 antigen. 
One Important note concerning the linkage study is that 
early embryos do not show completely synchronous cleavage 
I 
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rates. Although Inbred strains show a much tighter 
distribution of cell number per embryo as compared to outbred 
strains, there is still a lack of synchrony in cleavage rates 
in the inbred embryos. Therefore, when the backcross embryos 
are divided into morulae and blastocysts, a small percentage 
of Qa-2*/b embryos could have still been morulae. 
Conversely, a small percentage of Qa-2b/b embryos could have 
advanced to the blastocyst stage. Assuming that the Fed gene 
phenotype segregates with Qa-2 expression, this could cause 
the morulae, when analyzed by the embryo ELISA procedure, to 
have higher absorbances at 410nm than morulae that are known 
to be Qa-2*/b. 
Qa-2 expression on backcross embryos 
Embryos were collected at 93 hours post-hCG and 55% of 
the embryos were at the blastocyst stage and 45% of the 
embryos were at the morula stage. These proportions were not 
significantly different from the 50:50 ratio expected as 
diagrammed in Figure 4. The results of the linkage study are 
shown in Figure 38 and the data in Table 17. The blastocyst 
embryos expressed Qa-2 antigen while the morula embryos did 
not. According to the scheme in Figure 4, if the Ped gene is 
linked to the Qa region, then the blastocyst embryos should 
express Qa-2 antigen and the morula embryos should not 
express Qa-2 antigen. The linkage experiment, therefore, 
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Figure 38. Qa-2 expression by backcross embryos. Backcross 
embryos were collected at 93 hours post-hCG and 
assayed for the presence of Qa-2 using the embryo 
ELISA procedure. 141.16.6 was used at a dilution 
of 1:8 and the G-galactosidase conjugate at a 
dilution of 1:25. The results are reported as 
the A410nm per well (15 embryos/well). A total 
of 30 embryos was used for each point. The error 
bars represent the standard deviations 
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Table 17. Expression of Qa-2 antigen on backcross embryos 
Developmental Stage A410nm/ Mean A410nm/ 
of Backcross Embryos Well* Well (SD) 
Blastocyst 0.54 0.61 (0.09) 
0.67 
Morula 0.18 0.18 (0.01) 
0.17 
"Each well contained 15 embryos. 
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shows that the Ped gene is linked to the Qa region. 
One interesting consideration is whether Qa-2 antigens 
would be detected on morulae even if they were expressed. 
With only 15 embryos per well the level of Qa-2 might be 
undetectable and hence the morulae would appear to lack Qa-2 
antigen. Figure 33 shows that morula stage embryos that are 
Qa-2*/* do have detectable levels of Qa-2, almost as high as 
the blastocyst stage embryos. Morula embryos that are Qa-
2b/b show no detectable levels of Qa-2 as expected. This 
confirms the backcross embryo ELISA results in Figure 38, 
which shows that the backcross morulae are not expressing Qa-
2 antigen and are Indeed Qa-2'»/*». Thus, the data in Figures 
33 and 38 support the hypothesis that the Ped gene is linked 
to the Qa region of the H-2 complex. 
Effect of the Ped Gene on Embryo Survival 
Previous studies by Gates (1965) showed that slow 
cleaving embryos survived to term only one-third as 
frequently as did fast cleaving embryos in embryo transfer 
experiments. This suggested that the Ped gene, by 
controlling the rate of cleavage divisions In embryos, may 
affect the survival of embryos to term. Backcross pups were 
generated as shown in Figure 5 (see Materials and Methods) 
and typed at weaning to determine If Ped slow embryos (Qa-
2«>/b) survived to term less frequently than Ped fast embryos 
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(Qa-2*/* or Qa-2b/*) because of their rate of development. 
If the Ped gene has no effect on embryo survival, then one 
would expect to see 60% of the backcross mice to be Qa-2*/^ 
or Qa-2*/* and 60% to be Qa-2*/*, as diagrammed In Figure 6. 
Because the Ped gene Is linked to the Qa region, the Qa-2 
antigen Is a marker for Ped gene phenotype. If the Ped gene 
affects the survival potential of embryos then this ratio 
would be distorted and In the favor of Qa-2*/b or Qa-2*/* 
mice. 
Qa-2 typing could not be done at birth because Qa-2 
expression Is not detectable until 3-4 weeks of age on spleen 
or peripheral blood lymphocytes (Kincade et al., 1980). 
Therefore, newly weaned pups (3 1/2 to 4 weeks of age) were 
Qa-2 typed. Only mice from Utters that had 100% survival to 
weaning were Qa-2 typed. This eliminates the possibility 
that ratio distortion could be due to death after birth and 
before weaning and typing. 
Figure 39 shows the immunofluorescence profile for a 
prepubertal mouse known to be Qa-2*/t> (generated from a B6.K2 
X B6.K1 mating) using the 141.16.6 (ant1-Qa-2) monoclonal 
antibody. B6.K1 (Qa-2b/*) spleen lymphocytes were used as 
the negative control. The bimodal Immunofluorescence profile 
usually seen with Qa-2" mice is lost, but the profiles in 
Figure 39 show that the Qa-2*/* mice can easily be 
distinguished from Qa-2'>/* mice. Figure 40 shows typical 
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Figure 39. Immunofluorescence profile of bound 141.16.6 
(anti-Qa-2) to (B6.K29 x B6.K1<J)Fi (Qa-2*/b) 
( ) spleen lymphocytes. B6.K1 (Qa-2»>/«>) 
(• ) negative control lymphocytes are also 
shown. 141.16.6 was used at a dilution of 1:10* 
and the fluorescein conjugate at a dilution 
of 1:200. The peripheral blood lymphocytes were 
from mice 4 weeks of age 
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gure 40. Immunofluorescence profile of bound 141.16.6 
(anti-Qa-2) to backcross 08-2*/* ( ) and 
Qa-2a/b ( ) spleen lymphocytes. 141.16.6 
used at a dilution 1:10* and the fluorescein 
conjugate at a dilution of 1:200. The 
lymphocytes were from mice that were 3 1/2 to 4 
weeks of age (newly weaned) 
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results from the Qa-2 typing of newly weaned backcross mice. 
The Qa-2*/b backcross mouse is easily distinguished from the 
Qa_2b/b mouse. Qa-2*/* backcross mice [(B6.K19 x B8.K2d)] 
show immunofluorescence profiles identical to the Qa-2*/» 
backcross mice [(B0.K29 x 86.Kid)] (data not shown). 
The results of the embryo survival study ars shown in 
Table 18. The chi-square analyses are shown in Tables 19 and 
20. Both backcrosses were studied to look at maternal 
effects on survival. The results Indicate that there is no 
greater potential for Qa-2*/* or Qa-2*/" embryos to survive 
to term than Qa-2*/* embryos in a maternal environment that 
expressed Qa-2 antigen. The Fed gene does not appear to 
affect embryo survival to term in the backcrosses studied. 
However, the more interesting backcross, which should be 
studied in the future, is that with a Qa-2*/* mother. 
The Role of Qa-2 Antigen in Reproduction 
B6.K1. B6.K2 and Fi litter data 
It has been observed that the B6.K2 strain is more 
efficient in reproduction than the B6.K1 strain (Warner et 
al., 1988). Because the B6.K1 and B6.K2 strains differ only 
in their expression of Qa-2 antigen, this observation 
suggested that the Qa-2 antigen may play a role in 
reproduction. To study the role of the Qa-2 antigen in 
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Table 18. Qa-2 genotype of backcross mice at weaning (3 1/2 
to 4 weeks of age)* 
Backcross Total No. Qa-2*/* Qa-2*/b 
No. Litters Mice Mice 
Typed 
(B6.K29 X B6.K1 d)Fi 9 X 
B6.K1d 30 6 14 16 
(B6.K1 9 X B6.K2d)Fi 9 x 
86.Kid 33 5 17 16 
'Only litters with 100% survival to weaning were used 
in this study. 
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Table 19. Chi-square analysis of (B6.K29 x B6.K1<')Fi 9 x 
B6.K1d backcross mice 
Hypothesis: The Fed gene does not affect embryo survival. 
Therefore, slow developing embryos (Qa-Z*/*) 
have an equal chance of surviving to term as 
do fast developing embryos (Qa-2*/*). 
Results: Observed Expected 
Qa-2«>/b 16 15 
Qa-2*/b 14 15 
The observed and expected values are not significantly 
different (0.75<P<0.65). 
Conclusion: The Ped gene does not affect embryo survival 
in the backcross studied. 
Table 20. Chi-square analysis of (B6.KI9 x B6.K2d)Fi 9 x 
B6.K1d backcross pups 
Hypothesis: The Ped gene does not affect embryo survival. 
Therefore, slow developing embryos (Qa-2*/b) 
have an equal chance of surviving to term as 
do fast developing embryos (Qa-2*/*). 
Results: Observed Expected 
Qa-2»/* 16 16.5 
Qa-2»/* 17 16.5 
The observed and expected values are not significantly 
different (0.95<P<0.75). 
Conclusion: The Ped gene does not affect embryo survival 
in the backcross studied. 
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reproduction, breeding cages of B6.K1, B6.K2, (B6.K19 x 
B6.K2 <)) and (B6.K2 9 x B6.K1d) mice were set up and birth 
weight, size of litter, the number of males and females born, 
and weaning weights recorded. 
A summary of the litter data for the B6.K1, B6.K2, 
(B6.K19X B6.K2d) and (B6.K2 9 x 86.Kl^) is shown in Table 21. 
The complete litter records can be found Tables 70-73 (see 
Appendix C). Statistical comparisons of birth weights 
between the different crosses, shown in Table 22, reveal that 
the B6.K2 pups weigh more at birth than the B6.K1 (P<0.001), 
(B6.K1 9 X B6.K2d)Fi (P<0.001), or (B6.K2 9X B8.K1d)Fi 
(P<0.05) pups. The 86.K1 birth weight was significantly less 
than a11 of the other crosses except the (B6.K19 x 86.K2d) 
cross. The (86.K2 9 x B6.K1d)Fi pups are statistically 
heavier at birth than the (B6.K19 x 86.K2d)Fi pups (P<0.001), 
suggesting that there is a maternal effect associated with 
the Qa-2 antigen. From the data, Qa-2* mice have heavier 
pups at birth than do Qa-2* mice, suggesting a Qa-2 effect on 
birth weight. In the Fi generations, there are both Qa-2 and 
maternal effects on birth weight. 
Table 23 shows the results of the statistical comparison 
of litter sizes between the different crosses. Essentially 
no significant differences were observed between the 
different crosses, with the exception of the comparison of 
86.K1 litter size and (B6.K2 9 x B6.K1 litter size and the 
Table 21. Summary of B6.K1, B6.K2, and Fi litter data. 
Litter records can be found in Tables 70-73 in 
Appendix C 
Cross 
No. of 
Pups 
Born 
Mean Birth 
Weight (g) 
(SEM) 
No. of 
Litters 
Born 
Mean 
Size 
Litter 
(SEM) 
B6.K19 x 
B6.K1d 
114 1.28 (0.01) 20 5.7 (0.5) 
B6.K29 X 
B6.K2d 
101* 1.37 (0.01) 16 6.3 (0.6) 
B6.K19 X 
B6.K2d 
108 1.30 (0.01) 18 6.0 (0.4) 
B6.K29 X 
B6.K1d 
134 1.34 (0.01) 18 7.4 (0.4) 
"Litter 4, cage 2 (see Litter Records for B6.K2 in Table 
71 in Appendix C) was not used in the analyses due to the 
loss of all 10 pups following birth. 
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No.9 Mean 9 No.d Mean (* Total % Survival 
Weaned Weaning Weaned Weaning Weaned to Weaning 
Wt. (g) Wt. (g) 
(SEM) (SEM) 
47 11.1 (0.2) 55 13.1 (0.2) 102 89.5 
48 11.6 (0.3) 43 12.8 (0.3) 91 90.0 
45 10.8 (0.2) 55 12.3 (0.2) 100 92.6 
65 10.9 (0.2) 61 13.0 (0.1) 126 94.0 
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Table 22. Comparison of B6.K2, B6.K1 and Fi birth weights* 
Comparison P 
B6.K2 vs. B6.K1 0.001 
B6.K2 VS. (B6.K19 X B6.K2<^) 0.001 
B6.K2 vs. (B6.K29 X B8.K1d)  0.05 
B6.K1 vs. (B6.K19 x B6.K2d) N.S.» 
B6.K1 VS. (B6.K29XB6.K1d) 0.001 
(B6.KI9 X B6.K2d)  vs. (B6.K29 X B6.K1d)  0.001 
•Paired comparisons were done using Student's t tests. 
*N.S. = not significantly different. 
Table 23. Comparison of B6.K2, B6.K1 and Fi litter sizes* 
Comparison P 
B6.K2 vs. B6.K1 N.S.» 
B6.K2 vs. (B6.KI9 X B6.K2d)  N.S. 
B6.K2 vs. (B6.K29 X B6.K1d) N.S. 
B6.K1 VS. (B6.K1 9 X B6.K2d) N.S. 
B6.K1 VS. (B6.K29XB6.K1d) 0.01 
(B6.KI9 X B6.K2d)  vs. (B6.K29 X B6.K1 d) 0.01 
•Paired comparisons were done using Student's t tests. 
GN.S. = not significantly different. 
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comparison of the two Fi crosses. The (B6.K29 x 86.Kid) 
litter size Is significantly higher than the 86.K1 litter 
size (P<0.01) and the (B6.K19 x B6.K2d) Utter size. The 
data suggest that when the Qa-2 antigen Is expressed In the 
maternal environment larger litter sizes result. However, no 
significant difference was found between 86.K2 litter size 
and 86.K1 litter size, even though the B6.K2 maternal 
environment Is Qa-2* and the 86.K1 maternal environment Is 
not. The maternal effect on litter size may only be present 
In Fi crosses or backcrosses which have not been tested. 
Table 24 shows the statistical analyses of the female 
weaning weights. The only statistically significant result 
Is the comparison of the 86.K2 weaning weight to both of the 
Fi crosses. The 86.K2 weaning weight Is significantly higher 
than the (B6.K19 x B6.K2d) (P<0.01) and the (86.K29 x 86.Kid) 
weaning weights. 
The statistical analyses of the male weaning weights is 
shown in Table 25. In the males, the 86.K1 weaning weight is 
significantly higher than the (86.K19 x 86.K2d) (P<0.001) and 
the (B6.K29 X 86.Kid) is significantly higher then the (B6.K19 
X 86.K2d) (P<0.001). There are no other statistically 
significant results from the male weaning weight data. 
The male and female weaning weight data does not reveal 
any maternal or Qa-2 effects on weaning weights. The males 
are larger at weaning than the females (see Table 21), as 
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Table 24. Comparison of B6.K2, B6.K1 and Fi female weaning 
weights* 
Comparison P 
B6.K2 vs. 86.K1 N.S.» 
B6.K2 vs. (B8.K19 X B6.K2d) 0.01 
B6.K2 vs. (B8.K2 9 X B8.Kld) 0.01 
B6.K1 VS. (B6.K19X B6.K2d) N.S. 
B6.K1 VS. (B6.K29 X B6.K1d) N.S. 
(B6.K1 9 X B6.K2d) vs. (B6.K2 9 x B6.Kld) N.S. 
•Paired comparisons were done using Student's t tests. 
bN.S. = not significantly different. 
Table 25. Comparison of B6.K2, B6.K1 and Fi male weaning 
weights* 
Comparison P 
B6.K2 vs. B6.K1 N.S.» 
B6.K2 vs. (B6.K1 9 X B6.K2 <0 N.S. 
B6.K2 VS. (B6.K2 9X B6.K1 <0 N.S. 
B6.K1 VS. (B6.K1 9 X B6.K2<^ 0.001 
B6.K1 VS. (B6.K2 9X B6.K1 d) N.S. 
(B6.K1 9 X B6.K2 <0 VS. (B6.K2 9 x B6.K1 ^  0.001 
* Pal red comparisons were done using Student's t tests. 
bN.S. = not significantly different. 
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expected, but no other concluelone concerning the role of the 
Qa-2 antigen on weaning weight can be drawn from theee data. 
The percent eurvlval to weaning of each of the croseee 
le ehown In Table 21. The (B6.K29 x B6.K1d)Fi mice had the 
beet eurvlval rate from birth to weaning, followed by the 
(B6.K1 9 X B8.K2d)Fi mice. The B6.K1 and B6.K2 had 
approximately the eame survival rate. The higher survival 
rate of the Fi mice Is probably due to hybrid vigor. 
The sex ratio of B6.K1, B6.K2, and Fi crosses was 
examined for Qa-2 effects on the sex ratio. Although mice 
can be sexed at birth, It Is a difficult and somewhat 
Inaccurate method of determining the sex ratio. In the 
present study, mice were allowed to develop to weaning and 
then sexed. Only data from litters that had all of the pups 
surviving to weaning were examined for sex ratio distortion. 
A summary of the sex ratio data is shown in Table 26. In 
each of the crosses the sex ratio is not significantly 
different from the expected ratio of 50:50, suggesting that 
there is no Qa-2 antigen effect on the sex ratio. The % 
males in the (B6.K1 ? x B6.K2 0 cross (58.IX) is different 
from the expected value of 50%, however, statistically, the 
probability is between 0.2 and 0.1. The sex ratio may be 
approaching significance and with a larger sample size this 
could be determined. 
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Role of the maternal environment before implantation 
The finding that there are effects of the maternal 
environment expressing Qa-2 antigen on birth weights and 
litter size in Fi crosses suggests that there may be maternal 
effects on the rate of embryo development before 
implantation. Differences in the rate of development may 
account for differences in birth weights and in litter sizes, 
as suggested by Noyes et a1. (1961) in rats and by Doyle et 
a1. (1963) in mice. The mean cell number per embryo at the 
blastocyst stage (89 hours post-hCG) was examined In both of 
the Fi crosses used in the reproduction study. The results 
are shown in Table 27. 
At 89 hours post-hCG the mean cell number per embryo in 
the (B6.K19 X B6.K2^) embryos is not significantly different 
from that of the (B6.K2 9X B6.K1(* ) embryos. Differences in 
birth weight and litter size in Fi crosses can not be 
explained by differences in the rate of development during 
the preimplantation period. 
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Table 26. Number of males and females weaned from litters 
with 100% survival to weaning of B6.K1, B6.K2, 
and Fi mice. Litter records can be found in 
Tables 70-73 in Appendix C 
Cross No. 9 No. d Percent 
Weaned Weaned Male* 
B6.K1 9 X B6.K1 39 34 53.4 
B6.K2 9 X 
r> CM (D CO 36 40 47.4 
B6.K1 9 X B6.K2d 43 31 cn
 
00
 
B6.K2 9 X B6.Kld 52 53 49.5 
"The number of males (and females) in each of the 
crosses is not significantly different from the expected 
ratio of 50:50 by chi-square analysis. 
Table 27. Mean cell number per embryo at 89 hours post-
hCG in Fi crosses. Raw data shown in Tables 
67-68 (see Appendix A) 
No. of No. of Mean Cell No./ 
Fi Cross Embryos Expts. Embryo (SEM) 
Scored 
(B6.K1 9 X 
CM <
o a
 62 2 32.4 (1.5)" 
(B6.K29 X B6.K1 d) 52 2 29.4 (1.4) 
•Not significantly different from (B6.K29 x B6.K1d ). 
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DISCUSSION 
This dissertation reports the investigation of some of 
the non-immune functions of the mouse Major Histocompati­
bility Complex, or H-2 complex. Specifically, the role of 
the H-2 complex was studied in preimplantation embryo 
development and reproduction. The Ped (preimplantation 
embryo development) gene, a gene located in the H-2 complex, 
was studied for its role in various aspects of mouse embryo 
development. An antigen encoded by the H-2 complex, the Qa-2 
antigen was also studied for its role in reproduction in the 
mouse. 
Analysis of the Ped Gene 
The control of embryonic cleavage division is a complex 
phenomenon. Many factors can affect the rate of development 
in embryos, both genetic factors (maternal and embryonic) and 
environmental factors. The maternal genotype can have 
significant effects on the timing of the first cleavage 
(Chapman et al., 1977; Shire and Whitten, 1980; Moler et al., 
1981). Moler et al. (1981) found that the genotype of the 
embryo also plays a role in the rate of development in mouse 
lines selected for high embryo survival. The time of 
ovulation may also play a role in determining the timing of 
the first cleavage division and hence account for differences 
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In the rate of development (Edwards and Gates, 1959). 
Environmental factors such as the rate at which spermatozoa 
reach the site of fertilization In the oviducts and the rate 
at which It penetrates the zona pelluclda can also determine 
the timing of the first cleavage division and subsequent rate 
of cleavage divisions (Edwards and Gates, 1959; McLaren and 
Bowman, 1973; Krishna and Generoso, 1977). 
A gene has been described. Fed, which influences the 
rate of cleavage division in preimplantation mouse embryos 
(reviewed in Warner, 1986, and Warner et al., 1988). 
Previous studies on the Fed gene were conducted on embryos 
collected after development in the uterine environment (in 
vivo development), so it was not dear whether the phenotypic 
expression of the Fed gene, fast and slow developing embryos, 
was due to the uterine environment or to gene(8) in the 
embryos themselves. Studies on uterine secretions from 
several species have revealed an abundance of nutritive 
substances, cofactors, and hormones released by the maternal 
environment (reviewed by Johnson, 1979). It has been 
suggested that embryos are under a uterine control that 
appears to operate through deprivation of these nutrients, 
cofactors and hormones (Van Blerkom et al., 1979; Aitken, 
1979). These experiments suggest that slow and fast 
embryonic development may be due to forces in the uterine 
environment. 
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To test for Ped gene expression in embryos, independent 
of the uterine environment and control, embryos were 
collected and cultured in vitro and their Ped gene phenotype 
determined after in vitro development. Figures 21-25 and 
Tables 6 and 7 clearly demonstrate that Ped gene phenotype is 
maintained by embryos cultured In vitro. These experiments 
show that Ped gene expression is an intrinsic property of the 
embryos themselves. The control of cleavage divisions in 
early embryos is largely dependent on the genotype of the 
embryos themselves, namely the Ped gene. 
Differences in cleavage rates in embryos cultured in 
vitro are also not due to differences in ovulation times 
(response to hCG) between slow and fast developing strains, 
as shown in Figures 26 and 28. All of the strains used in 
the in vitro (see Figures 21-25 and Tables 6 and 7) and in 
vivo (see Figure 27 and Table 8) studies of Ped gene 
expression ovulated at approximately the same time, whether 
or not they were slow or fast developing strains. Earlier 
studies by Goldbard et al. (1982a) had shown that the Ped 
gene did not Influence the time of ovulation, and that Ped 
gene expression was not due to differences In response to 
hCG. The results In Figure 26 confirm previous work by 
Goldbard et al. (1982a). The Ped gene phenotype of 
developing embryos is due neither to the influence of the 
uterine environment nor to differences In response to hCG 
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between slow and fast developing mouse strains. 
Variation in cell number per embryo between slow and 
fast developing strains may be due to differences in how 
quickly the sperm reaches the site of fertilization or the 
rate at which the sperm penetrates the egg. Esworthy (1979), 
using artificial Insemination, found that Inbred mouse 
strains fertilized at the same time maintained differences In 
cell number per embryo at the blastocyst stage of 
development. The rate of travel to the oviducts for 
fertilization did not account for differences In the rate of 
development. A similar result was obtained by Niwa et al. 
(1980). Although the rate of sperm penetration has not been 
studied In the Inbred strains used In this dissertation, 
differences in penetration might account for differences in 
the first cleavage division, but not differences in the 
subsequent rate of development. Ped gene expression affects 
not only the first cleavage but also the subsequent rate of 
development (Goldbard et al., 1982a; see Figure 27). 
The association of the Ped gene with the Qa region had 
been suggested by the concordance of Ped gene expression and 
expression of the Qa-2 antigen, a marker in the Qa region 
(see Table 2; Warner et al., 1987b; Warner et al., 1988). 
Studies were presented that further support the association 
of the Ped gene with the Qa region. Recombinant congenic 
mouse strains on the C57BL/6 strain, differing only in the 
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genes of the Qa region, showed concordance of the fast Ped 
allele with Qa-2 expression, and the slow Ped allele with the 
lack of Qa-2 expression (see Figure 27 and Tables 8-10). 
Analysis of BALB/c substrains, which differ by genes of the 
Qa region, as shown in Tables 11-12, also support the 
association of the Ped gene with the Qa region. 
Background genes have been suggested to influence early 
embryo development as well as the Ped gene (Qoldbard and 
Warner, 1982). The BALB/c substrain data in Tables 11-12 
show that background genes (non-H-2 genes) do influence the 
rate of development, supporting the work of Qoldbard and 
Warner (1982). Although the BALB/cBy strain (Qa-2*) appears 
to be a fast developing strain when compared to other slow 
and fast developing strains, when compared to the BALB/cJ 
(Qa-2"), it is a slow developing strain. This further 
supports the association of the Ped gene with the Qa region. 
The finding that the BALB/cJ is a fast developing strain 
is inconsistent with that found by Qoldbard et al. (1982a), 
who found that the BALB/cJ is a slow developing strain. A 
possible explanation for this discrepancy may lie in the 
origin and maintainence of the BALB/cJ and BALB/cBy strains. 
The BALB/cBy was separated from the BALB/cJ strain at the 
National Institutes of Health in 1951, apparently because of 
a spontaneous mutation from Qa-2# to Qa-2* and became a part 
of the Jackson Laboratory (JAX) stock in 1974. Recently, 
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both the BALB/cJ and BALB/cBy were rederived due to Increased 
Interest in these mice because of work on the Qa-2 antigen. 
It has recently been suggested that the original BALB/cJ DNA 
library used for cloning H-2 complex genes was from a mixture 
of BALB/c substrains (R. Qoodenow, personal communication). 
Hence, work done on the BALB/cJ strain, prior to when the 
stocks were rederived, may reflect the impure nature of the 
BALB/cJ. The BALB/cJ mice used by Goldbard et a1. (1982a) 
could have been from the original BALB/cJ lines (before they 
were rederived), and therefore the nature of the BALB/cJ 
strain used by Goldbard et al. (1982a) would be suspicious. 
The BIO.M strain (H-2^), hypothesized to be a slow 
developing strain because of the massive deletions in the Qa 
region (Q1-Q9 genes are deleted), turned out to be a fast 
developing strain, faster than a11 other strains analyzed 
thus far (see Tables 13 and 14). Immunofluorescence analyses 
confirmed that this strain is indeed serologically Qa-2«» (see 
Figure 29). O'Neill et al. (1986) has suggested that in the 
H-2* haplotype, genes in the H-2K, H-2D, or Tla regions may 
serve the functional role of the deleted Qa region genes. 
The serological and DNA hybridization studies (Cook et al., 
1983; Figueroa et al., 1983; Sharrow et al., 1984; Weiss et 
al., 1984) show a great deal of similarity between the H-2K 
genes and the Qa region genes. Because this similarity is 
postulated to have occurred from a translocation of a pair of 
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Qa region genes to the K region, it has been suggested that 
in the H-2f haplotype the K region genes might have enough 
similarity to the Qa region genes to function as Qa region 
genes (O'Neill et al., 1986). In the BIO.M strain, genes in 
the K region or other genes in the H-2 complex may be 
compensating for the extensive deletions in the Qa region and 
therefore causing the BIO.M embryos to be Fed fast. Another 
possible explanation for the BIO.M results may lie in the 
derivation of the strain. The cross-over point that produced 
the BIO.M from the C57BL/10 x A.CA mating is unknown (Chella 
David, personal communication). The BIO.M strain carries the 
BIO background genes and the genes of the H-2f haplotype A.CA 
strain, but because the exact cross-over points are unknown, 
BIO genes might be present in the BIO.M strain and they might 
influence embryo development. 
Despite the BIO.M results, all of the other strains 
examined (see Tables 2 and 9-12) have shown an association of 
the Ped gene with the Qa region of the H-2 complex. Studies 
were undertaken to show formal linkage of the Ped gene with 
the Qa region. The results, shown in Figures 38 and Table 
17, show the segregation of the fast Ped allele with Qa-2 
antigen expression, therefore, the Ped gene is linked to the 
Qa region. These results and the concordance of Qa-2 antigen 
and Ped gene expression (Table 2), clearly demonstrate that 
the Ped gene is located in the Qa region of the H-2 complex. 
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The function of Qa region genes is unknown. Several 
Tines of evidence suggest that Qa region genes have Important 
biological roles (Robinson, 1987a). First, although the 
number of Qa region genes varies between strains, allelic 
genes and their products appear to be highly conserved. Qa 
region molecules lack a great deal of polymorphism. Second, 
the limited tissue distribution suggests an important role 
for Qa region genes. The distribution of Qa antigens on 
cells of the hematolymphoid system, suggests that Qa region 
genes may function in hematopoeitic/lymphoid cell 
differentiation (Harris et al., 1984). Finally, the fact 
that all Qa region proteins occur in a soluble form suggests 
that they may have a regulatory function in the immune 
system. This seems especially true of the Qa-2 antigen which 
is secreted by activated T lymphocytes (Soloski et al., 
1986). 
The finding that the Ped gene is located in the Qa 
region of H-2 complex is the first evidence which suggests a 
function for a Qa region gene. Assigning a function to one 
of the Qa region genes (control of embryonic cleavage 
divisions) suggests that other genes in this region may also 
function In development. Harris et al. (1984), based on the 
activation of Qa/Tla region genes in embryonic carcinoma cell 
lines, has suggested that Qa region genes may regulate groups 
of genes during embryonic development. This is supported by 
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Fahrner et al. (1987), who has suggested that class I genes 
may be developmental1y regulated and function In non-Immune 
processes such as cell-cell Interaction during embryogenesls. 
Expression of Qa-2 Antigen on Embryonic and Adult Cells 
The expression of Qa-2 antigen on preImplantation mouse 
embryos (Figure 33 and Table IS) confirms previous work by 
Warner et al. (1987a) using a different monoclonal antibody 
against the Qa-2 antigen. Transplantation class I H-2 
antigens have also been detected on preImplantation mouse 
embryo surfaces (Cozad and Warner, 1981, 1982; Qoldbard et 
al., 1984; Qoldbard et al., 1985). The presence of Qa-2 
antigens and class I transplantation antigens on 
preimplantation mouse embryos supports the hypothesis that 
class I genes are developmental 1 y regulated and may function 
in developmental processes. 
The immunofluorescence detection of Qa-2 antigen on 
peripheral blood and spleen lymphocytes using the EPICS flow 
cytometer showed that some of the Qa-2* strains had bimodal 
Immunofluorescence profiles (see Figure 36 and Table 16). 
Analysis of the two parameter histograms revealed that the 
two peaks seen in the immunofluorescence profiles were due to 
the binding of 141.16.6 to Qa-2 on cells of the same size. 
However, the cells were of different fluorescence Intensity 
(see Figures 31, 32, and 37). 
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The presence of the two populations of cells is probably 
not due to differential detection of Qa-2 antigen on B and T 
lymphocytes. In the mouse spleen, approximately 66% of the 
cells are B lymphocytes and 35% are T lymphocytes. In the 
peripheral blood, approximately 30% of the cells are B 
lymphocytes and 70% are T lymphocytes. It is known that Qa-2 
antigen is expressed on >95% of T lymphocytes and only on a 
small subpopulation of B lymphocytes (-25%) as determined by 
fluorescence-activated cell sorter analysis using 141.16.6 
(Hogarth et al., 1982). In Figure 30 approximately 70% of 
the cells analyzed expressed Qa-2 antigen, both in the spleen 
and in the peripheral blood. This is inconsistent with the 
percentage of T and B lymphocytes that express Qa-2 in the 
spleen and in the peripheral blood. 
Recently, Robinson et al. (1987) has demonstrated a 
number of Qa-2 precursor forms detectable by two-dimensional 
gel electrophoresis between different Qa-2* strains of mice. 
Three groups of polypeptides. A, B, and C (each with a 
molecular weight of 39,000 daltons) were detected and it was 
found that AB and ABC could give rise to cell surface Qa-2, 
but only group A polypeptides were essential. Qa-2'> mice 
showed no A, B, or C precursor polypeptides in their 2-D gel 
patterns. Interestingly, strains that were found to have 
only one peak in their immunofluorescence profile 
corresponded to the strains that have only the A precursor, 
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and strains that had two peaks In their immunofluorescence 
profiles corresponded to strains that had the AB precursors. 
A summary of the immunofluorescence profile results and the 
relationship to the Robinson et al. (1987) work is shown in 
Table 28. 
The correlation of the two peaks seen in the 
immunofluorescence profiles and the number of precursor 
polypeptides in Qa-2 2-D gels suggest that the different 
precursor polypeptides give rise to the one or two peaks in 
the immunofluorescence profiles. The number of polypeptides 
observed in the 2-D gels also correlates with the hypothesis 
that multiple genes (probably Q6-Q9) encode the Qa-2 antigen 
(Mellor et al., 1985). Robinson et al. (1987) suggest that 
the Q6-Q9 genes give rise to the three precursor polypeptides 
and are combining to form the Qa-2 antigen. 
The level of Qa-2 antigen expression, as determined by 
the amount of fluorescence, is higher for strains showing 
bimodal immunofluorescence profiles than for strains showing 
only one peak. This correlates with the finding that Qa-2 
antigen expression is higher for strains that are H-2D* than 
for strains that are H-2D^ (Hogarth et al., 1982). Strains 
that showed bimodal profiles are H-D* (C57BL/6, C57BL/10, 
B6.K2 and B6.K3), whereas strains that showed only one peak 
are H-2D<* (BALB/cJ, B10.D2, and A). 
Another observation concerning expression of Qa-2 on 
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Table 28. Relationship of number of peaks in the immuno 
fluorescence profiles (see Figure 36 and 
Table 16) and the number of precursor poly­
peptides in 2-D gel electrophoresis by 
Robinson et al. (1987) in various mouse 
strains 
Strain Qa-2 H-2 No. Peaks in Precursor 
Haplotype IF Profile Groups* 
C57BL/6 a b 2 ABC 
C57BL/10 a b 2 ABC 
B6.K2 a b 2 ABC 
86. K1 b b -b -
BALB/cJ a d 1 A 
BALB/cBy b d - -
A/J a a 1 A 
*Adapted from Robinson et a1. (1987), Table 1. 
»No peaks or precursor groups. 
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spleen and peripheral blood lymphocytes, is that the level of 
Qa-2 expression appears to be lower than other class I 
antigen (K, D, and L) expression. In order to detect the 
presence of the Qa-2 antigen, the photomuitiplier tube (PMT) 
voltage was turned up to increase the sensitivity to the 
fluorescence signal and the cells were analyzed on the log 
fluorescence scale to amplify the fluorescence signal. 
Studies of H-2K, D, and L antigen expression show high levels 
of expression on the linear fluorescence scale and the PMT 
voltage is kept low to keep the level of fluorescence on 
scale (data not shown). This suggests that the level of H-
2K, D, and L class I protein expression is higher on 
lymphocytes than the level of Qa-2 antigen expression. 
Further work is needed to confirm this observation. 
Comparison of the expression of Qa-2 antigen on 
lymphocytes (Figure 36) and on embryonic cells (Figures IT-
IS and 33) reveals that Qa-2 gene expression in adult cells 
is the same as in embryonic cells for the B6.K1, B6.K2, and 
C57BL/6 strains. It is interesting to speculate whether 
there in an embryonic form of Qa-2 and an adult form of Qa-2. 
Since it is believed that either Q7 and/or Q9 or Q6 and/or Q8 
genes encode the Qa-2 antigen (Mel lor et al., 1985; O'Neill 
et al., 1986; Waneck et al., 1987; Sherman et al., 1988), 
Q6/Q8 genes may be expressed in embryonic cells and Q7/Q9 
genes in adult cells or vice versa. 
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A panel of ant1-Qa-2 monoclonal antibodies recently 
developed by David Sachs may be able to recognize different 
epitopes on the Qa-2 antigen as determined by the Q6/Q8 or 
Q7/Q9 genes. If these antibodies do recognize Qa-2 as 
encoded by Q6/Q8 or Q7/Q9 then they could be used to 
determine if there is an adult and embryonic form of Qa-2. 
This panel of antibodies was tested on adult cells (see 
Figure 34), and it was found that all of the antibodies 
reacted with Qa-2 antigen on adult lymphocytes. When tested 
on embryos (see Figure 35), only two of the antibodies 
appeared to react with the Qa-2 expressed on embryos. As 
mentioned in the Results section, this lack of reactivity is 
probably due to the antibodies being in a dilute form. 
However, the possibility that these antibodies recognize 
epitopes common to the adult form of Qa-2, but not to the 
embryonic form of Qa-2 cannot be ruled out. In order to 
determine whether embryonic and adult forms of Qa-2 antigen 
exist, these monoclonal antibodies should be tested on 
lymphocytes and embryos in a more concentrated form, such as 
ascites fluid. 
Evaluation of the Embryo ELISA 
The embryo ELISA technique, used in this dissertation 
for the detection of Qa-2 antigens on embryos, is a highly 
sensitive technique, but is at times somewhat inconsistent. 
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The assay used is a modification of the assay described by 
Goldbard et al. (1984), in which a primary antibody against 
H-2 antigens is used, then a rabbit anti-mouse antibody is 
added, a protein A-G-galactosidase conjugate is added that 
binds to the rabbit anti-mouse antibody, and finally the 
substrate is added. This assay utilized five embryos per 
well and appeared to be pushing the limits of detection with 
so few embryos. Previous work by Gollnick (1986) also showed 
that the second antibody (rabbit anti-mouse) or the protein 
A-G-galactosidase conjugate had deteriorated in quality and 
resulted in inconsistent results. Because of this problem 
the assay was modified to have only two layers, the primary 
antibody and the G-galactosidase conjugate, without the 
protein A. Although this method has worked quite well, there 
are times when no yellow color (yellow color is indicative of 
the presence of Qa-2 antigen on the embryo) appears after a 
4-5 hour incubation with the substrate. 
The lack of yellow color in the final step of the embryo 
ELISA may be attributed to several things. First, the 3-
galactosidase conjugate used (from Bethesda Research 
Laboratories) was designed for use as a hybridoma screening 
reagent, and the exact active protein concentration and the 
number of G-galactosidase enzymes conjugated to antibody 
molecules are unknown. With a heterogeneous reagent, 
inconsistencies in results might be expected. Second, due to 
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rapid turnover of H-2 protein on the cell surface (Klein, 
1986), we may be performing the assay at points when varying 
amounts of Qa-2 antigen are on the cell surface. Finally, 
Qa-2 antigen on embryonic surfaces may be first expressed on 
the cell surface and then secreted (as in the activated T 
lymphocytes). If this is true, the primary antibody may be 
binding to Qa-2 that is later released and washed away during 
the wash steps. Or, due to secretion of Qa-2, there might be 
a variable amount of Qa-2 on the cell surface depending on 
when the assay is performed. It is important to note that 
increasing the number of embryos per well from five to 
fifteen has greatly improved the assay's reliability. 
Despite the problems, the embryo ELISA is a highly sensitive 
assay for use in detection of H-2 antigens on embryonic cell 
surfaces. Ways to modify the ELISA to make it more 
consistent and reliable will be discussed in the Further 
Experiments section. 
Effect of the Fed Gene on Embryo Survival 
Wilmut et al. (1986) has suggested that one cause of 
embryonic loss is an inappropriate relationship between the 
developing embryo and the uterine environment. A lack of 
synchronous development between the embryo and the uterus has 
been shown to cause embryonic death (McLaren and Michie, . 
1956; Noyes and Dickmann, 1960; Noyes et al., 1963; Webel et 
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al., 1970; Pope and First, 1985; Wllmut et al., 1986). 
Studies In various mammals have shown that variation In 
developmental stage can prejudice embryo survival by causing 
asynchronous development. In pigs, considerable variation in 
the stages of embryo development exists within a single sow 
(Dziuk, 1987). In studies to determine the effect of this 
variation on embryo survival it was found that embryos at a 
later stage of development had a better chance of survival 
than their less developed counterparts (Pope et al., 1982; 
Wilmut et al., 1986). In humans, Buster et al. (1985) found 
that embryos collected from a single uterus at the same time 
after fertilization exhibited great variability in their 
developmental stage. When transferred synchronously to a 
recipient uterus it was found that the more developed the 
embryos, the greater the chance of ensuing pregnancy. 
These studies all suggest that the tempo of development 
during the prelmplatantion period may be crucial in 
determining embryo survival. The control of the tempo of 
embryo development in mice can now be attributed largely to 
expression of the embryonic genome, specifically, expression 
of the Ped gene. The Ped gene, by controlling the rate of 
development, may have an important role in embryo survival. 
Gates (1965) found that when transferring slow cleaving 
embryos and fast cleaving embryos to a recipient uterus, the 
faster developing embryos survived to term one-third more 
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frequently than the slow developing embryos. Experiments 
were designed to study whether fast developing embryos (Ped 
fast) had a greater chance of survival to term than did slow 
developing embryos (Ped slow) (see Figure 5). 
In order to investigate the relationship between the 
rate of cleavage divisions (Ped gene expression) and 
embryonic survival, backcross mice were generated and their 
Qa-2 type determined. The Qa-2 antigen acts as a marker for 
the Ped gene because of its linkage relationship (see Figure 
38). Distortions of the expected 50:50 ratio in Qa-2 
expression of the backcross mice would indicate that the Ped 
gene, by influencing the rate of preimplantation development, 
influences embryo survival. As seen in Tables 18-20, in the 
two backcross generations of mice studied, the Ped gene did 
not appear to influence embryo survival. 
In these embryo survival studies the genotype of the 
maternal environment was essentially the same ((B6.KI9 x 
B6.K2cJ)Fi = Qa-2«»/« versus (B6.K2?x B6.K1 d )Fi = Qa-2»/«»). 
The embryonic genotype does not appear to influence embryo 
survival, but the data suggests that maternal genotype may be 
important. The expression of Qa-2 in the maternal 
environment in which the embryos were developing, allowed for 
equal survival of slow (Qa-2*/*) and fast (Qa-2*/'» or Qa-
2*/*) developing embryos. Possibly the presence of Qa-2 
antigen in the maternal environment helped the development of 
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the slow developing embryos. 
It has been suggested that the development of the embryo 
requires the female genome, whereas development of the 
placenta and membranes surrounding the embryo require the 
paternal genome (reviewed by Marx, 1988). The effect of the 
maternal genotype on embryo survival can best be seen in the 
DDK strain of mice. When DDK females are mated to males of 
other strains, high embryonic loss is encountered (Chapman et 
al., 1977). This effect is not seen when DDK males are mated 
to females of other strains. These findings imply that the 
maternal genotype has a profound effect on embryo survival. 
The original study focused on whether the Fed gene, by 
controlling the rate of development of embryos, is a 
determining factor In embryo survival. This study appears to 
indicate that maternal genotype (Qa-2 expression) may be more 
Important in determining embryo survival than embryonic 
genotype (presence of the fast Fed allele) in the crosses 
studied. It is Important to note that Gates' 1965 study, on 
which this study is based, Involved selection, through in 
vitro culturing of embryos, for the very slowest and fastest 
developing embryos within one strain of mice (an outbred 
strain). In an outbred strain of mice, the very slowest 
embryos probably would not survive the preimplantation period 
because of the deleterious effects of asynchronous 
development. However, In Gates' 1965 study. In vitro 
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culturing of the embryos allowed for development of the slow 
developing embryos without the influence of the uterine 
environment. The Ped gene may have no effect on survival 
because if the Ped slow allele were deleterious to the 
embryos, then the Ped slow strains probably would have 
already died out. Bradford (1979) found that genes that 
control embryo survival have a strong degree of dominance for 
high survival. If Ped slow embryos had a greater chance of 
dying, then this gene would have been eliminated in favor of 
genes involved in high embryo survival. Since Ped slow 
strains exist in the laboratory mouse, slow development must 
not be a lethal trait, at least in some uterine environments. 
It has been shown that in mice 30-40% of embryonic loss 
occurs before birth (MacDowell, 1924; Falconer, 1960). Many 
factors may be at work to cause embryonic loss, as suggested 
by Wilmut et a1. (1986). It is known that both maternal and 
embryonic genotype are involved in embryo survival (Mo1er et 
al., 1981; Craig-Veit and Anderson, 1985). The studies 
presented are preliminary studies into the role of the Ped 
gene in embryo survival. These studies do not attempt to 
examine environmental factors that may cause fetal loss after 
implantation, but rather the effect of the tempo of 
development on embryo survival. Further studies are needed 
to determine the role of the Ped gene (embryonic genotype), 
maternal genotype, and environmental factors on embryo 
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survival. 
The Role of the Qa-2 Antigen In Reproduction 
It has been observed that Qa-2* mice (B6.K2) are better 
breeders than Qa-2k mice (B6.K1) (Warner et al., 1988). To 
investigate whether the Qa-2 antigen is playing a role in 
reproduction, B6.K1, 86.K2, and Fi crosses were studied for 
various reproductive traits. 
The results of the study, shown in Tables 21-26 reveal 
that both the Qa-2 antigen and the maternal environment are 
influencing reproductive traits in 86.K1, 86.K2, and Fi mice. 
Larger birth weights and litter sizes are associated with the 
expression of Qa-2 antigen in the maternal environment. 
There are many factors known to influence birth weight 
in rodents, such as the nutrition and health of the mother, 
duration of the pregnancy, litter size, and fetal and 
maternal genotype (Noyes et al., 1961). In our studies, the 
nutrition and health of the mother are eliminated as factors 
because young healthy female mice were used and the diet is 
the same for every breeding cage. The duration of the 
pregnancy (length of gestation) is not known for the mice 
used in our studies and may be a factor in the results. 
Large fetal weights are usually associated with large 
litter sizes. In this study, however, this does not seem to 
apply. 86.K2 pups are larger at birth than the 86.K1 pups 
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(see Table 21) and yet they have the same mean litter size. 
The present study confirms that both fetal and maternal 
genotypes are important in birth weights (Qa-2 effect and the 
Qa-2 effect associated with the maternal environment). 
Litter size is primarily influenced by the ovulation 
rate of the female and the subsequent survival of the ova 
(Craig-Veit and Anderson, 1985). The natural ovulation rate 
of the four crosses studied has not yet been determined, so 
whether different ovulation rates account for differences in 
litter size is not known. Maternal genotype is known to be 
responsible for control of ovulation rate (Spruill and Eisen, 
1985) and the association of Qa-2 antigen expression in the 
maternal environment, suggests that the Qa-2 antigen may play 
a role in ovulation rate as well. 
Noyes et al. (1961) and Doyle et al. (1963) suggested 
that differences in the rate of preImplantation development 
may account for differences in birth weights and litter 
sizes. The data in the Table 27 shows that the rate of 
development before implantation is the same for both Fi 
crosses. Therefore, differences in birth weight and litter 
size in the Fi crosses are not due to preImplantation 
development but to factors during the postImplantation 
period. 
There was no effect of Qa-2 on the sex ratio in all of 
the crosses studied (see Table 26). Ashman (1985) found that 
175 
In the C57BL/6 strain (the background strain for the B6.K1 
and B6.K2 strains) the sex ratio shifted in favor of the 
females in multiparous females. This is not seen in the 
present study in the cages with multiple litters (see Tables 
70-73). 
Is the Qa-2 Antigen the Ped Gene Protein Product? 
The location of the Ped gene in the Qa region and the 
complete concordance of Qa-2 antigen expression with Ped gene 
phenotype (Warner et al. 1987b; Warner et al., 1988), 
suggests that the Qa-2 antigen is the Ped gene protein 
product. This is supported by the expression of Qa-2 antigen 
on Ped fast embryos and a lack of Qa-2 antigen on Ped slow 
embryos (Figure 33; Warner et al., 1987a). 
The Qa-2 antigen may act in controlling cleavage 
divisions by acting as a receptor on the embryonic cell 
surface. The three-dimensional structure of the class I 
antigen does reveal a binding site, suggesting that class I 
antigens function as receptors (Bjorkman et al., 1987a). 
Embryos that are Ped fast express the Qa-2 antigen on their 
cell surfaces and can bind regulatory or hormonal peptides in 
their class I binding sites. This interaction could in turn 
cause a conformational change in the Qa-2 antigen, which 
could influence cell-cell interaction and cause fast 
development. The interaction of regulatory proteins or 
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hormones and the Qa-2 antigen could also set Into motion 
biochemical changes within the embryo and this could lead to 
faster cleavage rates. The lack of Qa-2 antigen on the 
embryonic cell surface of Ped slow embryos would not allow 
for binding of regulatory proteins and hence cause slow 
development. 
Uterine hormones have already been shown to be important 
in synchronous development between the embryo and the uterine 
environment (Beier and Mootz, 1979; Wilmut and Sales, 1981; 
Wilmut et al., 1985a,b). This suggests that hormones are 
important in the rate of embryo development and could 
possibly Interact with the Qa-2 antigen to regulate the rate 
of development. Interferons could also interact with Qa-2 
antigen or the genes that encode the Qa-2 antigen to cause 
fast embryo development. Interferons have been shown to 
change cleavage rates of cells depending on the cell type and 
the type of interferon (Baron, 1984). Our laboratory is 
currently investigating this, and preliminary evidence 
suggests that interferon does cause an increase in cell 
number per embryo and Qa-2 antigen in outbred embryos. This 
further supports the hypothesis that the Qa-2 antigen is the 
Ped gene protein product. 
An alternative hypothesis is that the Ped gene protein 
product is not the Qa-2 antigen, but rather some as yet 
undefined Qa region protein. The data on the BIO.M (Tables 
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13 and 14) supports this hypothesis. The Ped gene protein 
product may be associated with the Qa-2 antigen like the 
insulin receptor is associated with class I proteins in place 
of 02-microglobulin (Due et al., 1986). 
If the Qa-2 antigen is indeed the Ped gene protein 
product, then the influence of the Qa-2 antigen on 
reproduction is actually the influence of the Ped gene on 
reproduction. The influence of the rate of preimplantation 
development (Ped gene expression) would help explain some of 
the results obtained in the reproduction study, (such as the 
association of the Qa-2 antigen with large birth weights and 
large litter sizes). Several studies have shown that large 
birth weights are associated with fast developing embryos 
(Noyes et al.,1961; Gates et al., 1961; Doyle et al., 1963). 
It is believed that because the fast developing embryos are 
at a later stage of development when they implant, they give 
rise to larger pups than slow developing embryos. This seems 
to be true of the data in Tables 21-25, which shows that 
larger birth weights are associated with the fast Ped allele. 
The exception to this is the (B6.K19 x B6.K2 )Fi pups, which 
are expressing the fast Ped allele but have pups similar in 
weight to Ped slow mice (B6.K1). This result suggests that 
the maternal genotype is also important in determining birth 
weights, as suggested earlier. 
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Summary 
The processes that occur during reproduction and 
development are complex and many factors are Involved In 
determining these processes. This work has examined one 
particular non-Immune function of the H-2 complex, namely the 
role of the H-2 complex in development and reproduction. 
The work in this dissertation has shown that the Ped 
gene phenotype is an inherent property of the embryos 
themselves. Fast and slow preimplantation development is not 
due solely to the influence of the uterine environment, but 
to the embryonic genotype, namely the particular allele of 
the Ped gene which is present. The Ped gene has been shown 
to be linked to the Qa region of the H-2 complex, suggesting 
a function for one of the Qa region genes. The Ped gene does 
not appear to play a role in embryo survival, however these 
studies were preliminary and further investigation is needed. 
Finally, the Qa-2 antigen, which we hypothesis is the Ped 
gene protein product, plays a role in reproduction in mice. 
Further Experiments 
The Ped gene has been studied in our laboratory for over 
10 years and there are still many areas left to investigate. 
Several areas need to be Investigated in order to gain a 
better understanding of how the Ped gene functions in 
development and reproduction. 
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The embryo ELISA procedure le a highly sensitive method 
of detection of H-2 antigens on preimplantation mouse embryos 
during development. There are several modifications that 
should be tested to increase the sensitivity and reliability 
of the assay though. The use of a biotin-streptavidin system 
(biotinylated anti-IgQ antibody and streptavid1n-0-
galactosidase enzyme conjugate) Instead of the sheep anti-
mouse IgQ-B-galactosidase conjugate could increase the 
sensitivity and specificity in the ELISA procedure. Another 
option is to use an ELISA amplification system (offered by 
Bethseda Research Laboratories) which utilizes NADP as the 
substrate and the enzyme alkaline phosphatase as the enzyme 
marker. This modification has been reported to increase the 
sensitivity 10-fold over conventional ELISA substrate-enzyme 
systems. 
The role of the Fed gene on embryo survival was only a 
preliminary study and the effects of maternal and embryonic 
genotype should be investigated. To study the importance of 
the maternal genotype on embryo survival, one could transfer 
fast developing embryos from a Ped fast strain into a 
recipient uterus of a Ped slow strain and vice versa. By 
transferring both Ped slow and Ped fast embryos into the same 
uterus (both Ped slow and Ped fast uterine environments), the 
role of competition between embryos could be studied. 
To investigate whether the maternal and embryonic 
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genotypes interact to determine embryo survival, additional 
backcross mice should be studied for their Qa-2 genotype. 
(B6.K1? x B6.K2d)Fi males could be mated to B6.K1 females and 
to B6.K2 females to study how embryos interact with the 
maternal environment. Conversely, (B6.K29 x B8.K1d)Fi males 
could be mated to B6.K1 females and to B6.K2 females. 
Several questions are still unanswered concerning the 
role of the Qa-2 antigen (Red gene) in reproduction. First, 
to answer the question of whether large birth weights are 
related to the stage at which they implant, the time of 
implantation should be determined for Ped slow and Fed fast 
strains. It has been shown that there is an estrogen surge 
at the time of implantation (McCormack and Greenwald, 
1974a,b). Spruill and Eisen (1985) have suggested that small 
pup weight is due to a reduced gestational period. 
Therefore, by determining the time of implantation, one could 
determine whether Ped fast strains implant later or not. The 
length of gestation should also be determined, since smaller 
birth weights are associated with shorter gestational periods 
(Spruill and Eisen, 1985). Second, to answer the question of 
whether the litter size is related to the ovulation rate, the 
natural ovulation rate of the crosses studied should be 
determined. 
Finally, experiments should be pursued to investigate 
whether the Qa-2 antigen is the Ped gene protein product. 
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One could microlnject Q7 and/or Q9 genes Into Ped alow one 
cell embryos to produce transgenic mice that are Qa-2*. If 
these mice are then mated to Ped slow mice and the resulting 
phenotype of the embryos is Ped fa&t, then the Qa-2 antigen 
is the Ped gene protein product. These experiments could 
also utilize the Q6 and/or Q8 genes to determine whether 
embyronic and adult forms of Qa-2 exist. 
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APPENDIX A 
RAW DATA FOR RED GENE GENETIC ANALYSIS 
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Table 29. CF1 raw data (56 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
28 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
3 
3 
2 
4 
3 
4 
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Table 29. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 
43 
44 
46 
46 
47 
48 
49 
50 3 
51 4 
Totals 2 51 3.7 (0.1) 
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Table 30. CF1 raw data (68 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 8 
2 7 
3 8 
4 8 
5 8 
6 8 
7 8 
8 8 
9 9 
10 7 
11 8 
12 8 
13 8 
14 8 
15 8 
16 6 
17 8 
18 8 
19 8 
20 8 
21 8 
22 8 
23 7 
24 8 
25 8 
26 7 
27 8 
28 8 
29 8 
30 8 
31 8 
32 8 
33 7 
34 7 
35 8 
36 8 
37 9 
38 8 
39 8 
40 8 
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Table 30. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
41 8 
42 8 
43 8 
44 8 
Totals 2 44 7,9 (0.1) 
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Table 31. CF1 raw data (80 hours post-hCG) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 26 
2 30 
3 17 
4 27 
5 18 
6 17 
7 16 
8 25 
9 18 
10 18 
11 18 
12 19 
13 20 
14 18 
15 16 
16 15 
17 14 
18 20 
19 21 
20 18 
21 17 
22 16 
23 16 
24 15 
25 16 
26 16 
27 16 
28 15 
29 18 
30 19 
31 18 
32 21 
33 27 
34 18 
35 17 
36 25 
37 18 
38 19 
39 20 
40 21 
41 20 
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Table 31. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 22 
43 18 
44 19 
Totals 2 44 19.0 (0.6) 
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Table 32. CF1 2 cell embryos collected at 44 hours 
post-hCQ and cultured in vitro for 24 
hours (total time post-hCG, 68) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 8 
2 7 
3 8 
4 8 
5 9 
6 8 
7 8 
8 7 
9 6 
10 8 
11 8 
12 8 
13 8 
14 7 
15 8 
16 8 
17 6 
18 8 
19 7 
20 8 
21 8 
22 8 
23 6 
24 5 
25 8 
26 8 
27 5 
28 6 
29 7 
30 6 
31 8 
32 6 
33 6 
34 6 
35 8 
36 6 
37 6 
38 8 
39 5 
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Table 32. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 8 
41 8 
42 7 
43 8 
44 7 
Totals 2 44 7.2 (0.2) 
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Table 33. CF1 4 cell embryos collected at 56 hours 
post-hCQ and cultured in vitro for 24 
hours (total time post-hCQ, 80 hours) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 6 
2 8 
3 12 
4 10 
5 8 
6 8 
7 12 
8 14 
9 8 
10 7 
11 8 
12 7 
13 7 
14 8 
15 8 
16 7 
17 8 
18 12 
19 10 
20 13 
21 14 
22 12 
23 10 
24 8 
25 10 
26 12 
27 13 
28 11 
29 15 
30 16 
31 16 
32 16 
33 15 
34 13 
35 10 
36 8 
37 8 
38 9 
39 7 
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Table 33. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 8 
41 10 
42 12 
43 13 
44 16 
45 14 
46 15 
47 9 
Totals 2 47 10.7 (0.4) 
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Table 34. CF1 8 cell embryos collected at 68 hours 
post-hCQ and cultured in vitro for 24 
hours (total time post-hCQ, 92 hours) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 29 
2 28 
3 28 
4 31 
5 23 
6 28 
7 29 
8 23 
9 35 
10 26 
11 26 
12 28 
13 30 
14 28 
15 29 
16 23 
17 32 
18 33 
19 24 
20 28 
21 27 
22 27 
23 16 
24 23 
25 22 
26 28 
27 29 
28 23 
29 34 
30 33 
31 34 
32 28 
33 22 
34 21 
35 20 
36 23 
37 24 
38 27 
39 25 
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Table 34. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
26 
29 
30 
32 
31 
31 
30 
28 
24 
25 
20 
Totals 2 50 27.1 (0.6) 
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Table 35. CF1 morula embryos collected at 80 hours 
post-hCQ and cultured In vitro for 24 
hours (total time post-hCQ, 104) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 33 
2 52 
3 70 
4 62 
5 32 
6 30 
7 68 
8 63 
9 31 
10 34 
11 60 
12 58 
13 56 
14 48 
15 65 
16 70 
17 52 
18 53 
19 54 
20 57 
21 59 
22 57 
23 56 
24 38 
25 32 
26 63 
27 61 
28 63 
29 34 
30 60 
31 56 
32 48 
33 42 
34 43 
35 45 
36 51 
37 48 
38 59 
39 40 
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Table 35. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 38 
41 37 
42 40 
43 46 
44 43 
45 45 
46 42 
Totals 2 46 49.9 (1.7) 
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Table 36. CF1 data for Figure 20 statistical analyses 
Type of Hours Expt. No. o Mean Log: 
Development post-hCG No. Embryos Cell No./ Cell 
Scored Embryo No. 
In VlV9 44 1 20 2.0 1.00 
In yIyo 44 2 26 2.0 1.00 
In y1y9 56 1 24 3.6 1.84 
In YlYQ 56 2 27 3.8 1.92 
In Yivo 68 1 17 7.8 2.96 
In vivo 68 2 27 7.9 2.98 
In YlY9 80 1 10 21.2 4.40 
In vivo 80 2 34 18.4 4.20 
In Yitr* 68 1 20 7.7 2.94 
In Yltre 68 2 24 6.8 2.76 
In Yitrp 80 1 17 8.6 3.10 
In Yitrç 80 2 30 11.8 3.56 
In vitro 92 1 23 27.4 4.77 
In Yitro 92 2 27 26.7 4.73 
In vitro 104 1 14 49.8 5.63 
In vitro 104 2 32 49.9 5.64 
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Table 37. B10.BR 2 cell embryos collected at 44 
hours post-hCG and cultured ±q vitro for 
24 hours (total time post-hCQ, 68 hours) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 8 
2 8 
3 6 
4 6 
5 8 
6 8 
7 8 
8 4 
9 9 
10 8 
11 8 
12 12 
13 6 
14 8 
IS 8 
16 8 
17 7 
18 8 
19 5 
20 4 
21 4 
22 7 
23 6 
24 8 
25 7 
26 5 
28 8 
28 6 
29 6 
30 5 
31 8 
32 7 
33 7 
34 6 
35 8 
36 8 
37 6 
38 7 
39 8 
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Table 37. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 8 
41 4 
42 6 
43 5 
44 8 
45 5 
46 7 
47 9 
48 6 
49 5 
50 4 
51 5 
52 5 
53 8 
54 7 
55 8 
56 8 
57 8 
58 11 
59 7 
60 7 
61 5 
62 8 
63 8 
64 8 
65 8 
66 8 
67 7 
68 8 
69 8 
70 8 
71 5 
72 8 
73 8 
74 5 
75 6 
76 8 
77 8 
Totals 3 77 7.0 (0.2) 
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Table 38. C57BL/6 2 cell embryos collected at 44 
hours post-hCG and cultured In vitro for 
24 hours (total time post-hCQ, 68 hours) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 8 
2 8 
3 8 
4 12 
5 8 
6 8 
7 8 
8 11 
9 8 
10 8 
11 8 
12 8 
13 11 
14 8 
15 8 
16 8 
17 8 
18 8 
19 7 
20 8 
21 8 
22 9 
23 6 
24 4 
25 5 
26 8 
27 8 
28 5 
29 4 
30 6 
31 5 
32 6 
33 6 
34 8 
35 8 
36 8 
37 8 
38 8 
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Table 38. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
39 8 
40 8 
41 8 
42 8 
43 8 
44 8 
46 17 
46 8 
47 8 
48 8 
49 10 
60 9 
61 10 
62 8 
63 8 
64 9 
66 8 
66 12 
67 7 
68 8 
69 7 
60 8 
61 8 
62 13 
63 8 
64 7 
66 8 
66 11 
67 7 
68 11 
69 8 
70 8 
71 9 
72 12 
73 6 
74 7 
76 8 
76 8 
77 9 
Totals 3 77 8 . 2  ( 0 . 2 )  
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Table 39. BIO.BR 8 cell embryos collected at 65 
hours post-hCQ and cultured Iq vitro for 
30 hours (total time post-hCQ, 95 hours) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 13 
2 31 
3 24 
4 17 
5 25 
6 29 
7 33 
8 61 
9 56 
10 50 
11 29 
12 31 
13 31 
14 29 
15 49 
16 32 
17 30 
18 29 
19 31 
20 17 
21 19 
22 40 
23 47 
24 30 
25 27 
26 37 
27 45 
28 11 
29 23 
30 29 
31 28 
32 23 
33 32 
34 26 
35 32 
36 32 
37 28 
38 24 
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Table 39. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
39 26 
40 43 
41 32 
42 25 
43 24 
44 30 
45 31 
46 40 
47 33 
48 31 
49 41 
50 52 
51 31 
52 38 
53 41 
54 28 
55 47 
56 38 
57 27 
Totals 4 57 32.2 (1.3) 
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Table 40. C57BL/6 8 cell embryos collected at 65 
hours post-hCQ and cultured in vitro for 
30 hours (total time post-hCQ, 96 hours) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 52 
2 51 
3 50 
4 47 
5 47 
6 46 
7 35 
8 35 
9 44 
10 38 
11 48 
12 42 
13 43 
14 33 
15 40 
16 45 
17 39 
18 26 
19 46 
20 53 
21 55 
22 37 
23 43 
24 51 
25 22 
26 31 
27 31 
28 27 
29 32 
30 33 
31 39 
32 32 
33 35 
34 31 
35 28 
36 38 
37 33 
38 37 
39 42 
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Table 40. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 31 
41 20 
42 40 
43 39 
44 34 
45 33 
46 42 
47 41 
48 51 
49 62 
50 41 
51 32 
52 52 
53 29 
54 45 
55 31 
56 46 
57 45 
58 64 
59 56 
60 63 
61 61 
Totals 4 61 40.9 (1.3) 
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Table 41. BIO.BR raw data (65 hours poet-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 7 
2 8 
3 8 
4 8 
5 7 
6 7 
7 8 
8 6 
9 7 
10 7 
11 8 
12 8 
13 8 
14 8 
15 8 
16 8 
17 8 
18 7 
19 8 
20 7 
21 7 
22 7 
23 8 
24 8 
25 8 
26 7 
27 6 
28 8 
29 9 
30 8 
31 7 
32 8 
33 8 
34 8 
35 8 
36 8 
37 7 
38 8 
39 6 
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Table 41. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
40 10 
41 8 
42 7 
43 7 
44 8 
45 7 
46 8 
47 7 
48 8 
49 8 
50 7 
51 6 
52 7 
53 8 
54 8 
55 8 
56 7 
57 7 
58 8 
59 8 
60 8 
61 6 
62 8 
63 6 
64 8 
Totals 4 64 7.5 (0.1) 
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Table 42. C57BL/6 raw data (66 houre post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 7 
2 16 
3 8 
4 9 
6 12 
6 8 
7 11 
8 8 
9 8 
10 8 
11 7 
12 8 
13 6 
14 8 
16 8 
16 12 
17 6 
18 8 
19 8 
20 8 
21 16 
22 8 
23 8 
24 6 
26 12 
26 8 
27 8 
28 9 
29 8 
30 7 
31 8 
32 8 
33 8 
34 8 
35 8 
36 8 
37 8 
38 8 
39 7 
40 7 
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Table 42. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
41 8 
42 7 
43 8 
44 8 
46 8 
46 8 
47 8 
48 8 
49 8 
50 10 
51 8 
52 9 
53 8 
54 8 
55 10 
56 8 
57 8 
58 8 
59 8 
60 8 
61 8 
62 8 
Totals 4 62 8.4 (0.2) 
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Table 43. B10.BR raw data (89 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 27 
2 23 
3 22 
4 18 
5 19 
6 28 
7 22 
8 25 
9 21 
10 16 
11 9 
12 29 
13 30 
14 25 
15 19 
16 23 
17 15 
18 14 
19 15 
20 20 
21 22 
22 19 
23 23 
24 15 
25 31 
26 25 
27 23 
28 19 
29 19 
30 20 
31 25 
32 27 
Totals 1 32 21.4 (0.9) 
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Table 44. CS7BL/6 raw data (89 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 1 47 
2 26 
3 30 
4 37 
5 29 
6 30 
7 20 
8 35 
9 30 
10 28 
11 42 
12 38 
13 42 
14 39 
15 43 
16 31 
17 37 
18 29 
19 22 
20 21 
21 16 
22 22 
23 38 
24 31 
25 37 
26 20 
27 41 
28 30 
29 27 
30 26 
31 29 
32 40 
33 35 
34 28 
Totals 1 34 31.6 (1.3) 
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Table 45. B10.BR 2 cell embryos collected at 44 
hours post-hCQ and cultured In vitro for 
24 hours 
Experiment No. Observation No. Cell No./ 
Embryo 
1 6 
2 4 
3 6 
4 8 
5 8 
6 13 
7 10 
8 5 
9 7 
10 8 
11 8 
12 8 
13 8 
14 8 
15 8 
16 8 
17 8 
18 8 
19 8 
20 8 
21 8 
22 7 
23 8 
24 7 
25 6 
26 8 
27 8 
28 8 
29 7 
30 7 
31 8 
32 8 
33 8 
34 7 
35 7 
36 8 
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Table 45. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
37 8 
38 8 
39 8 
40 6 
41 8 
42 7 
43 8 
44 8 
45 7 
46 8 
47 7 
48 6 
49 8 
50 8 
51 8 
52 7 
53 7 
54 7 
Totals 5 54 7.6 (0.2) 
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Table 46. B10.D2 2 cell embryos collected at 44 
hours post-hCQ and cultured In vitro for 
24 hours 
Experiment No. Observation No. Cell No./ 
Embryo 
1 8 
2 8 
3 7 
4 8 
5 8 
6 10 
7 8 
8 8 
9 8 
10 16 
11 8 
12 8 
13 10 
14 8 
15 8 
16 11 
17 8 
18 8 
19 8 
20 8 
21 8 
22 8 
23 9 
24 7 
25 9 
26 8 
27 8 
28 8 
29 8 
30 7 
31 8 
32 8 
33 8 
34 8 
35 8 
36 9 
37 9 
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Table 46. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
38 9 
39 8 
40 6 
41 8 
42 8 
43 10 
44 8 
45 8 
48 9 
47 8 
48 9 
5 49 9 
50 7 
51 8 
52 9 
53 8 
54 8 
55 8 
56 9 
57 8 
Totals 5 57 8.4 (0.2) 
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Table 47. B10.BR 2 cell embryos collected at 44 
hours post-hCG and cultured In vitro for 
46 hours 
Experiment No. Observation No. Cell No./ 
Embryo 
1 11 
2 23 
3 23 
4 10 
5 16 
6 29 
7 27 
8 17 
9 17 
10 17 
11 20 
12 15 
13 16 
14 29 
15 27 
16 26 
17 18 
18 30 
19 17 
20 23 
21 17 
22 16 
23 14 
24 23 
25 23 
26 19 
27 25 
28 25 
29 15 
30 22 
31 15 
32 25 
33 20 
5 34 
35 
36 
15 
29 
23 
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Table 47. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
37 22 
38 17 
39 17 
40 23 
41 19 
42 28 
43 24 
44 23 
45 18 
46 26 
47 24 
48 29 
49 25 
50 19 
51 25 
Totals 5 51 21.1 (0.7) 
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Table 48. B10.D2 2 cell embryos collected at 44 
hours post-hCQ and cultured jjQ vitro for 
46 hours 
Experiment No. Observation No. Cell No./ 
Embryo 
1 1 31 
2 49 
3 32 
4 41 
5 32 
2 6 30 
7 33 
8 30 
9 36 
10 18 
11 31 
12 17 
13 32 
14 18 
15 33 
16 31 
17 17 
18 17 
3 19 31 
20 31 
21 20 
22 17 
23 29 
24 29 
25 34 
26 27 
27 31 
28 28 
29 31 
30 19 
31 19 
32 31 
33 29 
34 34 
35 31 
36 30 
37 28 
38 23 
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Table 48. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
39 28 
40 24 
41 28 
42 24 
43 29 
44 32 
45 31 
46 30 
47 33 
48 29 
49 35 
50 34 
51 30 
52 20 
53 27 
54 29 
55 29 
56 28 
57 28 
58 31 
Totals 5 58 28.4 (0.8) 
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Table 49. B10.BR 2 cell embryos collected at 44 
hours post-hCG and cultured In vitro for 
54 hours 
Experiment No. Observation No. Cell No./ 
Embryo 
1 19 
2 24 
3 17 
4 24 
S 28 
6 26 
7 35 
8 18 
9 16 
10 27 
11 32 
12 20 
13 24 
14 30 
15 37 
16 32 
17 35 
18 27 
19 21 
20 28 
21 28 
22 22 
23 27 
24 26 
25 25 
26 32 
27 26 
28 27 
29 28 
30 27 
31 28 
32 20 
33 29 
34 41 
35 32 
36 31 
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Table 49. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
37 29 
38 28 
39 27 
40 21 
41 22 
42 26 
43 17 
44 21 
46 27 
46 25 
47 25 
48 23 
49 24 
50 29 
Totals S 50 26.3 (0.7) 
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Table 50. BIO.02 2 cell embryos collected at 44 
hours post-hCQ and cultured ±n vitro for 
54 hours 
Experiment No. Observation No. Cell No./ 
Embryo 
1 33 
2 31 
3 45 
4 24 
5 37 
6 33 
7 31 
8 49 
9 30 
10 43 
11 44 
12 38 
13 45 
14 24 
15 28 
16 53 
17 35 
18 38 
19 34 
20 40 
21 38 
22 36 
23 29 
24 44 
25 32 
26 46 
27 39 
28 35 
29 38 
30 60 
31 57 
32 53 
33 44 
34 64 
35 34 
36 57 
37 49 
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Table 50. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
38 46 
39 55 
40 42 
41 33 
42 50 
43 33 
44 31 
45 32 
46 39 
47 41 
48 38 
49 32 
50 48 
Totals 5 50 40.2 (1.3) 
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Table 51. BIO.BR and B10.D2 data for Figure 25 statistical 
analyses 
Hours Expt. No. of Mean Cell Log: C( 
Strain In vitro No. Embryos No./Embryo No. 
Scored 
BIO.BR 24 1 3 5.3 2.40 
BIO.BR 24 2 4 9.7 3.27 
BIO.BR 24 3 9 7.5 2.90 
BIO.BR 24 4 16 7.6 2.92 
BIO.BR 24 5 22 7.5 2.90 
BIO.02 24 1 5 7.8 2.96 
BIO.02 24 2 11 9.4 3.23 
BIO.02 24 3 15 8.0 3.00 
BIO.02 24 4 17 8.3 3.05 
BIO.02 24 5 9 8.2 3.03 
BIO.BR 46 1 4 22.8 4.51 
BIO.BR 46 2 2 28.0 4.80 
BIO.BR 46 3 13 18.5 4.20 
BIO.BR 46 4 14 20.1 4.32 
BIO.BR 46 5 18 22.7 4.50 
BIO.02 46 1 5 34.2 5.14 
BIO.02 46 2 13 27.2 4.77 
BIO.02 46 3 20 26.9 4.75 
BIO.02 46 4 12 29.8 4.89 
BIO.02 46 5 8 27.8 4.79 
BIO.BR 54 1 4 30.5 4.93 
BIO.BR 54 2 4 33.5 5.06 
BIO.BR 54 3 13 23.7 4.56 
BIO.BR 54 4 14 26.6 4.73 
BIO.BR 54 5 15 25.0 4.64 
BIO.02 54 1 6 35.3 5.14 
BIO.02 54 2 13 49.5 5.63 
BIO.02 54 3 13 37.2 5.21 
BIO.02 54 4 10 37.7 5.23 
BIO.02 54 5 8 36.8 5.20 
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Table 52. B6.K1 raw data (47 hours poet-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 1 2 
2 2 
3 2 
4 2 
5 2 
6 2 
7 2 
8 2 
9 2 
10 2 
11 2 
12 2 
13 2 
14 2 
15 2 
16 2 
17 2 
18 2 
19 1 
20 1 
21 1 
22 2 
23 2 
24 2 
25 2 
26 1 
27 2 
28 2 
29 2 
30 2 
31 2 
32 2 
33 2 
34 2 
35 2 
36 2 
37 2 
38 2 
39 1 
40 2 
41 2 
42 2 
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Table 52. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
43 2 
44 2 
46 1 
46 1 
47 2 
48 2 
49 2 
50 2 
51 2 
52 2 
53 2 
54 2 
55 2 
56 3 
57 2 
58 2 
59 2 
60 2 
61 2 
62 2 
63 2 
Totals 1 63 1.9 (0.1) 
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Table 53. B6.K1 raw data (53 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 ' 1 3 
2 2 
3 2 
4 4 
5 3 
6 4 
7 3 
8 3 
9 4 
10 2 
11 2 
12 2 
13 2 
14 3 
15 3 
16 2 
17 4 
18 2 
19 2 
20 3 
21 2 
22 2 
23 3 
24 3 
25 3 
26 2 
27 3 
28 3 
29 2 
30 2 
31 2 
32 3 
33 4 
34 2 
35 2 
36 2 
37 3 
38 3 
39 3 
40 4 
2 41 2 
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Tabla 53. (continuad) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 2 
43 4 
44 3 
45 3 
46 4 
47 2 
46 2 
49 3 
50 3 
51 2 
52 3 
53 2 
54 3 
Totals 2 54 2.7 (0.1) 
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Table 54. B6.K1 raw data (65 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 6 
2 5 
3 6 
4 8 
5 8 
6 8 
7 6 
8 6 
9 5 
10 5 
11 7 
12 7 
13 6 
14 7 
15 6 
16 5 
17 6 
18 6 
19 5 
20 6 
21 8 
22 8 
23 5 
24 5 
25 4 
26 6 
27 6 
28 5 
29 5 
30 5 
31 7 
32 6 
33 8 
34 5 
35 5 
36 6 
37 6 
38 7 
39 7 
40 5 
41 4 
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Table 54. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 5 
43 6 
44 6 
45 6 
46 6 
47 5 
48 5 
49 8 
50 8 
51 5 
52 7 
53 7 
54 6 
Totals 2 54 6.1 (0.2)  
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Table 55. B6.K1 raw data (77 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 12 
2 11 
3 9 
4 10 
5 9 
6 11 
7 11 
8 8 
9 8 
10 8 
11 8 
12 9 
13 8 
14 10 
15 10 
16 8 
17 8 
18 10 
19 15 
20 12 
21 10 
22 10 
23 9 
24 8 
25 8 
26 6 
27 8 
28 9 
29 9 
30 8 
31 8 
32 6 
33 10 
34 11 
35 10 
36 8 
37 8 
38 6 
39 6 
40 8 
41 9 
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Table 55. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 9 
43 8 
44 8 
45 10 
46 8 
47 6 
48 8 
49 9 
50 8 
51 8 
52 12 
53 11 
54 10 
55 9 
56 8 
57 8 
58 6 
Totals 2 56 8.9 (0.2) 
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Table 56. B6.K2 raw data (47 hours post-hCG) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 2 
2 2 
3 2 
4 2 
5 2 
6 2 
7 3 
8 3 
9 2 
10 2 
11 2 
12 3 
13 2 
14 2 
15 2 
16 2 
17 2 
18 2 
19 2 
20 2 
21 2 
22 2 
23 2 
24 2 
25 2 
26 2 
27 2 
28 2 
29 2 
30 3 
31 2 
32 2 
33 3 
34 2 
35 2 
36 2 
37 3 
38 2 
39 2 
40 2 
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Table 56. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
41 2 
42 2 
Totals 1 42 2 .1  (0 .1 )  
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Table 57. B6.K2 raw data (53 hours post-hCG) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
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Table 57. (continued) 
Experiment No. Observation.No. Cell No./ 
Embryo 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 5 
Totals 1 56 3.9 (0.8) 
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Table 58. B6.K2 raw data (65 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 8 
2 12 
3 9 
4 13 
5 8 
6 8 
7 8 
8 8 
9 8 
10 8 
11 11 
12 10 
13 6 
14 8 
15 8 
16 8 
17 12 
18 8 
19 13 
20 8 
21 8 
22 8 
23 8 
24 9 
25 8 
26 8 
27 8 
28 10 
29 8 
30 8 
31 8 
32 8 
33 8 
34 8 
35 8 
36 8 
37 8 
38 8 
39 8 
40 8 
41 8 
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Table 58. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 8 
43 8 
44 7 
45 9 
46 10 
47 12 
48 8 
49 8 
50 8 
51 9 
Total8 2 51 8.6 (0.2) 
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Table 59. B6.K2 raw data (77 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 16 
2 15 
3 17 
4 18 
5 20 
6 21 
7 15 
8 14 
9 20 
10 19 
11 17 
12 17 
13 18 
14 16 
15 19 
16 21 
17 20 
18 18 
19 19 
20 20 
21 21 
22 20 
23 18 
24 17 
25 19 
26 20 
27 18 
28 18 
29 17 
30 19 
31 21 
32 21 
33 20 
34 21 
35 18 
36 20 
37 21 
38 18 
39 15 
40 14 
41 16 
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Table 59. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 15 
43 20 
44 21 
45 19 
46 18 
47 18 
48 19 
49 18 
Totals 2 49 18.4 (0.3) 
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Table 60. 86.Kl and 86.K2 data for Figure 27 statistical 
anal yses 
Hours No. of No. Of Mean Cell Loga Cell 
Strain post-hCQ ExptS. Embryos No./Embryo No. 
Scored 
86. Kl 47 1 62 1.9 0.93 
86. K2 47 1 42 2.1 1.07 
86. Kl 53 1 40 2.7 1.43 
86. Kl 53 14 2.7 1.43 
86. K2 53 1 56 3.9 1.96 
86. Kl 65 1 39 6.1 2.60 
86. Kl 65 15 5.9 2.56 
86. K2 65 1 13 9.0 3.17 
86. K2 65 38 8.5 3.09 
86.Kl 77 1 36 9.3 3.21 
86. Kl 77 22 8.4 3.07 
86. K2 77 1 20 18.0 4.16 
86. K2 77 29 18.6 4.22 
86. Kl 89 1 33 20.1» 4.33 
86. K2 89 1 34 33.3" 5.06 
86. K2 89 2 44 27.9» 4.80 
•Data from by Gollnick et al. (1985). 
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Table 61. B6.K3 raw data (89 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 1 25 
2 32 
3 45 
4 25 
5 18 
6 30 
7 54 
8 48 
9 32 
10 29 
11 31 
12 31 
13 30 
14 23 
15 17 
16 49 
17 38 
18 25 
19 35 
20 42 
2 21 47 
22 40 
23 48 
24 15 
25 46 
26 48 
27 44 
28 30 
29 29 
30 40 
31 33 
32 19 
33 37 
34 33 
35 47 
36 20 
37 28 
38 31 
39 35 
40 43 
41 49 
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Table 61. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 
43 
44 
45 
46 
42 
19 
16 
Totals 2 45 34.3 (1.6) 
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Table 62. B6.K4 raw data (89 hours post-hCG) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 17 
2 IS 
3 25 
4 17 
5 18 
6 14 
7 12 
8 17 
9 25 
10 24 
11 27 
12 27 
13 20 
14 26 
15 17 
16 23 
17 26 
18 24 
19 22 
20 15 
21 24 
22 26 
23 25 
24 22 
25 23 
26 20 
27 20 
28 22 
29 16 
30 22 
31 13 
32 36 
33 29 
34 38 
35 27 
36 42 
37 36 
38 23 
39 29 
40 22 
41 24 
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Table 62. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 15 
43 10 
44 16 
45 25 
46 25 
47 17 
48 30 
49 12 
50 18 
51 21 
52 28 
53 27 
54 19 
55 14 
56 14 
57 19 
58 20 
59 29 
60 28 
61 18 
62 18 
63 21 
64 21 
65 23 
66 29 
67 21 
68 16 
Totals 4 68 22.1 (0 .8)  
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Table 63. BALB/cJ raw data (89 hours poet-hCG) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 28 
2 32 
3 31 
4 14 
5 60 
6 33 
7 30 
8 30 
9 59 
10 61 
11 51 
12 15 
13 28 
14 22 
15 33 
16 29 
17 30 
18 43 
19 26 
20 56 
21 31 
22 50 
23 52 
24 28 
25 30 
26 23 
27 29 
28 32 
29 46 
30 48 
31 50 
32 16 
33 25 
34 25 
35 24 
36 50 
37 37 
38 15 
39 30 
40 42 
41 17 
42 12 
43 24 
266 
Table 63. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
44 50 
46 17 
46 20 
47 34 
48 33 
49 25 
50 33 
51 26 
52 43 
53 32 
54 19 
55 30 
56 29 
57 16 
58 33 
59 38 
60 31 
61 40 
62 27 
63 55 
64 63 
65 23 
66 60 
67 61 
68 57 
69 62 
70 30 
71 62 
72 28 
73 38 
74 31 
75 42 
76 34 
77 41 
78 52 
79 22 
80 40 
81 35 
Total s 2 81 35.3 (1.5) 
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Table 64. BALB/cBy raw data (89 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 30 
2 17 
3 26 
4 12 
5 7 
6 31 
7 17 
8 14 
9 15 
10 16 
11 30 
12 31 
13 16 
14 14 
15 55 
16 17 
17 26 
18 10 
19 15 
20 33 
21 16 
22 23 
23 30 
24 14 
25 8 
26 14 
27 30 
28 19 
29 16 
30 36 
31 30 
32 32 
33 39 
34 40 
35 31 
36 13 
37 21 
38 38 
39 15 
40 19 
41 27 
42 65 
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Table 64. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
43 54 
44 26 
45 28 
46 23 
47 28 
48 29 
49 17 
50 15 
51 43 
52 31 
53 10 
54 14 
55 21 
56 29 
57 11 
58 53 
59 38 
60 9 
61 10 
62 35 
63 14 
64 22 
65 18 
66 15 
67 32 
68 32 
69 31 
70 32 
71 33 
72 17 
73 33 
74 29 
75 28 
76 29 
77 50 
78 18 
79 40 
80 56 
81 57 
82 43 
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Table 64. (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
83 34 
84 29 
Totals 2 84 26.5 (1.4) 
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Table 65. BIO.M raw data (65 hours post-hCG) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 1 9 
2 16 
3 9 
4 10 
5 11 
6 13 
7 8 
8 8 
9 8 
10 6 
11 8 
12 12 
13 8 
14 15 
15 9 
16 15 
17 8 
18 12 
19 11 
20 7 
21 16 
22 13 
23 9 
24 16 
25 11 
26 8 
27 12 
28 14 
29 16 
30 14 
31 15 
32 15 
33 15 
34 12 
35 13 
36 12 
37 16 
2 38 15 
39 5 
40 10 
41 6 
42 16 
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Table 65.  (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
43 8 
44 15 
45 8 
46 13 
47 15 
48 9 
49 16 
50 10 
51 9 
52 9 
53 9 
54 8 
55 11 
56 7 
57 8 
58 9 
59 15 
60 8 
61 8 
62 10 
63 9 
64 8 
65 9 
66 15 
67 8 
68 8 
69 9 
70 12 
71 9 
72 13 
73 9 
74 10 
75 10 
76 8 
77 14 
78 10 
79 8 
Totals 4 79 10.8 (0.3) 
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Table 66. BIO.M raw data (89 hours post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 35 
2 58 
3 33 
4 34 
5 58 
6 36 
7 49 
8 55 
9 44 
10 30 
11 42 
12 34 
13 29 
14 40 
15 54 
16 36 
17 34 
18 39 
19 38 
20 41 
21 39 
22 30 
23 52 
24 50 
25 53 
26 43 
27 46 
28 31 
29 56 
30 53 
31 30 
32 49 
33 27 
34 39 
35 35 
36 26 
37 47 
38 24 
39 35 
40 31 
41 28 
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Table 66.  (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
42 44 
43 27 
44 34 
45 35 
46 23 
47 35 
48 31 
49 53 
50 29 
51 58 
52 32 
53 32 
54 24 
55 44 
56 43 
57 40 
58 37 
59 50 
60 46 
61 48 
62 40 
63 42 
64 39 
65 57 
66 49 
Totals 4 66 39.9 (1.2) 
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Table 67. (B6.K19 x B6.K2<') raw data (89 hours 
post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 30 
2 37 
3 31 
4 39 
S 38 
6 33 
7 13 
8 16 
9 21 
10 27 
11 33 
12 25 
13 49 
14 55 
15 48 
16 47 
17 31 
18 36 
19 44 
20 32 
21 32 
22 18 
23 25 
24 18 
25 27 
26 31 
27 31 
28 27 
29 52 
30 55 
31 55 
32 31 
33 29 
34 28 
35 28 
36 39 
37 31 
38 29 
39 46 
40 64 
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Tablé 67.  (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
32 
18 
32 
21 
24 
23 
12 
35 
30 
27 
14 
16 
31 
30 
36 
26 
30 
33 
28 
42 
28 
60 
Totals 2 62 32.4 (1.5) 
276 
Table 68. (B6.K2 9 x 86.Kid) raw data (89 hours 
post-hCQ) 
Experiment No. Observation No. Cell No./ 
Embryo 
1 33 
2 32 
3 32 
4 32 
5 70 
6 33 
7 33 
8 17 
9 32 
10 19 
11 28 
12 31 
13 30 
14 34 
15 26 
16 28 
17 28 
18 21 
19 34 
20 31 
21 17 
22 34 
23 33 
24 56 
25 34 
26 32 
27 17 
28 22 
29 32 
30 31 
31 32 
32 18 
33 24 
34 34 
35 24 
36 30 
37 17 
38 23 
39 16 
40 21 
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Table 68.  (continued) 
Experiment No. Observation No. Cell No./ 
Embryo 
41 17 
42 18 
43 24 
44 35 
45 19 
46 31 
47 29 
48 39 
49 53 
50 31 
51 33 
52 31 
Totals 2 52 29.4 (1.4) 
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APPENDIX B 
STATISTICAL ANALYSIS SYSTEM (SAS) PROGRAMS 
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SAS Programs for Paired Comparisons of Means 
Comparison gf saH nvmbQr car gmbrv? 
//STATS JOB 
// EXEC SAS 
DATA TARKOWSKI; 
INPUT STRAIN $ CELLNUMBER M; 
CARDS; 
(Data is entered after the CARDS statement in the format 
specified in the INPUT statement.) 
PROC PRINT; 
PROC QLM; 
CLASS STRAIN; 
MODEL CELLNUMBER=STRAIN; 
MEANS STRAIN; 
PROC TTEST; 
CLASS STRAIN; 
VAR CELLNUMBER; 
Comparison af birthweights. litter aizas, WMPlnfl wçiqht? 
//STATS JOB 
// EXEC SAS 
DATA BIRTHWT; 
INPUT STRAIN $ BIRTHWT 
CARDS; 
(Data is entered after the CARDS statement in the format 
specified in the INPUT statement.) 
PROC PRINT; 
PROC GLM; 
CLASS STRAIN; 
MODEL BIRTHWT=STRAIN; 
MEANS STRAIN; 
PROC TTEST; 
CLASS STRAIN; 
VAR BIRTHWT; 
DATA LITTERSZ; 
INPUT STRAIN $ LITTERSZ ##; 
CARDS; 
280 
(Data Is entered after the CARDS statement in the format 
specified in the INPUT statement.) 
PROC PRINT; 
PROC QLM; 
CLASS STRAIN; 
MODEL LITTERSZ=STRAIN; 
MEANS STRAIN; 
PROC TTEST; 
CLASS STRAIN; 
VAR LITTERSZ; 
DATA WEANWT; 
INPUT STRAIN $ WEANWT ##; 
CARDS; 
(Data is entered after the CARDS statement in the format 
specified in the INPUT statement. Female and male data 
were entered in separate DATA groups.) 
PROC PRINT; 
PROC QLM; 
MODEL WEANWT=STRAIN; 
MEANS STRAIN; 
PROC TTEST; 
CLASS STRAIN; 
VAR WEANWT; 
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SAS Program for Analysis of in vivo and 
in vitro Kinetic Studies 
//KINETIC JOB 
// EXEC SAS 
DATA DEVELOPMENT; 
INPUT STRAIN $ HOUR EXPNO NOEMB CN M; 
LCN=L0Q2(CN); 
CARDS; 
(Data is entered after the CARDS statement according 
to the format in the INPUT statement [see Tables 36, 
49, and 49 in Appendix A].) 
PI88 
CLASS STRAIN; 
WEIGHT NOEMB; 
MODEL LCN=STRAIN HOUR(STRAIN)/SOLUTION; 
PROC GLM; 
CLASS STRAIN; 
WEIGHT NOEMB; 
MODEL LCN=STRAIN HOUR«STRAIN/SOLUTION; 
MEANS STRAIN; 
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APPENDIX C 
B6.K1, B6.K2, AND Fi LITTER RECORDS 
283 
Table 69. Breeding cages for B6.K1, B6.K2, Fi litter records 
Strain Cage 
# 
Female 
DOB* 
Male 
DOB 
Date breeders 
set-up 
B6.K2 9 X 
B B . K Z O  1 
2 
3 
4 
5 
6 
7 
8 
06-22-87 
06-22-87 
06-22-87 
09-12-87 
09-24-87 
09-24-87 
10-02-87 
10-02-87 
06-25-87 
06-25-87 
06-25-87 
09-12-87 
09-14-87 
09-14-87 
10-06-87 
10-06-87 
09-01-87 
09-01-87 
09-01-87 
11-01-87 
11-21-87 
11-21-87 
12-13-87 
12-13-87 
B6.K19 X 
B6.K1<5 1 
2 
3 
4 
5 
6 
7 
8 
06-29-87 
06-29-87 
06-29-87 
09-01-87 
09-07-87 
09-07-87 
10-13-87 
10-13-87 
07-01-87 
07-01-87 
07-01-87 
09-08-87 
09-07-87 
09-07-87 
10-05-87 
10-05-87 
09-01-87 
09-01-87 
09-01-87 
11-01-87 
11-11-87 
11-11-87 
12-10-87 
12-10-87 
B6.K19 X 
B6.K2d 1 
2 
3 
4 
08-20-87 
08-20-87 
09-01-87 
09-01-87 
08-15-87 
08-15-87 
09-05-87 
09-05-87 
10-06-87 
10-06-87 
11-02-87 
11-02-87 
B6.K29 X 
B6.K1(f 1 
2 
3 
4 
08-14-87 
08-14-87 
09-05-87 
09-05-87 
08-11-87 
08-11-87 
09-01-87 
09-01-87 
10-06-87 
10-06-87 
10-31-87 
10-31-87 
•DOB = Date of Birth. 
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Tabla 70. B6.K1 litter records 
Cage Litter No. Pups Date BIrthMt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
2 1 6 10-5-87 1.30 5 11-6-87 10.8 F« 
1.29 12.1 F 
1.31 12.4 HO 
1.28 12.1 M 
1.26 11.7 M 
1.22 -e 
1 1 6 10-13-87 1.33 6 10-29-87 13.8 F 
1.30 13.8 F 
1.33 15.8 F 
1.28 15.0 M 
1.49 17.0 M 
1.46 16.0 M 
2 2 1 10-26-87 1.23 
1 2 3 11-5-87 1.32 3 12-2-87 13.2 F 
1.39 12.7 M 
1.39 13.2 M 
1 3 4 11-6-87 1.45 4 12-2-87 13.4 F 
1.42 11.8 F 
1.27 14.2 M 
1.34 15.8 M 
1 4 7 11-25-87 1.35 5 12-22-87 13.1 F 
1.23 13.3 F 
1.22 12.7 M 
1.48 16.1 M 
1.28 14.3 H 
1.41 
1.32 
2 3 8 11-25-87 1.30 8 12-23-87 10.9 F 
1.35 11.8 F 
1.18 9.8 F 
1.24 9.8 F 
1.24 12.0 H 
1.21 12.5 M 
1.16 12.0 M 
1.25 11.9 M 
•F = female mouse at weaning. 
"H = male mouse at weaning, 
cpup died before weaning. 
Table 70. (continued) 
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Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
6 1 6 12-16-87 
6 1 6 12-17-87 
5 2 5 12-17-87 
1 5 3 12-17-87 
2 4 6 12-26-87 
6 2 4 1-6-88 
7 1 8 1-7-88 
8 1 6 1-7-88 
1.29 6 1-12-88 12.5 F 
1.29 10.9 F 
1.21 10.1 F 
1.30 15.0 M 
1.22 14.2 M 
1.28 13.5 H 
1.25 6 1-12-88 12.5 F 
1.27 12.1 M 
1.23 14.4 M 
1.20 13.1 M 
1.38 13.0 M 
1.32 12.4 M 
1.35 5 1-12-88 10.9 F 
1.22 11.7 M 
1.43 12.3 M 
1.30 13.7 M 
1.15 13.2 M 
1.25 3 1-12-88 10.9 F 
1.20 11.2 M 
1.35 11.5 M 
1.25 6 1-18-88 9.8 F 
1.21 9.6 F 
1.29 10.9 M 
1.21 11.5 M 
1.30 12.9 M 
1.28 14.0 M 
1.29 4 2-1-88 10.9 F 
1.25 11.1 F 
1.30 10.7 F 
1.35 12.3 M 
1.22 8 2-1-88 9.8 F 
1.34 10.0 F 
1.44 9.7 F 
1.26 10.3 F 
1.24 10.5 F 
1.33 11.1 M 
1.31 13.1 M 
1.20 13.7 M 
1.21 5 2-1-88 10.1 F 
1.48 12.1 F 
1.24 13.1 M 
1.20 12.9 M 
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Table 70. (continued) 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
5 3 4 1-8-88 
7 2 8 1-18-88 
8 2 9 1-21-88 
5 4 10 1-26-88 
8 3 5 1-28-88 
1.24 13.4 N 
1.22 - - -
1.26 
1.35 
1.21 
1.23 7 2-17-88 9.8 F 
1.24 10.1 F 
1.12 10.5 F 
1.18 12.5 M 
1.28 13.7 M 
1.35 13.2 M 
1.10 15.1 M 
1.28 
1.22 9 2-18-88 10.5 F 
1.48 10.0 F 
1.24 12.6 F 
1.25 9.9 F 
1.12 12.1 F 
1.23 10.9 F 
1.42 13.4 M 
1.28 13.1 M 
1.28 12.0 M 
1.30 8 2-24-88 10.9 F 
1.33 9.8 F 
1.25 9.5 F 
1.16 9.9 F 
1.22 12.1 M 
1.16 11.9 H 
1.30 13.9 M 
1.07 13.1 H 
1 . 2 1  
1.19 
1.32 4 2-25-88 10.5 F 
1.28 11.1 F 
1.22 12.9 M 
1.29 13.1 H 
1.16 
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Table 71. B6.K2 litter records 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1 1 6 10-6-87 1.44 6 10-29-87 12.0 F« 
1.45 17.0 F 
1.47 12.4 F 
1.50 13.0 F 
1.46 12.7 Mb 
1.34 18.5 M 
1 2 3 10-21-87 1.37 3 11-25-87 10.9 F 
1.35 9.8 F 
1.20 16.6 M 
1 3 4 10-26-87 1.57 4 11-25-87 10.5 F 
1.52 17.2 F 
1.69 16.3 M 
1.52 16.6 M 
1 4 9 11-11-87 1.25 7 12-9-87 10.2 F 
1.36 13.5 F 
1.31 11.3 F 
1.21 11.5 F 
1.34 13.5 F 
1.26 10.9 F 
1.32 12.8 M 
1.31 -e 
1.25 
2 1 7 12-4-87 1.43 16 12-30-87 11.6 F 
1.23 10.3 F 
1.32 10.9 F 
1.18 10.2 F 
1.32 13.2 F 
1.31 11.8 F 
1.30 12.8 F 
2 2 9 12-5-87 1.30 10.3 F 
1.38 11.7 H 
1.50 10.7 M 
1.40 11.5 M 
1.32 11.2 M 
1.38 9.4 H 
•F = 
bH s 
Cpgp 
female mouse at weaning, 
male mouse at weaning, 
died before weaning. 
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Table 71. (continued) 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
_ 13.6 M 
1.50 12.8 M 
1.40 10.1 M 
2 3 5 12-9-87 1.33 S 1-4-88 10.9 F 
1.41 10.1 F 
1.32 9.9 F 
1.40 11.3 M 
1.28 11.5 M 
6 1 3 12-23-87 1.35 3 1-18-88 10.1 F 
1.50 11.9 H 
1.42 12.0 M 
5 1 4 12-24-87 1.38 4 1-20-88 9.8 F 
1.40 10.1 F 
1.38 11.9 M 
1.42 12.5 M 
2 4 10 12-26-87 1.35 
1.25 
1.29 
1.21 
1.38 
1.50 
1.40 
1.42 
1.50 
1.42 
5 2 4 12-28-87 1.30 4 1-15-88 10.9 F 
1.35 9.8 F 
1.32 13.1 M 
1.29 14.0 M 
1 5 8 1-1-88 1.35 8 2-1-88 12.9 F 
1.21 12.7 F 
1.19 15.3 F 
1.25 12.5 M 
1.50 14.5 M 
1.42 13.0 M 
1.38 13.1 M 
1.33 15.8 M 
6 2 8 1-2-88 1.38 8 2-1-88 13.6 F 
1.25 10.9 F 
1.45 10.6 F 
1.50 11.8 F 
1.42 13.8 F 
1.50 9.7 M 
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Table 71. (continued) 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1.38 11.3 H 
1.19 11.8 M 
2 5 9 1-15-88 1.15 5 2-4-88 10.1 F 
1.34 11.3 F 
1.40 12.8 M 
1.46 13.5 M 
1.08 10.9 M 
1.35 
1.39 
1.30 
1.32 
2 6 7 1-19-88 1.47 7 2-15-88 9.9 F 
1.46 10.1 F 
1.45 12.1 F 
1.55 13.4 M 
1.01 12.8 M 
1.40 13.4 M 
1.44 12.8 H 
5 3 5 1-26-88 1.39 5 2-22-88 12.1 F 
1.64 12.0 F 
1.44 13.1 M 
1.64 13.0 H 
1.43 15.0 M 
5 4 10 1-28-88 1.32 7 2-25-88 10.1 F 
1.38 12.1 F 
1.22 9.9 F 
1.38 13.4 M 
1.35 13.1 M 
1.37 14.0 M 
1.41 13.5 M 
1.28 
1.19 
1.30 
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Table 72. B6.KI9 X B8.K2 dUtter records 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
2 1 4 11-8-87 
1 1 7 11-13-87 
2 2 8 11-18-87 
3 1 6 11-27-87 
3 2 5 11-30-87 
1 2 3 12-1-87 
4 1 4 12-3-87 
1.20 4 12-2-87 12.7 F» 
1.28 13.8 H*> 
1.30 12.0 M 
1.32 12.5 M 
1.23 6 12-9-87 8.4 F 
1.28 11.1 F 
1.55 9.8 F 
1.35 11.7 M 
1.37 10.0 M 
1.26 10.9 M 
1.35 -« 
1.19 4 12-15-87 12.7 F 
1.20 14.6 M 
1.35 13.0 M 
1.25 14.1 M 
1.10 
1.38 
1.24 
1.15 
1.29 6 12-23-87 10.9 F 
1.30 12.3 F 
1.23 9.9 F 
1.36 13.3 M 
1.32 12.9 M 
1.40 11.8 M 
1.25 5 12-28-87 10.9 F 
1.34 12.1 F 
1.35 13.1 M 
1.32 12.6 M 
1.50 13.4 M 
1.50 3 12-30-87 10.9 F 
1.40 10.7 F 
1.35 12.9 H 
1.34 3 1-2-88 11.2 F 
1.32 10.1 F 
•F = female mouse at weaning. 
= male mouse at weaning, 
cpups died before weaning. 
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Table 72. (continued) 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1.28 13.4  M 
1.23 
2 3 5 12-11-87 1.25 4 1-7-88 12.1 F 
1.21 13.3 F 
1.20 13.4 F 
1.26 14.1 F 
1.21 15.6 M 
1 3 9 12-20-87 1.30 18 1-14-88 9.4 F 
1.29 10.3 F 
1.25 9.5 F 
1.31 9.9 F 
1.55 10.3 F 
1.37 10.4 F 
1.26 11.1 F 
1.21 12.2 M 
1.25 13.1 M 
1 4 9 12-22-87 1.31 11.3 M 
1.33 12.2 M 
1.33 10.3 M 
1.31 11.3 H 
1.33 10.3 M 
1.30 10.9 M 
1.20 11.4 M 
1.30 9.3 M 
1.35 11.5 M 
2 4 8 12-22-87 1.30 8 1-18-88 9.8 F 
1.29 10.1 F 
1.29 10.2 M 
1.28 12.2 M 
1.35 12.5 M 
1.38 11.9 M 
1.40 11.5 M 
1.31 10.9 M 
4 2 7 12-24-87 1.34 7 1-19-88 9.9 F 
1.45 10.2 F 
1.26 13.3 F 
1.34 12.9 M 
1.30 13.4 M 
1.38 13.2 M 
1.28 12.9 H 
3 3 8 12-28-87 1.34 8 1-22-88 8.5 F 
1.35 10.7 F 
Table 72. (continued) 
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Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1.29 9.9 F 
1.37 11.4 F 
1.24 10.9 M 
1.19 13.2 M 
1.09 12.6 M 
1.28 13.4 M 
1-2-88 1.23 5 1-28-88 10.1 F 
1.55 10.5 F 
1.34 10.9 M 
1.29 11.4 M 
1.33 10.1 M 
1-12-88 1.34 5 2-9-88 10.8 F 
1.28 10.1 F 
1.24 13.1 H 
1.25 12.6 M 
1.27 13.1 M 
1.26 
1-19-88 1.28 4 2-12-88 10.9 F 
1.23 10.1 F 
1.30 13.1 M 
1.19 12.6 M 
1-19-88 1.32 5 2-15-88 10.1 F 
1.29 8.7 F 
1.23 12.9 F 
1.26 13.1 M 
1.29 13.9 M 
2-4-88 1.35 4 2-29-88 10.1 F 
1.29 12.1 F 
1.27 13.1 M 
1.34 14.5 M 
1.19 
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Table 73. B6.K2 9X B6.K1^ litter record 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1 1 10 11-6-87 1.30 10 12-1-87 11.4 F« 
1.35 10.9 F 
1.37 11.2 F 
1.34 11.8 Mb 
1.40 12.8 M 
1.50 11.9 M 
1.42 11.8 M 
1.37 11.7 M 
1.29 11.5 H 
1.29 12.0 M 
2 1 7 11-20-87 1.26 7 12-18-87 10.5 F 
1.27 12.0 F 
1.27 10.9 F 
1.30 13.3 H 
1.42 15.0 M 
1.33 13.2 H 
1.39 13.3 M 
4 1 5 11-27-87 1.32 5 12-19-87 10.1 F 
1.26 12.1 F 
1.27 13.0 F 
1.27 14.5 M 
1.40 12.1 M 
3 1 6 11-30-87 1.20 6 12-21-87 12.1 F 
1.19 10.1 F 
1.34 10.8 F 
1.34 13.1 M 
1.20 13.8 M 
1.28 13.5 M 
1 2 9 12-1-87 1.29 8 12-22-87 9.5 F 
1.34 9.2 F 
1.50 12.7 F 
1.40 10.2 F 
1.57 8.9 F 
1.35 11.6 M 
•F = female mouse at weaning. 
"M = male mouse at weaning. 
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Table 73. (continued) 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1.45 10.0 M 
1.40 12.9 M 
1.42 -e 
3 8 12-1-87 1.30 8 12-22-87 11.3 F 
1.35 11.3 F 
1.29 10.4 F 
1.40 11.1 F 
1.19 12.9 F 
1.35 10.3 H 
1.30 11.9 H 
1.31 12.9 M 
2 4 12-2-87 1.30 4 12-28-87 12.1 F 
1.34 9.9 F 
1.23 11.1 H 
1.45 13.1 M 
2 8 12-4-87 1.34 7 12-28-87 10.1 F 
1.50 9.7 F 
1.24 8.8 F 
1.39 12.3 M 
1.34 13.1 M 
1.35 13.9 M 
1.30 13.7 M 
1.28 
2 8 12-7-87 1.26 8 12-28-87 10.9 F 
1.10 11.2 F 
1.40 9.8 F 
1.20 8.5 F 
1.37 12.9 M 
1.36 13.1 M 
1.29 14.5 M 
1.29 13.0 M 
4 6 12-22-87 1.43 
1.49 
1.39 
1.31 
1.36 
1.29 
3 9 12-28-87 1.30 9 1-26-88 10.7 F 
1.29 10.2 F 
«Pup died before weaning. 
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Table 73. (continued) 
Cage Litter No. Pups Date BIrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
1.35 9.9 F 
1.38 12.1 F 
1.30 13.1 M 
1.33 13.0 M 
1.31 15.0 M 
1.34 13.5 H 
1.30 11.9 M 
3 3 7 1-5-88 1.30 7 2-1-88 8.8 F 
1.50 12.1 F 
1.29 12.8 F 
1.35 13.1 M 
1.45 13.2 M 
1.39 14.0 H 
1.38 13.0 M 
2 3 9 1-11-88 1.35 9 2-5-88 10.9 F 
1.40 12.0 F 
1.32 9.8 F 
1.43 11.2 F 
1.20 10.0 F 
1.19 12.9 M 
1.20 13.1 H 
1.45 11.1 M 
1.35 12.9 M 
1 5 9 1-12-88 1.51 9 2-10-88 10.1 F 
1.29 12.0 F 
1.32 10.1 F 
1.25 10.8 F 
1.37 11.0 F 
1.32 13.4 H 
1.41 12.9 H 
1.31 14.4 M 
1.35 13.1 M 
1 6 8 1-13-88 1.30 8 2-10-88 10.1 F 
1.35 8.8 F 
1.29 12.1 F 
1.40 10.8 F 
1.19 12.4 M 
1.35 13.5 M 
1.30 12.6 H 
1.31 14.1 M 
4 4 6 1-13-88 1.30 6 2-10-88 12.1 F 
1.39 10.8 F 
1.40 13.1 F 
Table 73. (continued) 
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Cage Litter No. Pups Date BlrthWt No. Pups Date Weaning 
# # Born Born (g) Weaned Weaned Wt (g) 
3 4 9 1-19-88 
3 5 6 2-1-88 
1.39 9.9 F 
1.29 13.4 M 
1.19 15.0 M 
1.30 9.9 F 
1.40 10.1 F 
1.39 13.1 F 
1.38 10.7 F 
1.39 12.9 F 
1.29 13.0 M 
1.30 13.5 M 
1.34 14.0 M 
1.35 13.9 M 
1.33 5 2-26-88 10.3 F 
1.39 12.5 F 
1.29 13.4 F 
1.39 13.4 M 
1.45 15.6 M 
1.35 -
